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Abstract
Alterations in the composition of commensal bacterial communities in the human intestine are associated
with enhanced susceptibility to multiple inflammatory diseases. Further, studies in murine model systems
have demonstrated that signals derived from commensal bacteria can influence immune cell development,
function and homeostatic regulation within the intestinal environment, leading to altered host susceptibility
to infectious or inflammatory diseases. However, whether commensal bacteria-derived signals regulate
protective immunity to viral pathogens that infect sites outside of the gastrointestinal microenvironment
remain poorly understood. Chapter 2 of this thesis examines this question and demonstrates that disruption
or absence of commensal bacterial communities results in impaired protective immunity to respiratory
influenza virus. Antibiotic (ABX)-mediated disruption of intestinal commensal bacteria significantly impaired
the innate and adaptive immune response, abrogated viral clearance and increased host mortality following
influenza virus infection indicating a crucial role for commensal bacterial communities in regulating antiviral
immune defense. Chapter 3 interrogates the influence of commensal bacteria-derived signals on the antiviral
immune response to systemic viral infection. Following infection with Lymphocytic Choriomeningitis virus
(LCMV), ABX-treated mice exhibited functionally impaired LCMV-specific CD4 and CD8 T cell responses
that correlated with significantly delayed viral clearance. Collectively, Chapters 2 and 3 indicate a global role
for commensal bacteria-derived signals in regulating immunity to mucosal or systemic viral infection. Chapter
4 examines the mechanisms underlying commensal bacteria regulation of antiviral immunity and identifies a
previously unrecognized role for commensal bacteria-derived signals in establishing the activation threshold
of the innate immune system. Genome-wide transcriptional profiling of macrophages isolated from ABX-
treated mice revealed decreased expression of genes associated with antiviral immunity. Moreover,
macrophages isolated from ABX-treated mice prior to viral infection exhibited defective responses to type I/II
IFNs and a reduced capacity to limit viral replication. Strikingly, adoptive transfer of macrophages from CNV
mice into ABX-treated mice prior to LCMV infection resulted in significantly improved virus-specific adaptive
immune responses and effectively restored the ability of ABX-treated mice to control viremia. Taken together,
the results presented in this thesis indicate that commensal bacteria-derived signals calibrate the activation
threshold of the innate immune system, providing tonic immune stimulation essential for optimal antiviral
immunity.
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ABSTRACT 
COMMENSAL BACTERIAL COMMUNITIES REGULATE ANTIVIRAL IMMUNITY 
 
Michael Christopher Abt 
 
David Artis, PhD 
Alterations in the composition of commensal bacterial communities in the human 
intestine are associated with enhanced susceptibility to multiple inflammatory diseases. 
Further, studies in murine model systems have demonstrated that signals derived from 
commensal bacteria can influence immune cell development, function and homeostatic 
regulation within the intestinal environment, leading to altered host susceptibility to 
infectious or inflammatory diseases. However, whether commensal bacteria-derived 
signals regulate protective immunity to viral pathogens that infect sites outside of the 
gastrointestinal microenvironment remain poorly understood. Chapter 2 of this thesis 
examines this question and demonstrates that disruption or absence of commensal 
bacterial communities results in impaired protective immunity to respiratory influenza 
virus. Antibiotic (ABX)-mediated disruption of intestinal commensal bacteria significantly 
impaired the innate and adaptive immune response, abrogated viral clearance and 
increased host mortality following influenza virus infection indicating a crucial role for 
commensal bacterial communities in regulating antiviral immune defense. Chapter 3 
interrogates the influence of commensal bacteria-derived signals on the antiviral immune 
response to systemic viral infection. Following infection with Lymphocytic 
Choriomeningitis virus (LCMV), ABX-treated mice exhibited functionally impaired LCMV-
specific CD4 and CD8 T cell responses that correlated with significantly delayed viral 
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clearance. Collectively, Chapters 2 and 3 indicate a global role for commensal bacteria-
derived signals in regulating immunity to mucosal or systemic viral infection. Chapter 4 
examines the mechanisms underlying commensal bacteria regulation of antiviral 
immunity and identifies a previously unrecognized role for commensal bacteria-derived 
signals in establishing the activation threshold of the innate immune system. Genome-
wide transcriptional profiling of macrophages isolated from ABX-treated mice revealed 
decreased expression of genes associated with antiviral immunity. Moreover, 
macrophages isolated from ABX-treated mice prior to viral infection exhibited defective 
responses to type I/II IFNs and a reduced capacity to limit viral replication. Strikingly, 
adoptive transfer of macrophages from CNV mice into ABX-treated mice prior to LCMV 
infection resulted in significantly improved virus-specific adaptive immune responses and 
effectively restored the ability of ABX-treated mice to control viremia. Taken together, the 
results presented in this thesis indicate that commensal bacteria-derived signals 
calibrate the activation threshold of the innate immune system, providing tonic immune 
stimulation essential for optimal antiviral immunity.  
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Chapter 1 
Introduction 
1.1 Commensal bacterial communities in health and disease 
All mammals are born sterile, but colonization with beneficial microbial species begins 
soon after birth (Dethlefsen et al., 2007; Ley et al., 2006a). Commensal microbial 
communities colonize host organisms at multiple barrier surfaces including the skin, 
mouth, nasopharynx, vaginal, and gastrointestinal tract, and establish a symbiotic 
relationship with the host organism. (Clemente et al., 2012; Ley et al., 2006a; Round and 
Mazmanian, 2009). These microorganisms have an important role in host nutrition by 
breaking down food by-products and producing essential vitamins. Commensal microbes 
also have a passive role in host defense by competing with other potentially pathogenic 
organisms for space and resources in the gut microenvironment (Hooper and Gordon, 
2001; Smith et al., 2007). Dysbiosis of commensal microbial communities, however, is 
associated with various disease states such as obesity (Turnbaugh et al., 2006), 
inflammatory bowl disease (Ott et al., 2004), and atopic disorders (Marra et al., 2009). 
These clinical observations highlight the need to better understand how commensal 
microbial communities shape human health and susceptibility to disease.  
1.1.1 Composition of intestinal commensal bacterial communities 
Intestinal commensal microbial communities are comprised of bacteria, fungi, protozoa, 
and viruses that inhabit the gastrointestinal tract (Breitbart et al., 2003; Ley et al., 2006a; 
Scupham et al., 2006). The bacterial component of these microbial communities is the 
most well defined and studied. A large degree of diversity of bacterial species is found 
throughout the intestine with the lowest total concentration of microbes found in the 
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duodenum and steadily increasing until the peak density of 1011 -1012 colony forming 
units (CFU) /mL of luminal content in the proximal large intestine (Marteau et al., 2001; 
Savage, 1977). Culture-based identification of the bacterial species residing in the 
human intestine have identified members of the Lactobacilli, Streptococci and 
Bacteroides genera, however, these techniques are limited because the majority of 
commensal bacterial species do not grow using current laboratory techniques 
(Adlerberth and Wold, 2009; Dubos et al., 1965). Use of high-throughput sequencing 
technology has expanded the ability to identify both culturable and non-culturable 
bacterial species residing in the human intestine and current estimates of total diversity 
range between 15,000 and 36,000 species (Frank et al., 2007). The majority of these 
bacteria belong to the Bacteroidetes (~68%) and Firmicutes (~31%) phyla, with smaller 
percentages from the Proteobacteria, Actinobacteria, Deferribacteres, and Tenericutes 
phyla (Figure 1) (Eckburg et al., 2005; Hayashi et al., 2002; Wang et al., 2003). Intestinal 
commensal bacteria exhibit spatial diversity along the intestinal tract with some classes 
of bacteria preferentially residing either in the lumen or the mucus that coats the apical 
surface of intestinal epithelial cells (Hill and Artis, 2010). Due to proximity, mucosal-
associated bacteria are more likely to interact with host cells. Therefore, the location of 
colonization is likely to be equally, or more important in influencing intestinal 
homeostasis as total quantity of particular bacterial species. 
1.1.2 Commensal bacterial communities and human disease 
Alterations in the composition of intestinal commensal bacterial communities have been 
linked with several human diseases. The occurrence of obesity in both mice and humans 
has been associated with a decrease in the frequency of Bacteroidetes and an increase 
among Firmicutes (Turnbaugh et al., 2006). The shift in the Bacteroidetes/Firmicutes 
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ratio increases the ability of the commensal bacteria to break down indigestible fiber into 
short-chain fatty acids (SCFA), thus providing an additional energy source that is 
capable of being converted into fat. (Ley et al., 2006b; Schwiertz et al., 2008). In addition 
to obesity, clinical evidence has linked commensal bacteria to the unregulated immune 
responses observed in inflammatory bowel diseases (IBD) such as Crohn’s disease (De 
Hertogh et al., 2006; Dicksved et al., 2008), ulcerative colitis (Rutgeerts et al., 2005), 
and coeliac disease (Tlaskalova-Hogenova et al., 2004), as well as colon cancer (Karin 
et al., 2006; Moore and Moore, 1995). Clinical investigations into the etiology of intestinal 
inflammatory disease has revealed decreased species diversity within the patients’ 
intestinal commensal bacterial community (Ott et al., 2004) and aberrant immune 
responses such as IgG antibody production (Macpherson et al., 1996), T cell activation 
(Duchmann et al., 1995), and proinflammatory cytokine secretion (Medina et al., 2008) in 
response to bacteria found within the intestine. Furthermore, deliberate manipulation of 
commensal bacterial using antibiotics or diversion of the fecal stream away from the 
inflamed portion of the intestine has been moderately successful in treating Crohn’s 
disease, thus strengthening the link between commensal bacterial communities and 
intestinal inflammation (Casellas et al., 1998; D'Haens et al., 1998; Rutgeerts et al., 
1991; Sartor, 2004).  
Perturbations of commensal bacterial communities have also been linked to other 
dysregulated inflammatory diseases at sites outside of the intestine, such as asthma and 
other atopic disorders (Penders et al., 2007a). In particular, there is a strong correlation 
between treating infants with multiple rounds of antibiotics and the development of 
asthma (Kozyrskyj et al., 2007; Marra et al., 2009). The presence of particular bacterial 
species in the intestine, such as Bifidobacterium pseudocatenulatum, Clostridium 
  4 
difficile, and Escherichia coli are also associated with increased cases of eczema (Gore 
et al., 2008; Penders et al., 2007b). Because of the correlation between altered 
commensal bacterial communities and inflammatory diseases, administration of 
“probiotic” bacterial species has been employed to prevent or ameliorate certain atopic 
and intestinal inflammatory diseases (Gionchetti et al., 2000; Hart et al., 2003; Hedin et 
al., 2007; Kukkonen et al., 2007; Mimura et al., 2004). Despite encouraging results, the 
full potential of probiotic therapy may not be realized until the mechanisms by which 
commensal bacterial communities shape the immune responses that drive these 
inflammatory diseases are understood.  
1.2 Commensal bacterial communities and the immune system 
Associations between commensal bacterial communities and human inflammatory 
diseases have implicated commensal bacteria-derived signals in shaping the immune 
responses that drive pathogenesis. Studies using murine model systems demonstrate 
that manipulation of commensal bacteria can alter mammalian immune cell homeostasis 
and specific commensal bacteria-derived signals have been identified that can impact 
immune cell function both within the intestinal tract and in peripheral tissues (Littman and 
Pamer, 2011; Macpherson and Harris, 2004). These commensal bacteria-derived 
signals can either have an immunoregulatory effect, creating a state that is refractory to 
inflammation, or conversely, act as an adjuvant, aiding in the propagation of an immune 
response. Innate immune cells responding to commensal bacterial-derived signaling can 
modulate both the local and systemic immune response (Honda and Littman, 2012; 
Littman and Pamer, 2011; Round and Mazmanian, 2009). This section will discuss the 
  5 
mechanisms through which commensal bacterial communities shape the host immune 
system.  
1.2.1 Impact of commensal bacterial communities on immune system 
development and homeostasis 
The commensal bacterial communities of the mammalian gastrointestinal tract are 
integral in shaping the development and function of the immune system. Mouse models 
enable the manipulation of the commensal bacterial communities and systematic 
investigation of how commensal bacteria influence immune responses of the host. 
Studies employing mice lacking bacterial communities (germ-free) demonstrate the need 
for commensal bacteria-derived signals in the development of gut-associated lymphoid 
tissues (GALT). Germ-free (GF) mice have fewer Peyer’s patches along the small 
intestine and the mesenteric lymph nodes of these mice have decreased cellularity 
(Smith et al., 2007). Further, commensal bacteria-derived signals have been shown to 
stimulate intestinal epithelial cells (IECs) to stimulate production of cytokines that foster 
lymphoid tissue genesis (Bouskra et al., 2008). Defective development of lymphoid 
architecture is not limited to the GALT as the spleen of GF mice lack germinal centers 
and have poorly formed T and B cell zones (Macpherson and Harris, 2004).  
Loss of commensal bacteria signaling alters the distribution, activation level, 
differentiation status, and inflammatory profile of dendritic cells, macrophages, NK cells, 
B cells, CD4 and CD8 T cells, both within the GALT and at distal sites within the host 
(Hill and Artis, 2010; Macpherson and Harris, 2004). GF mice exhibited fewer intestinal 
dendritic cells (DCs) (Williams et al., 2006), intraepithelial lymphocytes (Smith et al., 
2007), lamina propria CD4+ T cells (Macpherson and Harris, 2004), and IgA+ B cells 
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(Macpherson et al., 2001). These inherent developmental defects in GF mice make it 
challenging to parse out the cause of altered immune cell function and have been the 
motivating factor to develop complementary methods to study the impact of commensal 
bacterial communities on immune cell function at steady-state.  
Manipulation of commensal bacterial communities in mice reared in a conventional 
environment via antibiotic (ABX) treatment has demonstrated that commensal bacteria 
influence intestinal immune cell homeostasis even after the developmental stage. An 
example that illustrates this paradigm of interactions between commensal bacteria and 
immune cell populations is the role commensal bacteria have in influencing CD4 T cell 
differentiation in the intestinal lamina propria. GF mice exhibit fewer CD4 T helper 17 
(TH17) cells in the lamina propria of the small intestine compared to conventionally 
reared (CNV) mice (Atarashi et al., 2008; Niess et al., 2008). In addition to GF studies, 
selective depletion of commensal bacterial communities by oral administration with a 
specific antibiotic (vancomycin) also results in reduced percentage of TH17 cells in the 
lamina propria of the small intestine (Ivanov et al., 2008). The commensal bacteria, 
Segmented Filamentous Bacteria (SFB), were identified to be the driving factor in 
promoting the development of CD4 TH17 cells. The mechanisms through which SFB 
promotes of CD4 TH17 cell differentiation is believed to involve conditioning of DCs by 
Serum amyloid A, which promote differentiation into a RORγt+ TH17 lineage in CD4 T 
cells (Ivanov et al., 2009). As will be discussed in further detail later in Section 1.2.5, the 
induction of CD4 TH 17 cells by SFB has significant physiological consequences in 
immune homeostasis. While SFB can promote CD4 TH17 cell differentiation, another 
class of commensal bacteria, Clostridia, promotes CD4 T cells in the intestine to a T 
regulatory cell fate (Atarashi et al., 2011). These observations emphasize that signals 
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from distinct bacterial species can have a differential role in influencing the immune cell 
development within the intestine. 
Use of the GF mouse system has been critical in demonstrating a role for bacteria in 
the induction and propagation of intestinal inflammation. Production of inflammatory 
cytokines in the intestine is a hallmark characteristic of IBD and is believed to be driven 
by commensal bacteria stimulation (Duchmann et al., 1995; Fiocchi, 1998; Frank et al., 
2007; Kaser et al., 2010). Several transgenic mouse strains that are defective in 
immunoregulatory mechanisms, such as IL-10 production (Kuhn et al., 1993) or 
regulatory T cell development (Sadlack et al., 1993) spontaneously produce 
inflammatory cytokines in the intestine and develop intestinal inflammation. When re-
derived into a sterile, germ-free environment, however, these mouse strains no longer 
exhibit spontaneous disease, supporting the link between commensal bacteria and 
intestinal inflammation (Dianda et al., 1997; Schultz et al., 1999; Sellon et al., 1998). 
Furthermore, it has been demonstrated that transfer of colitis-inducing bacterial species 
from a genetically susceptible host into wild type recipients can initiate disease (Elinav et 
al., 2011; Garrett et al., 2010a; Garrett et al., 2007). Thus certain bacterial species are 
capable of inducing intestinal inflammation in otherwise healthy hosts. Conversely, 
probiotic bacterial species can ameliorate intestinal inflammation and disease (Dieleman 
et al., 2003; Round and Mazmanian, 2010). These divergent effects of commensal 
bacterial species on intestinal homeostasis highlight the need to understanding how 
commensal bacteria are detected by intestinal immune and non-immune cell 
populations. 
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1.2.2 Recognition of commensal bacteria-derived signals in the intestine 
The immune system within the GALT must be able to initiate an appropriate immune 
response against invading pathogens yet remain hypo-responsive to bacterial signals 
from the commensal bacteria. The resulting balance between proinflammatory and 
immunoregulatory signals is thought to be dependent on the context in which the 
bacterial signals are recognized. DCs are a key cell type that modulates the immune 
response within the intestine (Coombes and Powrie, 2008; Jaensson et al., 2008; Sun et 
al., 2007). DCs within the intestine are exposed to bacterial products via M cell antigen 
sampling within Peyer’s patches or directly by extending dendrites between tight 
junctions of IECs and into the intestinal lumen (Mach et al., 2005; Milling et al., 2005; 
Niess et al., 2005; Rescigno et al., 2001). Intestinal DCs are capable of phagocytizing 
live bacteria then migrating into the mesenteric lymph nodes to present commensal 
bacteria antigen to resident T and B cells (Macpherson and Uhr, 2004). This process is 
thought to be important in driving production of commensal bacteria specific IgA.  DCs 
express a wide range of pattern recognition receptors (PRRs) that can be activated by 
microbial products. PRRs expressed by DCs include members of the transmembrane 
toll-like receptor (TLR) family and the intracellularly residing nucleotide-binding 
oligomerization domain (NOD) like receptors (NLRs) (Iwasaki and Medzhitov, 2004; 
Medzhitov, 2007). Pathogen-associated molecular patterns (PAMPs) directly stimulate 
TLRs or NLRs leading to activation of the conserved Nuclear factor kappa B (NFκB), 
mitogen-activating pathway kinase (MAPK), and inflammasome signaling pathways 
resulting in the expression of a proinflammatory gene profile characterized by cytokines 
such as IL-12, IL-1β, and type I interferons (Akira and Takeda, 2004; Franchi et al., 
2009; Girardin et al., 2003a; Girardin et al., 2003b; Strober et al., 2006). However, not all 
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DC/PAMP interactions in the intestine result in proinflammatory immune responses. 
Stimulation of intestinal DCs with the TLR4 ligand, lipopolysacchride (LPS), does not 
result in costimulatory molecule upregulation or IL-12p70 expression as is normally seen 
with DCs derived from other tissues of the body. Instead, LPS stimulation results in 
elevated IL-10 production by intestinal DCs (Cerovic et al., 2009; Monteleone et al., 
2008; Takenaka et al., 2007). In addition, NOD2 signaling has been shown to negatively 
regulate TLR2 activation of the NFκB pathway and thereby attenuate expression of TH1 
associated cytokines IL-12, and IFN-γ (Watanabe et al., 2004; Yang et al., 2007).  
The intestinal epithelium maintains a physical barrier between the commensal bacteria 
of the intestinal environment and the host. Located at this host/bacteria interface, IECs 
experience constant, direct exposure from commensal bacterial communities and are 
therefore in a position to sense and respond to commensal bacteria. IECs can express 
TLRs and NOD receptors that sense bacterial stimuli (Fritz et al., 2006; Hisamatsu et al., 
2003; Medzhitov, 2007), though the anatomical location of these PRRs may be an 
important factor in determining responsiveness of IECs to bacterial stimulation. For 
example, TLR5, which recognizes bacterial flagellin, is only expressed on the basolateral 
surface of IECs, and therefore sequestered from bacterial contact on the apical surface 
of the cell (Gewirtz et al., 2001). Other cell membrane-associated PRRs, such as TLR2 
and 4 are expressed at low or undetectable levels in IECs (Abreu et al., 2001; Melmed et 
al., 2003) while endosomally or cytosolically located PRRs, such as TLR3,7,8,9 and 
NOD protein are expressed at higher levels in IECs (Medzhitov, 2007). Commensal 
bacteria-derived signaling in IECs via these PRRs influence intestinal immune cell 
development and are critical in maintaining homeostasis (Bouskra et al., 2008; 
Hasegawa et al., 2006; Nenci et al., 2007; Rakoff-Nahoum et al., 2004; Zaph et al., 
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2007). Commensal bacteria-derived signals acting upon IECs can induce an 
immunoregulatory environment characterized by cytokines such as IL-10, TGF-β, TSLP, 
and IL-25, which modulate DC, macrophage, T and B cell activation (Figure 2) (Dignass 
and Podolsky, 1993; He et al., 2007; Rimoldi et al., 2005a; Taylor et al., 2009; Zeuthen 
et al., 2008). Similar to DCs, PRR activation in IECs by invading pathogens can also 
elicit a proinflammatory response that is important in initiating the intestinal immune 
response to infection (Zilbauer et al., 2007). Thus IECs exhibits a PRR expression profile 
that limits continuous proinflammatory stimulation, but is poised to respond to invasive 
pathogens upon breakdown of the epithelial barrier. Therefore, while cells within the 
intestinal compartment express TLR and NOD receptors and the ligands for these PRRs 
are found within commensal bacterial communities, the outcome of PAMP/PRR 
interactions is dependent upon the context in which they occur. Recent work has 
elucidated several specific commensal bacteria-derived signals that can activate TLR or 
NOD signaling and influence immune cell homeostasis. These can be broadly 
categorized into signals that have an immunoregulatory effect or signals that promote 
proinflammatory immune responses. 
1.2.3 Immunoregulatory signals derived from commensal bacterial communities 
Commensal bacteria appear to be integral in inducing an immunoregulatory environment 
within the intestine. GF mice were reported to have reduced expression of IL-25 in the 
large intestine, an immunoregulatory cytokine involved in driving type 2 immune 
responses (Saenz et al., 2008; Zaph et al., 2008). Further, Clostridium species have 
been reported to induce accumulation of IL-10 producing Foxp3+ CD4 regulatory T cells 
in the lamina propria of the colon (Atarashi et al., 2011). Medzhitov and colleagues 
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implicate the commensal bacteria-derived signals LPS or lipoteichoic acid (LTA) in 
regulating intestinal immune homeostasis via TLR4 and TLR2 signaling, respectively. In 
this study, mice depleted of commensal bacterial communities by antibiotics display 
exacerbated intestinal inflammation and increased mortality following administration of 
dextran sodium sulfate (DSS) in the drinking water, a chemically-induced colitis model 
(Rakoff-Nahoum et al., 2004). However, ABX-treated mice, subsequently treated with 
LPS, were able to limit intestinal inflammation and recover from chemically-induced 
colitis (Rakoff-Nahoum et al., 2004). Subsequent studies have identified commensal 
bacteria-mediated protection to be dependent on MyD88-mediated TLR signaling on 
hematopoietic cells, particularly intestinal B cells (Kirkland et al., 2012; Rakoff-Nahoum 
et al., 2006). These results indicate that commensal bacterial communities can modulate 
intestinal inflammation and that a specific bacterial product can orchestrate these 
immunoregulatory effects in the absence of living commensal bacteria.  
Although TLR ligands have been predominantly shown to activate a proinflammatory 
response, TLR activation is capable of dampening an inflammatory response under 
certain conditions. A series of studies have demonstrated that signaling through TLR2 by 
polysaccharide A (PSA) could induce an environment refractive to inflammation. A 
unique form of PSA, specific to Bacteroides fragilis, induces an immunoregulatory 
phenotype in CD4 T cells that was highlighted by elevated production of the 
immunoregulatory cytokine IL-10 (Mazmanian et al., 2005; Mazmanian et al., 2008; 
Wang et al., 2006). Treatment with PSA isolated from Bacteroides fragilis prevents the 
induction of Helicobacter hepaticus-induced colitis, indicating that a single commensal 
bacteria-derived molecule can influence the immune response within the intestinal 
environment.  
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In addition to TLR ligands, commensal bacteria provide other signaling molecules that 
modulate the intestinal immune network and prevent pathologic inflammation. The 
NOD2 ligand muramyl dipeptide (MDP), a component of bacterial peptidoglycan, was 
found to negatively regulate the production of IL-12p40, IL-6 and TNF-α by DCs in vitro 
(Watanabe et al., 2008). Furthermore, in vivo administration of MDP resulted in a 
diminished proinflammatory cytokine profile of colonic lymphocytes and was able to 
protect against trinitrobenzene sulfonic acid (TNBS) induced colitis (Watanabe et al., 
2008). Van Kooyk and colleagues described a specific surface layer A protein (SlpA) 
present on the intestinal bacterial specie Lactobacillus acidophilus NCFM that enables 
bacterial binding to dendritic cells resulting in the production of IL-10 and inhibition IL-
12p70 (Konstantinov et al., 2008).  Also, butyrate, a SCFA byproduct of intestinal 
bacteria fermentation of dietary fibers (Roediger, 1980), has been shown to be a major 
energy source of colonic epithelial cells and can reduce the expression of TNF-α, TNF-β, 
IL-6 and IL-1β in lamina propria lymphocytes via NFκB inhibition in Crohn’s and 
ulcerative colitis patients (Luhrs et al., 2002; Segain et al., 2000). SCFA, via binding and 
signaling through the G-protein receptor 43 (GPR43) has been shown to limit 
inflammatory response (Le Poul et al., 2003; Maslowski et al., 2009). Mice deficient in 
GPR43 exhibited exacerbated intestinal inflammation following treatment with DSS. 
Similarly, GF mice, which lack the bacteria to break down fiber into SCFA also exhibited 
increased weight loss and rectal bleeding following DSS administration (Maslowski et al., 
2009). Treatment of these GF mice with acetate in the water to supplement SCFA 
deficiency markedly diminished disease severity and proinflammatory cytokine levels in 
the intestine, demonstrating that a commensal bacteria-derived metabolite could limit 
inflammatory responses and disease progression (Maslowski et al., 2009). Each of these 
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commensal bacteria-derived products described in this section is a potential conduit 
through which the intestinal commensal bacteria can regulate the immune system. 
1.2.4 Proinflammatory signals derived from commensal bacterial communities 
Although signals from commensal bacterial communities can help establish an 
immunoregulatory environment, there is also evidence from human and mouse studies 
linking commensal bacteria to promotion of intestinal inflammatory diseases. As 
described in Section 1.2.1, GF and ABX-treated mouse studies have demonstrated the 
role for commensal bacteria in dictating the balance between proinflammatory TH17 and 
regulatory T cells populating the GALT (Atarashi et al., 2008; Ivanov et al., 2008; Niess 
et al., 2008). Takeda and colleagues attributed this capability to bacterial-derived ATP 
preferentially inducing TH17 CD4+ T cells. ATP was shown to act on a population of 
CD70high CD11clow accessory cells that express P2X receptors, a family of ATP-binding 
receptors. ATP stimulation induced these cells to express IL-6 and IL-23p19, cytokines 
that can promote TH17 cell development and survival(Atarashi et al., 2008). In addition to 
ATP, several commensal bacterial species have been demonstrated to have 
proinflammatory properties. Klebsiella pneumoniae and Proteus mirabilis were identified 
by high-throughput sequence screening of intestinal bacterial communities from the T-
bet-/- x Rag2-/- ulcerative colitis (TRUC) mouse model. These commensal bacterial 
species could elicit intestinal inflammation when transferred to wild type or Rag2-/- 
recipients (Garrett et al., 2010a). In another study, commensal bacterial species 
Bacteroides vulgatus and Bacteroides thetaiotaomicron isolated from the intestine 
bacterial communities of a Il10r2, Tgrbr2 double knockout mice, an IBD-susceptible 
mouse strain, induced spontaneous intestinal inflammation where as Enterobacteriaceae 
species identified from the same IBD-susceptible mice did not elicit onset of disease 
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(Bloom et al., 2011). While these studies have identified particular bacterial species that 
can elicit proinflammatory effects on the host, the specific bacterial products and 
mechanism of action by which these commensal bacterial species have proinflammatory 
effects remains poorly defined. This gap in knowledge highlights the need to identify 
specific bacterial signals and the immune pathways that are activated by commensal 
bacteria.  
1.2.5 Commensal bacterial communities influence the systemic inflammatory 
immune response 
The effect of commensal bacterial communities on the immune system go beyond the 
intestine and have been shown to influence immune responses and cell populations at 
peripheral sites. For example, GF mice exhibit diminished proinflammatory cytokine 
responses to subcutaneous LPS injection or ischemic perfusion (Amaral et al., 2008; 
Souza et al., 2004). In addition, mice depleted of commensal bacterial communities via 
ABX treatment exhibit an exacerbated, TH2 cytokine mediated, allergic response to 
intranasal challenge OVA or house dust mite antigen (Hill et al., 2012; Noverr et al., 
2005). Furthermore, it was demonstrated that commensal bacterial communities were 
responsible for ameliorating the severity of spontaneous diabetes in MyD88-/- NOD mice 
(Wen et al., 2008). In addition, peptidoglycans derived from commensal bacteria were 
demonstrated to stimulate recruitment of bone marrow-derived neutrophils to the 
peritoneal cavity through the NOD1 receptor and enhance phagocytosis of bacteria 
(Clarke et al., 2010). Many of the bacterial species and products identified in regulating 
intestinal immune homeostasis also influence systemic immune responses to 
autoimmune inflammatory diseases. SFB, which can promote TH17 cell differentiation in 
the intestinal mucosa, can exacerbate TH17 dependent peripheral autoimmune 
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inflammatory disease such as arthritis, and experimental autoimmune encephalomyelitis 
(a murine model for multiple sclerosis) (Kriegel et al., 2011; Wu et al., 2010b). In addition 
to regulating intestinal inflammation, signaling through commensal bacteria-derived 
SCFA, can limit inflammatory immune responses in murine models of arthritis and 
asthma (Maslowski et al., 2009). This body of literature has been crucial in 
demonstrating that the commensal bacterial communities can influence the immune 
response in multiple tissues.  
The mechanism by which signals originating from the intestine have a systemic effect 
on the immune response remains unclear. One possible explanation is that bacterial 
products translocate across the intestinal epithelium and circulate throughout the host to 
stimulate the systemic immune system. In known incidences of bacterial translocation of 
commensal bacteria, mice exhibit elevated proinflammatory cytokines in the serum and 
spleen and increased expression of immune activation markers (Brenchley et al., 2006; 
Sonnenberg et al., 2012). Restifo and colleagues found that bacterial translocation of 
intestinal commensal bacteria had an adjuvant effect on the cytotoxic capability of tumor-
specific CD8 T cells (Paulos et al., 2007). Combined, these studies suggest that signals 
derived from bacteria within the intestine can aid in immune activation throughout the 
host. Whether commensal bacteria-derived signals are influencing the systemic immune 
system at steady-state, either via basal bacterial translocation or an alternative 
mechanism has yet to be examined and will be the focus of Chapter 4 of this thesis. 
1.2.6 Commensal bacterial communities influence the immune response to 
infection 
Commensal bacterial communities can also augment the immune response and aid in 
protective immunity against pathogenic infection. For example, SFB, described in 
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previous sections to exacerbate immune response in autoimmune inflammatory 
diseases, has a protective role following infection with a murine enteropathic bacterium, 
Citrobacter rodentium (Ivanov et al., 2009). Clearance of C. rodentium, which induces a 
robust TH17 immune response (Mangan et al., 2006), was enhanced in mice colonized 
with SFB, a commensal bacteria that drives CD4 TH17 cell differentiation (Ivanov et al., 
2009). In addition, following selective depletion of commensal bacterial communities with 
metronidazole, mice are more susceptible to Citrobacter infection, further indicating a 
role for commensal bacteria in host immunity (Wlodarska et al., 2011). Belkaid and 
colleagues reported that mice depleted of commensal bacterial communities with 
antibiotics had diminished IFN-γ and IL-17 production following infection with the 
intestinal parasite Encephalitozoon cunniculi. This diminished immune response 
correlated with a higher parasite burden compared to wild type mice. In this report, oral 
administration of the specific TLR ligand CpG, but not LPS, was sufficient to recapitulate 
the immune response in the ABX-treated mice and resulted in parasite clearance in a 
TLR9 dependent manner (Hall et al., 2008). ABX-mediated depletion of commensal 
bacteria also revealed a critical role for commensal bacteria in protective immunity 
following intestinal infection with Toxoplasma gondii, via commensal bacteria driven 
stimulation of intestinal DCs (Benson et al., 2009). Studies conducted using another 
intestinal pathogen, Salmonella enterica, found that ABX-treatment increased host 
susceptibility to Salmonella infection, characterized by increased bacterial translocation 
and intestinal inflammation (Croswell et al., 2009; Garner et al., 2009; Sekirov et al., 
2008). Susceptibility to infection-induced colitis persisted in mice for up to two weeks 
after termination of ABX treatment suggesting that enduring alterations in the 
composition of commensal bacterial communities may be responsible for the inability to 
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limit inflammation (Croswell et al., 2009). GF mice, which lack production of the 
commensal bacteria induced antimicrobial peptide RegyIII, also exhibit increased 
bacterial dissemination when orally challenged with Salmonella typhimurium (Vaishnava 
et al., 2008). In contrast to these studies demonstrating that commensal bacteria 
augment immunity to infection, commensal bacteria-derived signals can also suppress 
immune responses to the benefit of the pathogen. Two studies have demonstrated that 
enteric viral infections can use immunoregulatory signals from commensal bacteria to 
improve viral infectivity (Kane et al., 2011; Kuss et al., 2011).  Combined, these reports 
establish an important role for commensal bacterial communities in influencing the 
immune response following intestinal bacterial, parasitic, or viral infection.  
Few studies, however, have investigated the influence of commensal bacteria-derived 
signals on host immune responses to pathogens that infect tissues outside of the 
gastrointestinal tract. Early studies reported that GF mice were more susceptible to 
influenza A and coxsackie B viral infection (Dolowy and Muldoon, 1964; Schaffer et al., 
1963). However, these studies were limited in the immunological and pathological 
parameters examined and failed to address the underlying mechanisms for increased 
susceptibility. More recently, Oliveira and colleagues found that GF Swiss/NIH mice 
infected with Leishmania major failed to heal skin lesions and had increased parasite 
burden at 13 weeks post-infection (Oliveira et al., 2005). Impaired control of Leishmania 
in GF mice was attributed to defective macrophage activation and killing of the parasite 
(Oliveira et al., 2005). GF mice were also found to have increased susceptibility to 
Listeria monocytogenes infection due to impaired T cell homing to sites of infection 
(Inagaki et al., 1996). Another study by Tanaka and colleagues reported that GF mice 
infected with murine cytomegalovirus had a reduced virus-specific CD8 T cell response 
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in the lung compared to conventionally-reared (CNV) mice despite comparable viral 
levels (Tanaka et al., 2007). As described in section 1.2.1, GF mice have impaired 
development of the immune system. Therefore, the underlying cause of defective 
immune responses in GF mice to infection may be an underdeveloped immune system. 
To account for this possibility, antibiotics have been employed prior to infection to allow 
for normal immune development before disruption of commensal bacteria-derived 
signaling. Iwasaki and colleagues reported that antibiotic-mediated manipulation of 
commensal bacteria resulted in impaired adaptive immune responses to viral infection in 
the lung (Ichinohe et al., 2011). This effect was associated with defective activation of 
the inflammasome, a pathway activated by bacterial products that is also important in 
conferring protective immunity against a subset of viruses, including influenza virus and 
poxviruses (Lamkanfi and Dixit, 2011). This study indicates that commensal bacterial 
communities aid in the induction of the immune response to a non-intestinal, mucosal-
associated viral infection. Whether depletion of commensal bacteria selectively regulates 
inflammasome-dependent pathways or this observation represents broader 
immunological crosstalk mechanisms between commensal bacteria and other antiviral 
will be addressed in Chapters 2 and 3.  
1.3 Immune responses to viral infection 
Viruses consist of DNA or RNA encoding genes encapsulated by a protein and/or lipid 
coat to protect the genetic material (Alberts et al., 2002). A virus does not possess the 
capacity to replicate independently and therefore must gain entry into a cell to access 
the molecular machinery necessary to synthesize more copies of itself (Alberts et al., 
2002). The biological goal of a virus upon infection is to replicate without detection by the 
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host organism. Viral replication can cause stress and potentially death to the host cell as 
resources are diverted to replication of the virus causing accumulation of viral copies 
and rupture of the host cell membrane (Alberts et al., 2002). Higher order organisms 
have developed an immune system to rapidly detect and clear the virus from the host or, 
as is the case in persistent viral infections, control replication and limit virus-induced 
tissue damage. The immune system accomplishes this goal through the coordinated 
response of multiple specialized cells of the innate and adaptive immune system. This 
section will discuss the mechanisms of viral detection and the cells involved in the 
antiviral immune response. 
1.3.1 Recognition of viral pathogens by the immune system 
Detection of a viral infection by the immune system is primarily accomplished by distinct 
PRRs that are expressed by immune and non-immune cells and recognize PAMPs 
associated with viruses. Viral PRRs initiate a cascade of signaling events that lead to 
transcription of a gene program specified for antiviral defense (Seth et al., 2006). A virus 
must gain entry into a cell to establish infection and correspondingly most of the PRRs 
that detect viruses are located in the cytosol or endosomal compartments. TLRs consist 
of a extracellular domain of leucine rich repeats and a cytoplasmic Toll/Interleukin-1 
(TIR) signaling domain (Akira and Takeda, 2004). The leucine rich repeat region of the 
TLR contains the ligand binding domain of the receptor and provides specificity for 
PAMP recognition (Akira and Takeda, 2004). A subset of the TLRs (TLR 3,7,8, and 9) 
exhibit binding affinity for various viral derivatives and are expressed in the endosomal 
compartment of cells (Akira and Takeda, 2004). TLR3 recognizes double-stranded RNA 
and is expressed in most innate immune cells except of plasmacytoid DCs (pDCs) and 
neutrophils (Schroder and Bowie, 2005). Deficiency in TLR3 expression can lead to 
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decreased production of proinflammatory cytokines and has been shown to correlate 
with an impaired ability to suppress herpes simplex virus (Tabeta et al., 2004; Zhang et 
al., 2007). TLR7 and TLR8 share the same activating ligand, long single-stranded RNA, 
and both drive interferon alpha (IFN-α) production in pDCs (Heil et al., 2004; Lee et al., 
2007). Unmethylated CpG DNA motifs, a common feature found in both bacterial and 
viral genomes are the ligands for TLR9, and, therefore, TLR9 has a critical role in 
detecting infection by DNA viruses (Hemmi et al., 2000). For example, infection of Tlr9-/- 
mice with a DNA virus such as murine cytomegalovirus results in diminished induction of 
type I IFNs and increased mortality compared to wild-type controls (Tabeta et al., 2004). 
These endosomal TLRs represent one group of the PRRs that detect viral infection. 
Host cells have also evolved to detect viruses replicating in the cytoplasm with a family 
of cytosolic PRRs that sense intracellular nucleic acid. The two most well characterized 
cytoplasmic nucleic acid sensors of this recently described family are retinoic acid-
inducible gene (RIG-I) and melanoma differentiation-associated gene 5 (MDA5) 
(Thompson et al., 2011). Both of these proteins sense RNA in the cytoplasm, with RIG-I 
detecting 5’-triphosphorylated(Hornung et al., 2006; Pichlmair et al., 2006), uncapped 
single-strand RNA and MDA5 responding to long double-stranded RNA (Kato et al., 
2006). Ligand binding to these two PRRs leads to recruitment of mitochondrial antiviral 
signaling protein (MAVS) followed by activation of NFκB and interferon response factor 
(IRF) 3 and 7, which bind to the Ifnβ promoter and initiate transcription (Honda et al., 
2005; Kawai et al., 2005). Mice with genetic deletion of either RIG-I or MDA5 exhibit 
increased susceptibility to several viral infections including paramyxoviruses, influenza 
virus, Japanese encephalitis virus, and picornavirus, demonstrating the in vivo relevance 
of these PRRs in mounting protective antiviral immunity (Kato et al., 2006). In addition to 
  21 
RIG-I and MDA5, a growing list of RIG-I-like receptors have been identified and the 
importance of these receptors in antiviral defense are just starting to be understood 
(Thompson et al., 2011). Collectively, the main function of viral PRRs appears to be to 
detect virus inside a host cell and to rapidly initiate a gene program to limit viral 
replication and to trigger the immune system into action 
1.3.2 Type I IFNs are critical initiators of antiviral immunity 
The initial host cell response to viral infection leads to production of several 
proinflammatory factors including the type I IFN cytokine family. Type I IFNs, which were 
originally identified as a secreted factor that “interfered” with viral replication in culture 
(Isaacs and Lindenmann, 1957), are critical in defense against most viruses (Hwang et 
al., 1995; Muller et al., 1994). Type I IFNs coordinate the antiviral immune response in 
three distinct steps; i.) induction of a gene program to limit viral replication, ii.) activation 
innate immune cells, iii) drive CD4 and CD8 T cell differentiation and B cell antibody 
production (Figure 3).  
The Type I IFNs family consists of IFN-β (a single gene) and IFN-α (gene with multiple 
isoforms) and are direct downstream targets of PRRs signaling, such as RIG-I, MDA5 
and TLR3, as discussed in the previous section (Thompson et al., 2011). The cellular 
source of type I IFNs during a viral infection, in addition to the virus-infected cell itseIf, 
are innate immune cells such as pDCs and macrophages, which are stimulated via IFN 
signaling in a positive feedback manner to produce more type I IFNs (Jung et al., 2008; 
Kumagai et al., 2007). Production of type I IFNs from either of these cell types have 
been demonstrated to be critical in supporting the expansion of the antiviral immune 
response and control of viral infection (Jung et al., 2008; Kumagai et al., 2007). The type 
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I IFN receptor is composed of two subunits (IFNAR1 and IFNAR2) that are expressed 
ubiquitously in hematopoietic and non-hematopoietic cells and signal through Janus 
kinases prophorylation of the transcription factors STAT1 and STAT2 (Li et al., 1997). 
Phosphorylation of STAT1 and STAT2 results in formation of a heterodimer that 
associates with IRF9, forming a transcription factor complex (ISGF3), that translocates 
to the nucleus and initiates transcription of interferon response genes (IRG) (Trinchieri, 
2010). Ablation of type I IFN signaling has lead to well characterized impairments in host 
antiviral immunity to multiple viruses, highlighting the ubiquitous need for these cytokines 
in defense against viral infection (Moskophidis et al., 1994; Muller et al., 1994).  
Expression of IRGs following IFN signaling leads to induction of numerous defense 
mechanisms that make the cell refractory to viral replication. For example, IFN signaling 
leads to expression of a family of enzymes named 2’-5’ oligoadenylate synthases (OAS) 
that activate RNase L, an enzyme that degrades host and viral RNA and therefore limits 
viral replication as well as produces dsRNA for RIG-I/MDA5-mediated recognition and 
subsequent production of type I IFNs (Malathi et al., 2007; Stark et al., 1998). Other IFN-
inducible genes such as the Mx and PKR proteins have similar effects of inhibiting the 
replication process of the virus (Haller et al., 2007). Further, IFN signaling can cause 
infected cells to undergo apoptosis and therefore deny the virus access to the cellular 
machinery needed for self-replication (Stetson and Medzhitov, 2006). Programmed cell 
death via apoptosis also prevents viral-induced cell lysis and release of newly 
synthesized virus. Combined, these type I IFN driven mechanisms of prevention and 
containment represent the first line of defense against viruses.  
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1.3.3 Induction of the innate immune response to viral infection 
In response to viral infection the innate immune system is activated by detection of 
cytokines produced by virally infected host cells or cellular debris caused by virus-
induced cell death. Innate immune cell types consist of macrophage, DCs, pDCs, 
neutrophils, basophils, eosinophils, mast cells, NK cells, and innate lymphoid cells. 
These cells exhibit diverse characteristics and functions in response to distinct classes 
of pathogens. The broad function of innate immune cells is to be early responders to an 
invasive pathogen and coordinate induction of a protective adaptive immune response. 
Macrophages and DCs are two innate cell types that are critical antiviral defense and 
induction of the adaptive immune system. 
 Macrophages, crucial sentinel cells of the innate immune system, rapidly respond to 
type I IFNs secreted by virally-infected cells by increasing phagocytic activity and 
releasing nitric oxides into the local environment which are capable of limiting viral 
replication (Fujimoto et al., 2000; Guidotti et al., 2000; Saura et al., 1999). In addition, 
macrophages produce an array of proinflammatory chemokines and cytokines that lead 
to the recruitment of other effector immune cells and create a proinflammatory cytokine 
milieu to shape the immune response (Guidotti and Chisari, 2001; Peschke et al., 1993). 
Consistently, studies using macrophage-deficient mice or macrophage depletion 
techniques have reported impaired viral clearance and diminished induction of the 
adaptive immune response demonstrating the importance of this innate immune cell 
following viral infection (Kim et al., 2008; Kumagai et al., 2007; Seiler et al., 1997).  
In addition to macrophages, DCs are another innate immune cell population critical in 
the propagation of the antiviral immune response. The main purpose of DCs is to 
function as antigen presenting cells (APCs) that prime the adaptive immune response. 
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DCs specialize in the uptake and processing of antigens into short peptide segments 
that are packaged on major histocompatability complex (MHC) class I and II molecules 
and presented to T cells (Bevan, 2006; Yewdell and Haeryfar, 2005). DC exposure to 
proinflammatory cytokines and/or PRR stimuli creates a feedforward loop, inducing DCs 
to produce more proinflammatory chemokines and cytokines, increase antigen uptake, 
and upregulate costimulatory molecules such as CD80, CD86 and CD40 (Kato et al., 
2006; Masson et al., 2008; West et al., 2004). DCs migrating from the site of infection to 
the draining lymph nodes act in concert with lymphoid resident DCs to present antigen 
on MHC class I and II to naïve CD8 and CD 4 T cells (Allenspach et al., 2008; Yewdell 
and Haeryfar, 2005). Costimulatory molecule interactions and proinflammatory cytokine 
stimulation provide a critical second and third stimulatory signals, along with the initial T 
cell receptor-MHC-peptide engagement, to prime naïve T cells and drive T cell 
differentiation (Masson et al., 2008). DCs either remain at the site of infection to 
stimulate and direct newly recruited innate and adaptive immune cells or migrate to 
draining lymph nodes to present viral antigen to naïve CD4 and CD8 T cells leading to 
initiation of the adaptive immune response (McGill et al., 2009).  
1.3.4 Induction of the adaptive immune response to viral infection 
When the initial antiviral mechanisms of the innate immune system are insufficient to 
control viral infection the adaptive arm of the immune provides crucial cell-mediated (T 
cells) and humoral (antibody producing B cells) immune responses to control viral 
infection. The importance of the adaptive immune response has been demonstrated in 
several models of viral infection where mice lacking an adaptive immune system can not 
control infection and succumb to the viral infection (Franco and Greenberg, 1995; 
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Palladino et al., 1995; Xu et al., 2004). Three cell types comprise the adaptive immune 
response; Cytotoxic CD8 T cells, CD4 T helper cells and B cells. All of these cell types 
express antigen specific surface receptors, the T cell receptor (TCR) or B cell receptor 
(BCR), that enable the adaptive immune response to target effector responses against 
specific pathogens. Upon stimulation of the TCR or BCR with their cognate antigen CD4, 
CD8 T cells and B cells undergo rapid clonal expansion, creating a pool of effector cells 
(Hugues et al., 2004). Effector functions include direct cell lysis of virus-infected cells, 
production of antiviral effector cytokines, and production of antibodies. Expansion of the 
adaptive immune response corresponds with viral clearance and is followed by a 
contraction of the effector cells and establishment of a pool of memory cells (Figure 4). 
Memory CD4, CD8 T cells and B cells establish long-lasting immunity and prevent 
recurrent infections with the same virus (Harrington et al., 2008; Harty and Badovinac, 
2008; Slifka et al., 1998).  
During a viral infection, in addition to MHC/TCR binding and costimulatory molecule 
interaction, CD4 T helper cells receive a third signal from proinflammatory cytokines, 
such as type I IFNs and IL-12, that activates a gene program that directs the 
differentiation of the CD4 T cell into a TH1 phenotype (Whitmire, 2011). TH1 cells act to 
coordinate the adaptive and innate immune response against the virus by producing 
cytokines such as IFN-γ and IL-2 that reinforce the antiviral response and aid in T cell 
proliferation (Williams and Bevan, 2007). TH1 cells also support B cell antibody 
production and isotype class switching through CD40-CD40L interactions (Bishop and 
Hostager, 2001). These functions are critical for the antiviral response as loss of the 
CD4 T cell responses severely impairs the size and quality of the adaptive immune 
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response and can lead to persisting viral infection and host mortality (Leist et al., 1989; 
Louten et al., 2006; Xu et al., 2004).  
Cytotoxic CD8 T cells limit viral infection by directly targeting and eliminating virally-
infected cells or producing antiviral cytokines. CD8 T cell-mediated cell lysis can occur 
via ligand mediated cell death (Fas/FasL interaction) (Topham et al., 1997) (Trapani and 
Smyth, 2002) or production and release of cytotoxic lytic granules, such as perforin and 
granzyme, at the interface of the CD8 T cell and target cell (Hou and Doherty, 1995; 
Peters et al., 1991). CD8 T cells also produce of effector cytokines IFN-γ and TNF-α that 
can directly induce cell programmed death or stimulate surrounding innate cells, such as 
macrophages and NK cells, to increase cytolytic activity (Kaech et al., 2002). Studies in 
mice deficient of CD8 T cells have reported impaired viral clearance and decreased host 
survival demonstrating the essential role of the CD8 T cell response has in protective 
antiviral immunity (Fung-Leung et al., 1991; Qi et al., 2006).  
Through the BCR, B cells can detect virus as soluble antigens in the lymphatics or in 
the virus’ native form on the surface of macrophages or DCs (Depoil et al., 2008; Junt et 
al., 2007; Qi et al., 2006). Endocytosis of antigen through BCR binding, leads to antigen 
processing and presentation on MHC-II molecules allowing B cells function as an 
addition APC driving T cell proliferation (Crawford et al., 2006). In addition, B cells 
secrete virus-specific antibodies that can either neutralize free virus or bind to a virally-
infected cell and target it for antibody dependent cell-mediated cytotoxicity. The 
importance of the B cell response during primary viral infection varies for different 
viruses, but in general, the primary B cell response aids in the latter stages of viral 
clearance (Franco and Greenberg, 1995; Graham and Braciale, 1997; Palladino et al., 
1995). Following primary infection, germinal center reactions and B cell affinity 
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maturation leads to the differentiation of long lived plasma cells that secrete high affinity 
antibodies into circulation and are highly effective at preventing secondary infection 
(Franco and Greenberg, 1995; Tarlinton, 2006). Combined the cells of the adaptive 
immune system direct a targeted response to control viral infection in the host. 
1.4 Two models of viral infections: mucosal-associated influenza virus and 
systemic Lymphocytic Choriomeningitis virus 
1.4.1 Influenza virus and pathogenicity 
Seasonal influenza virus infection results in a significant burden on the health system 
causing approximately 200,000 hospitalizations and 36,000 deaths in the United States 
annually (Thompson et al., 2003). The most susceptible populations are infants, the 
elderly, or individuals with pre-existing health concerns (Thompson et al., 2003). 
However, influenza pandemics, caused by introduction of a new subtype of influenza 
virus into the population can cause death in otherwise healthy adults, as was the case in 
1918 with the Spanish flu epidemic or the more recent H5N1 highly pathogenic avian 
influenza virus, (Taubenberger and Morens, 2008; Webster and Govorkova, 2006). 
Inflammation and tissue damage resulting from influenza virus infection is predominantly 
localized to the lung and is characterized by pulmonary hemorrhaging and edema, 
inflammatory infiltrates, and necrotizing bronchitis (Taubenberger and Morens, 2008). 
Mouse-adapted influenza viral strains mimic disease pathogenesis in humans and 
provide an excellent model to study the immune response to the virus and formation of 
protective immunity (Kuiken et al., 2010). The murine viral infection model will be used in 
Chapter 2 to study virus-induced pathology and immune responses to a local, non-
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intestinal, mucosal-associated viral infection following disruption of commensal bacterial 
communities. 
Influenza A virus is an enveloped, single-stranded RNA virus member of the 
Orthomyxoviridae family (Cheung and Poon, 2007). The virus is composed of eight RNA 
gene segments that encode ten proteins, two of these proteins, hemagglutinin (HA) and 
neuraminidase (NA), are expressed on the viral capsid and are highly immunogenic 
epitopes that serve as direct targets for neutralizing antibodies (Cheung and Poon, 
2007). Influenza virus primarily infects respiratory epithelial cells but can also infect 
alveolar macrophages and other immune cells that are recruited to the site of infection 
causing cell death by cytolysis or apoptosis within forty hours of infection (Julkunen et 
al., 2001). Severity of the influenza virus infection depends on a combination of host-
derived and viral-specific factors. Multiple influenza virus strains have been adopted for 
the murine model and cause different degrees of pathology. In this thesis the H1N1 
influenza A/Puerto Rico/8/34 strain (PR8) and the A/X-31 H3N2 strain (X31) will be 
employed. In immunocompetent mice, infection with a low dose of PR8 virus (~300 
TCID50) causes significant morbidity and lung tissue damage lasting 1-2 weeks. X31 viral 
infection, even when administered at a much higher dose (~1x105 TCID50), is cleared 
from the mouse at a quicker rate and causes substantially less morbidity (Bouvier and 
Lowen, 2010; Decman et al., 2010)(personal observations). Morbidity can be monitored 
by weight loss and/or blood oxygen saturation levels, enabling non-invasive measures of 
disease progression (Verhoeven et al., 2009). These two influenza virus strains will be 
used in Chapter 2 to assess the protective capacity of the antiviral immune response. 
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1.4.2 The immune response to influenza virus infection 
Successful clearance of influenza virus infection requires a coordinated innate and 
adaptive immune response. Defects in PRR expression (Ichinohe et al., 2011; Kato et 
al., 2006), the IFN signaling pathway (Mordstein et al., 2010; Price et al., 2000), DC 
(McGill et al., 2008), macrophage (El Bakkouri et al., 2011; Kumagai et al., 2007), CD8 T 
cells (Epstein et al., 1993) and B cells (Graham and Braciale, 1997) all lead to increased 
host mortality following challenge with influenza virus demonstrating the importance of 
each arm of the immune system in controlling influenza virus infection. Infected 
respiratory epithelial cells initiate the immune response by producing type I IFNs and 
chemokines to recruit and activate innate immune cells into the lung (Julkunen et al., 
2001; Sanders et al., 2011). Resident alveolar macrophages and DCs are activated by 
IFN stimulation and produce proinflammatory factors to increase the magnitude of the 
response (McGill et al., 2009). Neutrophils, NK cells and inflammatory monocytes are 
recruited to the lung and in combination with alveolar macrophages clear virally-infected 
cells and cellular debris (Hermesh et al., 2010; Tate et al., 2009; Tumpey et al., 2005). 
Meanwhile, DCs migrate to the draining mediastinal lymph nodes to present antigen to 
naïve CD4 and CD8 T cells to initiate the adaptive immune response (Belz et al., 2004; 
Kim and Braciale, 2009). Following clonal expansion, virus-specific T cells home to the 
lung starting around 6-7 days post-infection and produce effector cytokines and induce 
apoptosis via secretion of lytic granules and Fas/FasL interactions (Topham et al., 
1997). Induction and recruitment of the adaptive immune response rapidly leads to viral 
clearance by approximately day 10-12 post-infection (Kohlmeier and Woodland, 2009). 
However, if the immune response is delayed or defective, influenza virus infection can 
cause severe damage to the lung tissue, disrupting gas exchange that can potentially be 
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fatal. This fine balance highlights the critical nature for a rapid and robust immune 
response to viral infection.  
1.4.3 Lymphocytic Choriomeningitis virus and pathogenicity 
Lymphocytic Choriomeningitis Virus (LCMV) is an enveloped, single-stranded RNA virus 
belonging to the Arenaviridae family (Oldstone, 2002a). Unlike influenza virus, LCMV is 
a natural murine pathogen that results in a systemic infection with virus circulating 
through the blood to infect multiple tissues of the host (Ahmed et al., 1987; Sydora et al., 
1996). As a non-cytolytic virus, most of the inflammation and tissue damage associated 
with LCMV infection is induced by the cytotoxic effects of the inflammatory immune 
response (Khanolkar et al., 2002). LCMV gains access to a cell through binding with the 
α-dystroglycan receptor, a cell surface receptor for proteins of the extracellular matrix 
that is ubiquitously expressed in multiple tissues (Cao et al., 1998; Rojek et al., 2007). 
The cell tropism and replicative capacity of LCMV varies from between strains. For 
example, the Armstrong (Arm) strain of LCMV establishes an acute infection that is 
rapidly controlled and cleared by the host within a week (Ahmed et al., 1984a; Ahmed et 
al., 1984b). On the other end of the spectrum the clone 13 strain (cl-13), which carries 
two point mutations increasing α-dystroglycan receptor affinity and viral polymerase 
activity (Cao et al., 1998; Matloubian et al., 1993), exhibits increased macrophage-
tropism and results in prolonged viremia and persisting virus in immunoprivileged organs 
such as the kidney and central nervous system (Ahmed et al., 1984b; King et al., 1990). 
The LCMV strain used in this thesis, T1b, exhibits a lymphocyte-tropism and results 
viremia lasting approximately 2 weeks (Blackburn et al., 2009; King et al., 1990). The 
intermediate phenotype of this LCMV strain can be exploited to identify defects in 
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antiviral immunity that might otherwise be unobserved with an acute or chronic LCMV 
strain. Characterization of the immune response to LCMV infection has led to the 
development of molecular tools, such as identification of virus-specific T cells by MHC-
tetramer staining, which enable a comprehensive analysis of the antiviral immune 
response (Altman et al., 1996) (Oldstone, 2002b). These studies have greatly improved 
our understanding of the innate and adaptive antiviral immune response and the tools 
developed in the LCMV infection system will be employed in Chapter 3 to address the 
influence of commensal bacterial communities on the immune response to a systemic 
viral infection.  
1.4.4 The immune response to Lymphocytic Choriomeningitis virus 
The immune response to LCMV has been extensively characterized and has served as 
a prototypic model to study the immune response to viral infection. Because LCMV 
infects multiple organs of the host, there is not one anatomical location that recruits 
activated immune cells as is the case in influenza virus infection of the lung. Instead 
activated effector cells of the innate and adaptive immune system can be found in 
multiple organs. 
Similar to other viral infections, LCMV is capable of stimulating PRRs RIG-I, MDA5, 
TLR3, 7, and 9 to induce an early burst of type I IFN production that initiate the immune 
response (Lee et al., 2009; Zhou et al., 2010). However, signaling via TLR7 and 9, 
particularly in plasmacytoid DCs, is the predominant source of type I IFN production 
immediately following LCMV infection. (Jung et al., 2008; Montoya et al., 2005). 
Disruption of TLR signaling via genetic knockout of the TLR signaling protein MyD88, 
results in significantly decreased type I IFN levels in the serum and diminished innate 
  32 
and adaptive immune response leading to persisting viral titers in the host (Chen et al., 
2005; Jung et al., 2008; Kolumam et al., 2005; Zhou et al., 2005). DCs and macrophage 
have separate but critical roles in initiating a protective immune response. As early as 48 
hours post-infection, splenic DCs upregulate costimulatory markers CD80, CD86, and 
CD40 and are producing proinflammatory cytokines to direct T cell expansion and 
differentiation (Belz et al., 2005; Montoya et al., 2005). Deletion of DCs results in a 
diminished LCMV-specific CD8 T cell population demonstrating that DCs are the 
predominant APC in LCMV infection (Probst and van den Broek, 2005). Macrophages, 
stimulated by IFN signaling, increase phagocytic activity and are important in limiting 
spread of viral infection (Lang et al., 2010). Macrophage activation at this early stage of 
infection before the adaptive immune response has been primed is a critical determinant 
in whether the virus is ultimately cleared (Lang et al., 2010; Oehen et al., 2002; Seiler et 
al., 1997).  
LCMV infection induces both a cell-mediated and humoral arms of the adaptive 
immune system, but the T cell response, particularly the CD8 T cell response has been 
the more extensively studied and characterized (Hangartner et al., 2006; Khanolkar et 
al., 2002; McDermott and Varga, 2011). The virus-specific CD8 T cell response robustly 
expands and migrates to infected tissue, aiding in viral clearance through cell-mediated 
cytotoxicity and production of effector cytokines such as IFN-γ and TNF-α (Ahmed et al., 
1984a; Khanolkar et al., 2002). Control of acute LCMV infection is dependent on the 
CD8 T cell response as loss of these cells or ablation of their effector mechanisms 
results in persisting viral infection (Fung-Leung et al., 1991; Intlekofer et al., 2008; Kagi 
et al., 1995). Infection with chronic strains of LCMV lead to defective CD8 T cell 
responses, termed CD8 T cell exhaustion, that is characterized by upregulation of 
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inhibitory receptors and progressive loss of effector function (Blackburn et al., 2009; 
Wherry, 2011; Wherry et al., 2003; Zajac et al., 1998). Because of the tight link between 
the LCMV-specific CD8 T cell response and viral progression, characterizing the quality 
of the CD8 T cell response is an excellent indicator of the overall ability of the host to 
respond to and control viral infection (Fuller et al., 2004; Wherry et al., 2005). As such, it 
will be used in Chapter 3 of thesis to assess the quality of the antiviral immune response 
to a systemic viral infection following depletion of commensal bacterial communities. 
1.5 Outline of Thesis 
It is increasingly apparent that the commensal bacterial communities can shape immune 
cell development and function. Commensal bacterial communities have been 
demonstrated to have either an adjuvant or immunoregulatory effect in the context of 
intestinal infection. The focus of this thesis will be to explore the influence of commensal 
bacterial communities on antiviral immunity to non-intestinal viral infections. Through use 
antibiotic-mediated disruption of commensal bacterial communities or GF mice, Chapter 
2 will address whether commensal bacterial communities aid in induction of a host 
protective immune response following infection with influenza virus. The impact of 
commensal bacteria-derived signals on immunity to a systemic viral infection will be 
investigated in Chapter 3 through probing the innate and adaptive immune response to 
LCMV following depletion of commensal bacterial communities. Lastly, Chapter 4 will 
examine the fundamental role for commensal bacteria-derived signals in calibrating the 
activation threshold of the innate immune system required for immunity to viral infection. 
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Figure  1.  (A)  Quantification  of  bacterial  phyla  based  on  total  bacterial  16S  rDNA  in  stool 
samples isolated  from  naïve,  conventionally‐reared,  C57BL/6  mice.  (B)  Phylum  level 
classification of  intestinal bacterial communities of naïve C57BL/6 mice based on 16S rDNA 
frequencies in stool sample. (Adapted from (Hill et al., 2010)).  
 
 
Figure 1. Composition of intestinal bacterial communities. 
 
 
 
 
 
 
 
 
 
 
  35 
Figure 2. Specific signals, derived  from  intestinal bacterial communities,  stimulate different 
cell  types within  the  intestine  (e.g. DCs  and  IECs).  Commensal  bacteria‐derived  signals  can 
influence DCs and  IECs  to  induce either an  immunoregulatory or proinflammatory cytokine 
environment. This cytokine mileu of the  intestinal microenvironment can condition antigen 
presenting cells and influence CD4+ T cell differentiation within the intestinal mucosa.  
  
 
 
Figure 2. Commensal bacteria-derived signals regulate intestinal immune 
homeostasis. 
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Figure 3.  Following viral infection of a cell, PRR signaling initiates Type I IFN production (IFN‐
α/β),  which  shapes  the  host  antiviral  response  in  three  phases.  (1)  Type  I  IFNs  act  in  an 
autocrine or  paracrine manner  to  induce  transcription of  interferon  response  genes  (IRGs) 
that  limit viral  replication.  (2) Sentinel  innate  immune cells, such as macrophages and DCs, 
are  stimulated  by  Type  I  IFN  to  produce  proinflammatory  cytokines,  increase  antigen 
processing  and  presentation,  and  upregulate  costimulatory  molecules.  (3)  Type  I  IFN 
stimulation contributes to CD4 and CD8 T cell expansion and B cell antibody prodution.  
 
 
Figure 3. Type I Interferons initiate multiple phases of host antiviral defense. 
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Figure 4.  The cell‐mediated (CD4 and CD8 T cells) and humoral (B cells) arms of the adaptive 
immune response expand in response to viral  infection. Following control of viral  infection, 
memory  populations  of  all  three  adaptive  immune  cell  types  are  established  and  prevent 
recurrent infection. 
 
Figure 4. Kinetics of the adaptive immune response to viral infection.  
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Chapter 2 
Loss of commensal bacterial communities results in impaired 
immunity to influenza virus infection in the lung 
2.1 Abstract 
Commensal bacterial communities regulate intestinal immune cell development and 
differentiation. Furthermore, commensal bacteria-derived signals can act as an adjuvant 
in augmenting the immune response against intestinal infections. However, whether 
alterations in commensal bacterial communities can influence host protective immunity 
to viral infection in tissues outside of the intestinal tract remains poorly defined. In this 
chapter, I identify a role for commensal bacteria-derived signals in promoting protective 
antiviral immunity following influenza virus infection. Antibiotic (ABX)-treated mice 
challenged with two different strains of influenza A virus (PR8 or X31) exhibited impaired 
lung function and severe bronchiole epithelial degeneration following infection, resulting 
in increased host mortality. ABX-treated mice exhibited a diminished adaptive immune 
response that correlated with elevated viral titers in the lung. Further, ABX-treated mice 
exhibited a defective innate immune response characterized by decreased production of 
proinflammatory cytokines and chemokines in the lung and reduced expression of IFN-
induced antiviral defense genes in alveolar macrophages at day 3 post-infection. 
Restoration of IFN responsiveness in ABX-treated mice re-established protective 
antiviral immunity after influenza virus infection. Taken together, these data indicate that 
signals derived from commensal bacterial communities regulate the innate and adaptive 
immune response that is critical for host survival following respiratory viral infection.  
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2.2 Introduction 
Commensal microbial communities that colonize the barrier surfaces of the skin, vaginal, 
upper respiratory, and gastrointestinal tract of mammals consist of parasites, bacteria, 
fungi and viruses (Breitbart et al., 2003; Ley et al., 2006a; Scupham et al., 2006). The 
largest and most diverse microbial communities reside within the intestine where non-
culture based methods have identified an estimated 15,000-36,000 individual bacterial 
species (Eckburg et al., 2005; Frank et al., 2007; Wang et al., 2003). These commensal 
bacteria have multiple beneficial properties ranging from aiding in metabolism to 
competing with invasive pathogens to occupy an environmental niche (Hooper and 
Gordon, 2001; Macpherson and Harris, 2004; Sonnenburg et al., 2006). Recent studies 
in patients have identified that alterations in the composition of bacterial communities are 
associated with susceptibility to diabetes, obesity, cancer, inflammatory bowl disease 
(IBD), allergy and other atopic disorders, highlighting the potential impact of host-
commensal interactions in influencing multiple metabolic and chronic inflammatory 
diseases (Ley et al., 2006b; Manichanh et al., 2006; Moore and Moore, 1995; Penders et 
al., 2007a; Penders et al., 2007b).  
Studies utilizing gnotobiotic (germ-free), antibiotic-treated or selectively colonized mice 
have demonstrated that the absence or alterations in composition of commensal 
bacterial communities results in impaired lymphoid tissue development, dysregulated 
immune cell homeostasis and altered susceptibility to multiple infectious or inflammatory 
diseases in the gastrointestinal tract (Amaral et al., 2008; Herbst et al.; Smith et al., 
2007; Souza et al., 2004). For example, Mazmanian and colleagues identified a 
zwitterionic polysaccharide (PSA) isolated from Bacteroides fragilis that ameliorated 
intestinal inflammation in two murine models of IBD (Mazmanian et al., 2008). In contrast 
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colonization of the intestine with Segmented Filamentous Bacteria (SFB), is associated 
with increased frequencies of CD4+ TH17 cells in the lamina propria of mice, a 
proinflammatory subset of CD4 T cells. (Ivanov et al., 2009; Ivanov et al., 2008). 
Consistent with a proinflammatory role, signals derived from commensal bacteria can act 
as an adjuvant, augmenting immune responses following parasitic or bacterial infections 
of the intestine (Benson et al., 2009; Hall et al., 2008; Ivanov et al., 2009).  Thus, 
depending on the context, commensal bacteria-derived signals are capable of 
dampening or exacerbating inflammatory immune responses in the intestinal 
microenvironment. However, the role of commensal bacteria-derived signals in 
augmenting the immune response to infection in tissues distal to the gastrointestinal 
tract remains largely unexplored. 
The immune response to respiratory viral infections must efficiently clear virus from the 
lung tissue while limiting tissue damage to this important barrier surface. Proper 
regulation of this delicate balance is vital to host survival and requires rapid induction of 
the antiviral immune response followed by prompt cessation of effector mechanisms 
upon control of the pathogen. It is unknown whether signals derived from commensal 
bacterial communities contribute to modulating the immune response to respiratory viral 
infection in a manner similar to what has been observed during intestinal infections. To 
address this question, the commensal bacterial communities of mice were deliberately 
manipulated by antibiotic treatment and challenged with influenza virus. 
 Influenza virus is a cytolytic virus that infects the epithelial cells of the respiratory tract 
leading to severe lung pathology (Julkunen et al., 2001). Host protection is dependent on 
a coordinated innate and adaptive immune response to control viral replication 
(Kohlmeier and Woodland, 2009; McGill et al., 2009). Following alteration or absence of 
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commensal bacterial communities, however, influenza virus-infected mice were unable 
to clear the virus, exhibited severe degeneration of the bronchiole epithelial layer and 
succumbed to infection. These antibiotic-treated (ABX) mice exhibited an impaired 
innate and adaptive immune response indicating that commensal bacteria-derived 
signals are important in augmenting the immune response to viral infection of the 
respiratory tract.  
 
2.3 Methods 
2.3.1 Mice and viruses 
C57BL/6 mice (4-6 weeks old) were purchased from the National Cancer Institute 
(Frederick, MD). Mice were maintained in specific pathogen–free facilities at the 
University of Pennsylvania. GF C57BL/6 mice were maintained in plastic isolator units 
and fed autoclaved chow and water. The University of Pennsylvania Institutional Animal 
Care and Use Committee (IACUC) approved all protocols, and all experiments were 
performed according to the guidelines of the University of Pennsylvania IACUC. 
Mice were inoculated intranasally (i.n.) with recombinant influenza viruses expressing 
the LCMV GP33 (PR8-GP33: 368 TCID50, X31-GP33: 1x105 TCID50). Recombinant 
influenza virus strains containing the LCMV GP33–41 epitope inserted in the 
neuraminidase stalk region were obtained from Dr. Richard J. Webby (St. Jude 
Children’s Research Hospital, Memphis, TN), propagated in eggs, and stored at -80°C. 
The replication and pathogenicity of these recombinant strains of X31 and PR8 were not 
substantially different from their non-recombinant counterparts (data not shown). Prior to 
i.n. infections, mice were anesthetized by intraperitoneal (i.p.) injection of 0.2 mL of 
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Avertin (2-2-2 Tribromoethanol dissolved in tert-amyl alcohol (Sigma-Aldrich); working 
stock 20 mg/mL diluted in PBS). 
2.3.2 Oral antibiotic treatment 
Mice were provided autoclaved drinking water supplemented with ampicillin (0.5 mg/mL, 
Sigma), gentamicin (0.5 mg/mL, Gemini Bio-Products), metronidazole (0.5 mg/mL 
Sigma), neomycin (0.5 mg/mL, Med-Pharmex), vancomycin (0.25 mg/mL, Novaplus), 
and sucralose (4mg/mL, Splenda, McNeil Nutritionals, LLC). Splenda was added to 
make the antibiotic cocktail more palatable. Antibiotic treatment was started 2-4 weeks 
prior to infection and continued for the duration of the experiment. 
2.3.3 16s rDNA isolation and tracheal bacterial cultures 
Stool pellets were collected 2 weeks following antibiotic treatment and total DNA was 
extracted using QIAamp DNA stool Mini Kit (Qiagen). Quantification of 16S rDNA was 
performed by qRT-PCR using degenerate bacterial 16S rDNA-specific primers (5’-
AGAGTTTGATCCTGGCTCAG-3’; forward), (5’-CTGCTGCCTYCCGTA-3’; reverse), (5’-
FAM-TA+ACA+CATG+CA+AGTC+GA-BHQ1-3’; probe; + precedes the position of LNA 
base).  
Trachea tissue segment was isolated under sterile conditions with particular attention 
to ensuring the trachea sample was separated from the esophagus. An approximate 2-3 
cm portion of the trachea from the bottom of the larynx to where the trachea splits into 
the bronchioli was removed and mechanically homogenized in PBS. The resultant 
homogenate was plated by serial dilution on LB agar plates and grown under aerobic or 
anaerobic conditions for 48 hours.  
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2.3.4 Pulse oximetry 
Mice were anesthetized with Avertin then neck and throat hair was removed with a 
chemical depilatory agent (Nair, Church & Dwight Co.) one day prior to infection. 
MouseOx Tm Pulse-Oximeter neck sensors (Starr Life Sciences, Oakmount, PA) were 
placed on exposed skin and blood oxygen saturation was recorded with Starr MouseOx 
software v. 5.1. Pulse oximetry readings were allowed to stabilize and fifteen seconds of 
measurements were averaged.  
2.3.5 Isolation of cells from the lung parenchyma and bronchiole alveolar lavage 
fluid 
Bronchoalveolar lavage cells (BAL) were obtained by inflating the lung with PBS via the 
tracheal cannula and recovering the PBS wash. This was repeated 2x to obtain 
increased cellular yield. The lung was perfused by cutting the hepatic vein and injecting 
PBS into the right ventricle. The excised lung was cut into small pieces and digested 
with 1 mg/mL collagenase D (Roche) and 20 µg/mL DNase Type IV (Sigma-Aldrich) in 
complete media (DMEM supplemented w/ 10% FBS, 10µg/mL penicillin/streptomycin, 
10mM HEPES, 0.5mM β-mercaptoethanol, 10µg/mL L-glutamine, 5mM sodium 
pyruvate) for 30 min at 37°C under constant agitation. Single cell suspensions were 
obtained by mechanical disruption through 70µm cell strainers followed by red blood cell 
(RBC) lysis.  
2.3.6 Flow cytometry, cell sorting, tetramer, and intracellular cytokine staining 
Single cell suspensions were surface stained in FACS Buffer (PBS, 2% BSA, 0.2mg 
Sodium Azide, 2mM EDTA) using standard flow cytometric staining protocol with 
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fluorescently conjugated antibodies specific to CD3ε, CD4, CD8α, CD11c, CD19, CD25, 
CD43, CD45, CD69, CD160, F4/80, Ly6c, MHC-I (H-2Kb), MHC-II (I-A/I-E) 
(eBioscience), CD5, CD44, CD80, CD86, Ly6g (clone 1A8), ICOS, LAG-3, PD-1 (clone 
RMP1-30) (Biolegend), CD40 (BD Biosciences), CXCR3 (R&D Systems), 2B4 (BD 
Pharmingen), CD11b, and granzyme B (Invitrogen). Major histocompatibility complex 
(MHC) class I peptide tetramers were made and used to identify virus-specific CD8 T 
cells (Altman et al., 1996). Alveolar macrophages were identified as Non-T, Non-B, Non-
NK cells (NTNBNNK), CD11c+, F4/80+. Inflammatory monocytes were identified as 
NTNBNNK, CD11c-, F4/80-, Ly6g-, Ly6c+, CD11b+. Neutrophils were identified as 
NTNBNNK, CD11c-, F4/80-, Ly6g+, CD11b+. Dendritic cells were identified as 
NTNBNNK, F4/80-, CD11c+, MHC-IIhi. Plasmacytoid dendritic cells were identified as 
NTNBNNK, non-alveolar macrophage, non-inflammatory monocyte, non-neutrophil, 
CD11cint, PDCA-1+. Alveolar macrophages from naïve or d3 PR8-gp33 virus infected 
CNV or ABX-treated mice were sorted directly into TRIzol LS (Invitrogen) using a BD 
Aria (Beckson Dickson). Additional macrophages from the sample were separately 
sorted to ensure sort purity (≥95%). For intracellular cytokine analysis, 106 splenocytes 
or 105 cells isolated from the lung were cultured in a 96-well plate in complete media with 
viral peptides (0.2 µg/ml) and brefeldin A (Golgiplug, eBioscience) for 5 hrs at 37°C. 
After staining for surface antigens as described above, cells were stained for intracellular 
cytokines using the Cytofix/Cytoperm kit (BD/Pharmingen) and fluorescently conjugated 
antibodies specific for IL-2 (eBioscience), IFN-γ (BD Pharmingen), TNF-α (Biolegend), 
MIP-1α (R&D Systems). The CD107a assay was performed as previously described 
(Blackburn et al., 2009). Cell viability was assessed with Live/Dead AQUA stain 
(Invitrogen). Samples were collected by using a LSR II flow cytometer (Becton 
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Dickinson). All flow cytometry data was analyzed by FlowJo v 8.8 (Treestar). Pie charts 
were created using the Pestle and SPICE programs (Mario Roederer; Vaccine Research 
Center, NIAID, NIH). 
2.3.7 Virus-specific antibody and cytokine ELISA 
PR8 IgM and IgG serum antibody concentrations were determined by ELISA as 
previously described (Ahmed et al., 1984b; Mozdzanowska et al., 2000). In brief, 1,000 
HAU/mL of purified PR8 was adsorbed to plates and bound antibody was detected using 
anti-IgM or -IgG conjugated to alkaline phosphatase (Sigma) and developed with p-
nitrophenol phosphate (Sigma). PR8 antibody concentrations were determined using 
anti-HA antibody standards of IgM (clone H35-C7-2R1) or IgG (clone H36-4-5.2). Optical 
densities (OD405-750) were measured using an ELISA reader and concentrations 
calculated using SoftMax Pro software (Molecular Devices). BAL wash supernatant were 
analyzed for cytokines and chemokines by luminex multiplex bead array (Millipore).  
2.3.8 RNA isolation, cDNA preparation, and RT-PCR 
RNA was isolated from cells using an RNeasy mini-kit (Qiagen) and from lung tissue 
using mechanical homogenization and TRIzol isolation (Invitrogen) according to the 
manufacturer’s instructions. cDNA was generated using SuperScript reverse 
transcriptase (Invitrogen). RT-PCR was performed on cDNA using SYBR green 
chemistry (Applied Biosystems) and commercially available primer sets (Qiagen). PA 
influenza-specific primers and probes (Sense: CGGTCCAAATTCCTGCTGAT; Anti-
Sense: CATTGGGTTCCTTCCATCCA; Probe: 
CCAAGTCATGAAGGAGAGGGAATACCGCT) were used in combination with Taqman 
PCR Master Mix (ABI) to determine influenza virus genome copies then converted to 
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TCID50/ gram of lung tissue. Reactions were run on an RT-PCR system (ABI7500; 
Applied Biosystems). Genes of interest were normalized to β-actin and displayed as fold 
difference relative to uninfected CNV control mice. 
2.3.9 Histological sections and pathology 
Lungs were inflated with 4% paraformaldehyde, embedded in paraffin and 5-µm sections 
were cut and stained with hematoxylin and eosin. Blind scoring of H&E-stained lung 
tissue sections by a board-certified veterinary pathologist reflect degree of luminal 
exudates (0-5) and degree of bronchiole epithelial degeneration and necrosis (0-5), for 
an overall maximum score of 10.  
2.3.10 Poly I:C administration in influenza virus infected mice 
ABX-treated mice were administered 30µg of polyinosinic-polycytidylic acid (poly I:C - 
Sigma) i.n. at d -1 and 100µg i.p. at d3 post influenza virus infection (PR8-GP33). 
Control CNV and ABX-treated mice received 30µl of PBS i.n. at d -1 and 100µl i.p. at d3.  
2.3.11 Statistical analysis 
Results represent means ± SEM. Statistical significance was determined by the 
unpaired, two tailed, Student’s t-test for individual timepoints, two-way ANOVA test for 
timecourse experiments, logrank test for survival curve, or two-part t-test for comparison 
of groups that contained samples that were below the limit of assay detection. Statistical 
analyses were performed using Prism GraphPad software v4.0. (*p < 0.05; **p < 0.01; 
***p < 0.001). 
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2.4 Results 
2.4.1  Antibiotic-mediated alterations of commensal bacterial communities result 
in enhanced susceptibility to influenza A virus infection. 
Signals derived from commensal bacterial communities regulate intestinal immune cell 
homeostasis and susceptibility to multiple inflammatory diseases in the gastrointestinal 
tract (Garrett et al., 2010b; Honda and Littman, 2012; Rakoff-Nahoum et al., 2004; 
Round and Mazmanian, 2009). Furthermore, depletion of commensal bacteria leads to 
impaired anti-pathogen immune responses to intestinal parasitic and bacterial infections, 
indicating an adjuvant-like role for commensal bacteria-derived signals in augmenting 
the immune response to intestinal infection (Benson et al., 2009; Hall et al., 2008; Ivanov 
et al., 2009). However, it is not clear whether commensal bacteria-derived signals 
regulate immunity to viral pathogens that infect sites distal to the gastrointestinal tract. 
To address this question, naïve C57BL/6 mice were orally administrated broad-spectrum 
antibiotics for two weeks, subsequently infected with influenza virus (H1N1 influenza 
A/Puerto Rico/8/34 strain with LCMV GP33 epitope) and immunologic, virologic and 
pathologic parameters were analyzed.  
As reported previously, antibiotic treatment resulted in a significant reduction of 
commensal bacteria along the intestinal tract as well as a dramatic shift in the 
composition of intestinal bacterial communities (Figure 5A) (Hill et al., 2010; Hill et al., 
2012). In addition, trachea homogenate samples from conventionally-reared (CNV) or 
antibiotic (ABX) treated mice were cultured under aerobic and anaerobic conditions to 
examined the impact of antibiotic treatment on the composition of commensal bacterial 
communities of the upper respiratory tract. Similar to the gastrointestinal tract, there was 
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a loss of culturable aerobic and anaerobic commensal bacteria in the upper respiratory 
tract of ABX-treated mice compared to CNV mice (Figure 5B). Despite the loss of 
culturable commensal bacteria in the upper respiratory tract, the lung architecture 
(Figure 5C) and composition of lung resident immune cells (Figure 5D) remained 
unchanged in the steady-state in ABX-treated mice compared to CNV mice. 
Following exposure to influenza virus infection, CNV mice lost approximately 20% of 
their original body weight (Figure 6A) and had reduced lung function as measured by 
blood oxygen saturation at day 10 (d10) post-infection (Figure 6B). Approximately 80% 
of the mice were able to recover and clear virus from the lungs by d12 post-infection 
(Figure 6C,D). In contrast, ABX-treated mice lost significantly more weight and had a 
drastic drop in blood oxygen saturation following influenza virus infection (Figure 6A,B). 
Further, ABX-treated mice had significantly higher viral titers in the lung (Figure 6C) and 
increased mortality (Figure 6D), demonstrating a deleterious physiological consequence 
of altering commensal bacterial communities in the context of respiratory influenza virus 
infection.  
2.4.2 ABX-treated mice exhibit severe lung pathology following influenza virus 
infection 
Histopathological examination of lung sections from CNV mice at d12 post-infection 
compared to uninfected control mice (Figure 5C) revealed peribronchiolar inflammation 
and epithelial hyperplasia, suggestive of wound healing and tissue repair (Figure 7A,B). 
Consistent with impaired lung function and increased mortality, lung sections from ABX-
treated mice at d12 post-infection revealed more pronounced epithelial cell necrosis 
(Figure 7C,D), increased exudate and dead cells in the bronchiolar lumen (Figure 7E, 
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arrows), and in the most severe cases, complete loss of the bronchiole epithelial layer 
(Figure 7F, arrows). Scoring of histological sections of the lung confirmed increased 
prevalence of epithelial cells with morphologic features of degeneration and necrosis in 
ABX-treated mice relative to CNV mice (Figure 7G). In agreement with histologic 
analysis, increased cell death was observed in the bronchiole alveolar lavage (BAL) fluid 
of ABX-treated mice at d12 post-infection compared to CNV mice following staining with 
a cellular viability dye (Figure 7H,I). 
To further explore the relationship between commensal bacterial communities and 
antiviral immunity, gnotobiotic or “germ-free” (GF) mice were infected with influenza virus 
and compared to CNV and ABX-treated mice. Similar to a previously published report 
(Dolowy and Muldoon, 1964), GF, as well as ABX-treated mice, exhibited increased 
weight loss (Figure 8A), impaired viral clearance (Figure 8B) and reduced virus-specific 
antibody titers (Figure 8C) compared to CNV mice. Histological examination of the lung 
at d12 post-infection revealed more severe bronchiole epithelial degeneration in GF and 
ABX-treated mice compared to CNV mice (Figure 8D-F). These data support a critical 
role for commensal bacteria-derived signals in promoting optimal antiviral immunity.  
2.4.3 ABX-treated mice exhibit a diminished influenza virus-specific adaptive 
immune response 
Increased lung pathology and impaired viral clearance in ABX-treated mice suggests an 
impaired immune response to influenza virus infection. The cell-mediated and humoral 
adaptive immune response is critical for viral clearance and host survival (Palladino et 
al., 1995; Wu et al., 2010a). To interrogate the adaptive immune response CNV and 
ABX-treated influenza virus-infected mice were sacrificed at d7 post-infection. 
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Histological examination of the lung revealed significant recruitment of lymphocytes into 
the alveolar spaces of CNV mice while ABX-treated mice had relatively diminished 
lymphocyte infiltration (Figure 9A). Quantification by flow cytometric analysis confirmed 
significantly fewer CD8 T cells in the lung parenchyma and bronchiole alveolar lavage 
fluid (BAL) of ABX-treated mice compared to CNV mice (Figure 9B,C). 
Major histocompatability complex (MHC) class I tetramer specific for the gp33-41 
epitope (Altman et al., 1996), expressed by recombinant PR8-GP33 virus, or tetramer 
specific for the endogenous np366-374 amino acid sequence of nucleoprotein of 
influenza virus (the two dominant CD8 T cell epitopes for influenza virus) were employed 
to more thoroughly investigate the influenza virus-specific CD8 T cell response. CNV 
mice infected with PR8-GP33 virus generated large populations of influenza virus-
specific (H-2Db/GP33+ and H-2Db/NP366+) CD8 T cells present in the BAL fluid (Figure 
9D) and lung parenchyma (Figure 9E,F) by d7 post-infection. In contrast, the total 
number of influenza virus-specific CD8 T cells present in these tissues was significantly 
reduced in ABX-treated mice (Figure 9D-F). In addition to an impaired CD8 T cell 
response, ABX-treated mice exhibited lower titers of PR8-specific IgM and IgG in the 
serum at d12 post-infection (Figure 9G). Collectively, these data demonstrate diminished 
humoral and cell-mediated adaptive immune responses to influenza virus infection in 
ABX-treated mice that correlates with impaired viral clearance from the lung and 
increased host susceptibility.  
Expression of activation markers such as CD69, CD25, and the cytotoxic granulated 
protein Granzyme-B is rapidly upregulated early following acute viral infection and then 
downregulated as the infection is controlled (Harty et al., 2000; Lawrence and Braciale, 
2004; Wherry et al., 2007). The expression of these molecules on DbGP33 tetramer+ 
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CD8 T cells (Figure 10A) at day 7, 10, and 12 p.i was assessed for an in depth 
phenotypic profile of the CD8 T cell activation over the course of influenza virus infection 
(Figure 10B).  While DbGP33 tetramer+ CD8 T cells from CNV mice downregulated early 
activation markers between d7 to 12 post-infection, expression of CD69 and CD25 
remained elevated in DbGP33 tetramer+ CD8 T cells isolated from ABX-treated mice 
(Figure 10, Table 1). Elevated expression of these molecules, along with Granzyme-B 
and CD43, persisted on influenza virus-specific CD8 T cells isolated from the lung of 
ABX-treated mice at d12 post-infection. These data are consistent with a delay in the 
adaptive immune response to influenza virus and sustained activation of virus-specific 
CD8 T cells due to prolonged viral persistence. 
2.4.4 ABX-treated mice exhibit an impaired CD8 T cell response and rapidly 
succumb to the weakly pathogenic X31-GP33 influenza A virus. 
Infection with the PR8 strain of influenza virus results in substantially increased morbidity 
and impaired viral clearance in ABX-treated mice compared to CNV mice, making 
comparisons of the functional quality of the CD8 T cell response at a particular timepoint 
challenging. To better study the influenza virus-specific CD8 T cell response in ABX-
treated mice, CNV or ABX-treated mice were infected with X31-GP33 virus (H3N2 
strain), a less pathogenic strain of influenza virus that causes minimal morbidity and 
mortality in CNV mice (Bouvier and Lowen, 2010; Decman et al., 2010). Despite 
infection with a less virulent influenza virus strain, ABX-treated mice still exhibited 
increased weight loss (Figure 11A), elevated viral titers (Figure 11B), increased epithelial 
degeneration (Figure 11D) and increased mortality (Figure 11C) following exposure to 
X31-GP33 virus compared to CNV mice. X31-gp33 virus-infected CNV mice exhibited 
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robust adaptive immune responses by d7 post-infection characterized by large 
population of influenza virus-specific CD8 T cells in the BAL fluid (Figure 12A), lung 
parenchyma (Figure 12B), mediastinal lymph nodes (Figure 12C)  and spleen (Figure 
12D) Further, following ex vivo stimulation with GP33 peptide infiltrating virus-specific 
CD8 T cells in the lung were capable of simultaneously producing multiple effector 
molecules (IFN-γ, TNF-α, IL-2, Mip-1α, CD107a) (Figure 12E). In contrast, ABX-treated 
mice exhibited a significant reduction in the number of influenza virus-specific CD8 T 
cells isolated from multiple compartments (Figure 12A-D) and these virus-specific T cells 
were less capable of simultaneously producing multiple effector molecules indicating a 
functionally impaired virus-specific CD8 T cell response in ABX-treated mice. (Figure 
12E). Thus, following infection with two separate strains of influenza virus, ABX-treated 
mice exhibited a diminished influenza virus-specific CD8 T cell response that correlated 
with impaired viral clearance and increased host mortality. 
2.4.5 Impaired innate antiviral immune responses in ABX-treated mice 
The impaired antiviral CD8 T cell response in ABX-treated mice following either PR8-
GP33 or X31-GP33 virus infection suggested a potential defect in the early innate 
immune response. To test this hypothesis, the recruitment and activation of early 
responding innate immune cells was assessed at d3 following PR8-GP33 virus infection. 
There was a comparable influx of macrophages, inflammatory monocytes, neutrophils, 
plasmacytoid dendritic cells (Figure 13A), and conventional dendritic cells (Figure 13B) 
into the lung of CNV versus ABX-treated mice. Further, conventional dendritic cells 
exhibited a similar activation profile in CNV versus ABX-treated mice at d3 post-infection 
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(Figure 13C). These data suggested that recruitment of innate immune cells and 
upregulation of costimulatory molecules was intact in the ABX-treated mice. 
The cytokine environment in the lung early following viral infection is a critical factor 
that shapes the quality of the adaptive immune response (McGill et al., 2009; Sanders et 
al., 2011), therefore the cytokine milieu in CNV or ABX-treated mice prior to and early 
following infection was assessed. IL-10 is an immunoregulatory cytokine that has been 
demonstrated to influence the antiviral immune response (Brooks et al., 2006; McKinstry 
et al., 2009; Sun et al., 2009; Zajac et al., 1998) and expression of this cytokine can be 
modulated by the microbiota (Amaral et al., 2008; Mazmanian et al., 2008; Ueda et al., 
2010). However, assessment of IL-10/eGFP reporter Vertex mice following 
administration of antibiotics revealed no significant differences in the frequency of IL-
10/eGFP+ macrophages, dendritic cells, CD4 T cells, CD8 T cells, or B cells isolated 
from the lung parenchyma (Figure 14A) or spleen (Figure 14B) of CNV versus ABX-
treated mice. Further, no difference in mRNA expression of Il10 was observed in the 
spleen (Figure 14C) or lung (Figure 14D) of C57BL/6 CNV versus ABX-treated mice. In 
addition, following influenza virus infection, a similar increase in IL-10 was detected in 
the BAL fluid of CNV versus ABX-treated mice (Figure 14E). Combined, these analyses 
indicate that impaired antiviral immune responses in ABX-treated mice were not 
associated with dysregulated IL-10 production prior to or following influenza virus 
infection. In contrast, reduced levels of proinflammatory cytokines and chemokines were 
detected in the BAL fluid of ABX-treated mice early following influenza virus infection 
(Figure 15A). Induction of these proinflammatory chemokines and cytokines are critical 
to the propagation of the innate immune response and suggest that the functional quality 
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of the innate immune response to respiratory viral infection is impaired following ABX-
mediated alterations in commensal bacteria.  
 
2.4.6 Diminished induction of IFN responsive genes and protection against 
influenza virus challenge following restoration of IFN responsiveness in ABX-
treated mice  
While there was no difference in the total numbers of innate immune cells that 
accumulated in the lung, less proinflammatory cytokines and chemokines were present 
following influenza virus infection in ABX-treated mice compared to CNV mice (Figure 
13, 15). This observation lead to the hypothesis that the quality of the innate antiviral 
response was impaired in ABX-treated mice. To test the magnitude of the innate 
immune response, mRNA expression of key antiviral defense genes in the lung was 
assessed early following influenza virus infection. Despite a similar number of innate 
immune cells present in the lung between CNV and ABX-treated mice, there was 
significantly reduced expression of interferon-related antiviral defense genes (Ifnb, Irf7, 
Mx1, Oas1a, Il28b [Ifnλ], Il6, Tnfa, Ccl3 [Mip1α] and Il1b) in ABX-treated mice compared 
to CNV mice at d3 post-infection (Figure 15B). Combined, the decreased expression of 
proinflammatory cytokines and antiviral defense genes demonstrate a diminished innate 
immune response in ABX-treated mice following influenza virus infection.  
Diminished expression of these macrophage-associated interferon response genes 
suggested an impaired macrophage response in ABX-treated mice following viral 
infection.  Alveolar macrophages are resident immune cells in the lung and are among 
the first immune cells to encounter influenza virus in the respiratory tract (McGill et al., 
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2009). The response of these cells is crucial for the rapid induction of immune defense 
mechanisms (Peschke et al., 1993; Tumpey et al., 2005). To assess the quality of the 
macrophage response following influenza virus infection, alveolar macrophages were 
sorted from d3 post-infection CNV or ABX-treated mice and assessed for expression of 
key antiviral defense genes (Figure 16A). At d3 post-infection alveolar macrophages 
from ABX-treated mice had a reduced induction of interferon response genes such as 
Mx1, Irf7, Stat1, Ifit3 and Ifnb (Figure 16B). These results identify macrophages as an 
innate cell type that exhibits a diminished antiviral immune response to influenza virus 
infection following antibiotic-mediated perturbation of commensal bacterial communities. 
Combined, these findings demonstrate that ABX-mediated alterations in commensal 
bacteria result in impaired induction of innate antiviral defense mechanisms following 
respiratory viral infection. 
To test whether if restoring the IFN response in ABX-treated mice could provide 
protective immunity to influenza virus infection, the synthetic TLR ligand poly I:C, known 
to stimulate endogenous type I IFN production (Proietti et al., 2002), was administered to 
ABX-treated mice 1 day prior to and 3 days following influenza virus infection. ABX-
treated mice receiving PBS had drastic weight loss (Figure 17A), loss of lung function 
(Figure 17B) and high mortality following influenza virus infection (Figure 17C). In 
contrast, administration of poly I:C to influenza virus infected ABX-treated mice resulted 
in less weight loss (Figure 17A) as well as marked improvements in lung function and 
survival (Figure 17B,C), suggesting that re-calibrating the immune response to IFN 
stimulation could overcome the need for commensal bacteria-derived signaling in 
mounting an efficient immune response to influenza virus infection. 
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2.5 Discussion 
This chapter demonstrates that antibiotic-mediated disruption of commensal bacterial 
communities impairs host protective antiviral immunity. Following mucosal-associated 
influenza virus infection ABX-treated mice exhibited an impaired innate and adaptive 
immune response. Impaired antiviral immunity was characterized by diminished 
induction of antiviral defense genes by alveolar macrophages, fewer virus-specific CD8 
T cells, reduced circulating viral-specific antibodies and elevated viral titers. Consistent 
with a role for commensal bacteria-derived signals in promoting protective antiviral 
immunity, commensal bacteria-depleted hosts exhibited severe bronchiole epithelial 
degeneration, impaired oxygen exchange and increased mortality following influenza 
virus infection. Protective immunity was partially restored in ABX-treated mice by 
administering the TLR ligand poly I:C to boost the diminished type I IFN response 
observed in ABX-treated mice. These data provide evidence of a role for commensal 
bacteria in modulating the immune response to an ongoing viral infection in a tissue 
distal to the intestinal tract. It is unclear, however, whether commensal bacteria-derived 
signals can only influence the immune response to mucosal-associated viruses that 
infect tissues in close proximity to resident bacterial communities or if these signals 
influence the systemic immune response against viruses that infect multiple peripheral 
tissues. This question will be addressed in Chapter 3. 
In a recent report Iwasaki and colleagues also observed that deliberate manipulation of 
commensal bacteria resulted in impaired antiviral immunity in the lung (Ichinohe et al., 
2011). This defect was associated with decreased expression of genes involved in the 
inflammasome pathway in the lung of antibiotic-treated mice compared to CNV mice 
following influenza virus infection (Ichinohe et al., 2011). While our studies also observed 
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decreased Il-1b mRNA expression in whole lung tissue following infection, alveolar 
macrophages isolated from CNV or ABX-treated mice did not exhibit significant 
differences in expression of inflammasome related genes such as Il-1b, ll-18, and Nlrp3 
(data not shown). Instead, alveolar macrophages isolated from ABX-treated mice 
exhibited significantly reduced expression of antiviral interferon response genes such as 
Mx1 and Oas1a, suggesting a novel interplay between commensal bacteria and 
interferon signaling pathways that are critical in response to most viruses.  Further, two 
recent reports have identified a fundamental interaction between the intestinal microbiota 
and enteric viruses where the virus utilizes the presence of commensal bacteria to 
enhance infectivity of the gastrointestinal tract (Kane et al., 2011; Kuss et al., 2011). 
Antibiotic treatment did not alter influenza virus infectivity of the respiratory mucosa in 
our studies suggesting that enteric and respiratory viruses have evolved different 
mechanism to promote replication. Collectively, these reports highlight the dynamic 
interrelationship between viral pathogens, commensal bacteria and the immune system 
and support a model where commensal bacteria-derived signals can coordinately 
influence multiple innate immune cell types to impact the immune response in the lung in 
an infection setting. Further these data provoke the possibility that commensal bacteria 
may provide tonic stimulation on innate immune cells prior to infection, thereby 
predisposing the immune system to rapidly respond to pathogens upon initial encounter. 
This hypothesis will be the focus of Chapter 4. 
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Figure 5. Oral antibiotic treatment alters commensal bacterial communities in the 
intestine and upper respiratory tract, but not immune cell populations in the lung. 
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Figure  5. Culturable  bacteria  from  (A)  stool  samples  or  (B)  trachea  homogenates  of  naïve 
CNV or ABX‐treated mice following two weeks of antibiotic treatment. Samples were plated 
on (A) Schaedler’s or (B) LB agar and incubated for 48hrs in aerobic or anaerobic conditions 
(L.o.D., limit of detection). (C) H&E stained lung sections from naïve CNV or ABX‐treated mice 
(scale bar: 200µm). (D) Total number of hematopoietic cells in the lung parenchyma of CNV 
or ABX‐treated mice at steady‐state. Cells quantified by flow cytometric analysis. CD4 T cells 
gated  on  CD45+,  CD3ε+,  CD4+.  CD8  T  cells  gated  on  CD45+,  CD3ε+,  CD8α+.  B  cells  gated  on 
CD45+,  CD19+,  MHC‐IIhi.  Alveolar  macrophages  gated  on  CD45+,  NTNB,  CD11c+,  F4/80+. 
Neutrophils  gated  on  CD45+,  NTNB,  CD11b+,  Ly6g+.  Monocytes  gated  on  CD45+,  NTNB, 
CD11b+, Ly6c+. Dendritic cells gated on CD45+, NTNB, F4/80‐, Ly6g‐, CD11c+, MHC‐IIhi. NK cells 
gated  on  CD45+,  NTNB,  NK1.1+.  Eosinophils  gated  CD45+,  NTNB,  F4/80‐,  SSChi,  Siglec‐F+. 
Plasmacytoid  dendritic  cells  gated  on  CD45+,  NTNB,  non‐alveolar  macrophage,  non‐
neutrophil,  non‐monocyte,  CD11cint,  PDCA‐1+.  Data  representative  of  three  independent 
experiments n = 3‐5 mice per group. Data shown are the mean ± SEM. **p <0.01. 
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Figure 6. CNV or ABX‐treated C57BL/6 mice were infected intranasally (i.n.) with 368 TCID50 
recombinant  influenza virus PR8‐GP33. Timecourse of (A) weight  loss and (B) blood oxygen 
saturation  following  infection  (representative  exp.  n=5:  †  signifies  mice  below  70%  initial 
weight were sacrificed). (C)  Influenza virus genome copies  in the  lung at d12 post‐infection 
assessed by qPCR and displayed as TCID50/gram of lung tissue based on a standard curve of 
genome  copies  versus  TCID50  (L.o.D.,  limit  of  detection).  (D)  Survival  curve  following  PR8‐
GP33 infection. Survival curve is a combination of five independent experiments; CNV n=27, 
ABX n=25. Data representative of five independent experiments with n=5‐6 mice per group. 
Survival statistics determined by logrank test. Viral titer statistics determined by two‐part t‐
test. *p<0.05, **p <0.01, ***p<0.001. 
 
 
Figure 6. ABX-treated mice have a higher morbidity and mortality rate following 
influenza virus infection. 
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Figure 7. ABX-treated mice exhibited increased lung pathology following 
influenza virus infection. 
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Figure  7.  H&E  stained  lung  section  of  (A,B)  CNV  or  (C‐F)  ABX‐treated  mice  at  d12  post‐
infection.  Black  box/arrows  highlight  (A,B)  epithelial  hyperplasia,  (C,D)  epithelial  cell 
necrosis, (E) cellular debris and exudate in lumen and (F) loss of bronchiole epithelium (scale 
bar: 50µm A,C,E,F; 20µm B,D). (G) Disease score of bronchiole epithelial degeneration at d12 
post‐infection. (H) Flow cytometric analysis and (I) frequency of dead cells in the BAL fluid of 
CNV or ABX‐treated at d12 post‐infection as assessed by an amine reactive viability dye. Data 
representative of three independent experiments with n=5 mice per group. Data shown are 
the mean ± SEM. **p <0.01. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  63 
Figure  8.  CNV,  ABX‐treated  or  GF  C57Bl/6  mice  were  infected  i.n.  with  368  TCID50 
recombinant  influenza  virus  (PR8‐GP33  strain).  (A)  Timecourse  of  weight  loss  following 
infection.  (B)  Influenza  virus  genome  copies  in  the  lung  at  d12  p.i.  assessed  by  qPCR  and 
displayed as TCID50/gram of lung based on a standard curve of genome copies versus TCID50 
tissue.  (C) PR8‐specific  IgM and  IgG titers  in serum at d12 post‐infection. H&E stained  lung 
sections  of  (D)  CNV,  (E)  ABX,  or  (F)  GF mice  at  d12  post  infection.  Black  arrows  highlight 
bronchiole  epithelial  necrosis/loss  (scale  bar:  50µm).  Data  representative  of  two 
independent experiments with n=5 mice per group. Viral titer statistics determined by two‐
part t test. Data shown are the mean ± SEM. *p<0.05, ** p <0.01. 
 
 
Figure 8. GF mice have increased morbidity, impaired viral clearance and 
exacerbated lung pathology following influenza virus infection. 
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Figure  9.  (A)  H&E  stained  lung  sections  demonstrate  lymphocyte  infiltration  into  alveolar 
spaces at day 7 p.i. (scale = 200µm) (B) Total number of T cells in the lungs and (C) BAL fluid 
at  day  7  p.i.  (D‐F)  Total  number  of  influenza  virus‐specific  DbGP33  tetramer+  CD8  T  cells 
isolated  from  the  (D)  BAL  fluid  or  (E)  lung  parenchyma  at  d7  post‐infection.  (F)  DbNP366 
tetramer+  CD8  T  cells  isolated  from  the  lung  parenchyma  at  d7  post‐infection.    (G)  PR8‐
specific  IgM and  IgG titers  in the serum at d12 post‐infection. Data representative of three 
independent  experiments  with  n=4‐5  mice  per  group.  Data  shown  are  the  mean  ±  SEM. 
*p<0.05, **p< 0.01. 
 
 
Figure 9. ABX-treated mice exhibit a diminished adaptive immune response 
following influenza virus infection. 
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Figure 10. Phenotypic profile of DbGP33 tetramer+ CD8 T cells isolated from the lung of CNV 
(black line) or ABX‐treated (red line) mice at d7,10,12 post‐infection. Gray shaded histograms 
are  CD44lo  CD8  T  cells  isolated  from  the  lung.  Numbers  in  italics  represent  MFI.  Data 
representative of three independent experiments with n=4‐5 mice per group. *p<0.05, **p< 
0.01. 
 
 
 
Figure 10. Influenza virus-specific CD8 T cells have an altered phenotype in ABX-
treated mice that correlates with impaired activation. 
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Table 1. Frequency of DbGP33 tetramer+ CD8 T cells that express CD69, CD25, Granzyme‐b, 
CD43 or CXCR3 at d7, 10, or 12 post influenza virus infection (PR8‐GP33 strain). Positive gate 
determined by expression of markers on naïve CD44lo CD62Lhi, CD8 T cells. Data shown are 
the mean ± SEM. *p<0.05, **p<0.01, ***p<0.001. 
 
 
 
Table 1. Expression of activation markers on influenza virus-specific CD8 T cells. 
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Figure 11. CNV or ABX‐treated C57Bl/6 mice were infected i.n. with 1x105 TCID50 recombinant 
influenza  virus  X31‐GP33.  (A)  Timecourse  of  weight  loss  following  infection.  (B)  Influenza 
virus  genome  copies  in  the  lung  at  d7  post‐infection  assessed  by  qPCR  and  displayed  as 
TCID50/gram of  lung  tissue based on a  standard  curve of  genome  copies  versus  TCID50.  (C) 
Survival  curve  following  infection.  (D) H&E stained  lung  section of CNV or ABX  lungs at d7 
post‐infection  (black  arrow  highlights  epithelial  necrosis/loss;  scale  20µm).  Data 
representative of three independent experiments with n=4‐5 mice per group. Survival curve 
statistics  determined  by  logrank  test.  Viral  titer  statistics  determined  by  two‐part  t‐test. 
*p<0.05, **p <0.01, ***p<0.001. 
 
 
Figure 11. ABX-treated mice are susceptible to weakly pathogenic X31-gp33 
influenza virus strain. 
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Figure  12.  Total  number  of  DbGP33  tetramer+  CD8  T  cells  in  the  (A)  BAL,  (B)  lung,  (C) 
mediastinal lymph nodes, and (D) spleen at d7 post‐infection. (E) Lung cells were stimulated 
with GP33 peptide for 5hrs  in the presence of BFA. Proportion of GP33 peptide responsive 
CD8  T  cells  in  the  lung  producing multiple  effector molecules  (IFN‐γ ,  TNF‐α,  IL‐2, MIP‐1α, 
CD107a). Data representative of three independent experiments with n=4‐5 mice per group. 
Data shown are the mean ± SEM.  *p<0.05, **p <0.01, ***p<0.001. 
 
Figure 12. Diminished and functionally impaired influenza virus-specific CD8 T 
cell response in ABX-treated mice following X31 virus infection. 
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Figure 13. Recruitment and activation of innate immune cells in the lung is 
equivalent in CNV and ABX-treated mice following influenza virus infection. 
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Figure 13. (A) Total numbers of alveolar macrophages, inflammatory monocytes, neutrophils 
and plasmacytoid dendritic cells (pDC) isolated from BAL fluid at d3 post‐infection. Alveolar 
macrophages gated on CD3ε‐, CD5‐, CD19‐, NK1.1‐ (Non T, Non B, Non NK cells ‐ NTNBNNK), 
CD11c+,  F4/80+.  Inflammatory monocytes  gated  on  NTNBNNK,  CD11c‐,  F4/80‐,  Ly6g‐,  Ly6c+, 
CD11b+.  Neutrophils  gated  on  NTNBNNK,  CD11c‐,  F4/80‐,  Ly6g+,  CD11b+.  pDC  gated  on 
NTNBNNK, non‐alveolar macrophage, non‐neutrophil, non‐inflammatory monocyte, CD11cint, 
PDCA‐1+.  (B) Total numbers of dendritic cells  (DCs)  isolated from the  lung parenchyma and 
mediastinal lymph node (medLN). DCs are gated on NTNBNNK, F4/80‐, CD11c+, MHC‐IIhi cells. 
(C)  Expression of CD86 and CD40 on naïve or d3 post‐infection DCs  isolated  from  the  lung 
and  medLN  of  CNV  or  ABX‐treated  mice.  Data  representative  of  four  independent 
experiments with n=3‐5 mice per group. Data shown are the mean ± SEM. 
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Figure 14. Frequency of  the  IL‐10 competent  immune cells  in  the  (A)  lung, or  (B)  spleen of 
naïve,  CNV  or  ABX‐treated  IL‐10/eGFP  reporter  Vertex  mice.  B  cells  were  gated  on  live, 
CD45+, CD19+, MHC‐IIhi. CD4 T cells were gated on live, CD45+, CD3ε+, CD4+. CD8 T cells were 
gated  on  live,  CD45+,  CD3ε  +,  CD8+. Dendritic  cells were  gated  on  live,  CD45+,  CD3ε‐,  CD5‐, 
CD19‐  (Non‐T, Non‐B  ‐ NTNB) CD11c+, MHC‐IIhi.  Splenic macrophages  from  the  spleen were 
gated  on  live,  CD45+,  NTNB,  CD11b+,  F4/80+.  Alveolar  macrophages  were  gated  on  live, 
CD45+, NTNB, CD11c+, F4/80+. (C,D) Relative expression of Il‐10 mRNA in the (C) spleen or (D) 
lung of naïve CNV or ABX‐treated mice. (E) IL‐10 protein present in the BAL fluid of influenza 
virus  infected  CNV  or  ABX‐treated  mice  (PR8‐GP33).  IL‐10  levels  determined  by  luminex 
multiplex  bead  array.  Statistical  analysis  of  individual  timepoints was  done  by  Student’s  t‐
test. Data representative of two independent experiments with n=3‐5 mice per group. Data 
shown are the mean ± SEM. *p<0.05, **p<0.01. 
 
Figure 14. Equivalent IL-10 expression in CNV and ABX-treated mice at steady-
state and following influenza virus infection. 
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Figure  15.  (A)  Proinflammatory  cytokines  and  chemokines  present  in  BAL  fluid  d3  post 
influenza virus infection. (B) Fold induction of antiviral defense gene expression in the lung at 
d3 post‐influenza virus  infection compared to  lung of naive CNV mice as assessed by qPCR. 
Data  representative of  two or more  independent  experiments with n=3‐5 mice per  group. 
Data shown are the mean ± SEM. *p< 0.05, **p<0.01. 
 
Figure 15. Diminished induction of antiviral defense genes and proinflammatory 
cytokines in the lung of ABX-treated mice at D3 following influenza virus 
infection. 
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Figure  16.  CNV  or  ABX‐treated mice were  infected with  influenza  virus  (PR8‐GP33).  At  d3 
post‐infection, alveolar macrophages (NTNBNNK, F4/80+, CD11c+) were sorted from the BAL 
and  RNA  was  purified  to  assess  in  vivo  induction  of  antiviral  defense  genes  by  qPCR.  (A) 
Representative  FACS  plot  demonstrating  pre  &  post‐sort  purity  of  alveolar  macrophages. 
FACS plots gated on CD45+ cells. (B) Gene expression displayed as fold induction over naïve 
alveolar macrophages from CNV mice. Data representative of two independent experiments 
with n=3‐5 mice per group. Data shown are the mean ± SEM. *p <0.05, **p<0.01. 
 
Figure 16. Alveolar macrophages from influenza virus infected, ABX-treated mice 
exhibit diminished expression of antiviral defense genes. 
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Figure  17.  CNV  or  ABX‐treated  mice  were  infected  with  influenza  virus  (PR8‐GP33).  Mice 
received 30µg of poly I:C (ABX+pIC group) or PBS (CNV & ABX group) i.n. at d ‐1 and 100µg of 
poly I:C or PBS i.p. at d3. (A) Weight loss and (B) blood oxygen saturation following infection 
(representative exp. n=4‐6: † signifies mice below 70% initial weight were sacrificed). Weight 
loss statistics determined by two‐way ANOVA comparing ABX+pIC to ABX (p<0.01) or CNV to 
ABX  (p<0.01).  (C)  Survival  curve  following  influenza  virus  infection.  Survival  curve  is  a 
combination  of  2  independent  experiments.  CNV  n=10,  ABX  n=8,  ABX+pIC  n=12.  Survival 
statistics determined by logrank test comparing ABX+pIC to ABX (p<0.05) or ABX+pIC to CNV 
(p=0.12). *p <0.05, **p<0.01.  
 
Figure 17. Restoration of IFN responsiveness partially protects ABX-treated mice 
against influenza virus challenge. 
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Chapter 3 
Commensal bacteria-derived signals augment innate and 
adaptive immune responses following systemic viral infection 
3.1 Abstract 
Commensal bacterial communities can modulate intestinal immune homeostasis and 
response to infection in the gastrointestinal tract. Data presented in Chapter 2 
demonstrated a role for commensal bacteria-derived signals in promoting the antiviral 
immune response to a localized respiratory viral infection (influenza virus). Whether 
commensal bacteria-derived signals influence immunity to systemic viral infection, 
however, remains poorly defined. To test this, CNV or ABX- treated mice were infected 
with Lymphocytic Choriomeningitis Virus (LCMV) and the induction and quality of the 
innate and adaptive immune responses were analyzed. Macrophages isolated from 
ABX-treated mice exhibited lower expression of co-stimulatory molecules and impaired 
activation the type I interferon (IFN) signaling pathway. The diminished innate immune 
response was associated with a defective adaptive immune response. ABX-treated mice 
exhibited a functionally impaired LCMV-specific CD8 T cell response and delayed 
control of viral replication compared to CNV control mice. Collectively, these studies 
indicate that signals derived from commensal bacteria aid in the induction of a rapid 
antiviral immune response required for immunity to systemic viral infection.  
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3.2 Introduction 
Intestinal commensal bacteria are important in the development and homeostasis of the 
GALT (Artis, 2008; Macpherson and Harris, 2004). Immunologic analysis of mice that 
were reared in the absence of live commensal bacteria (GF mice), highlight the 
significance of the relationship between commensal bacterial communities and the 
intestinal immune system. For example, the Peyer’s patches and mesenteric lymph 
nodes of GF mice are reduced in cellularity and fewer CD4 and CD8 T cells reside in the 
intraepithelial compartment compared to CNV control mice (Glaister, 1973) (Macpherson 
and Harris, 2004). In addition to developmental defects, loss of commensal bacteria-
derived signaling impacts intestinal immune cell homeostasis and inflammation, altering 
immune cell differentiation, migration, and antibody production (Ivanov et al., 2008; 
Macpherson and Uhr, 2004; Niess and Adler, 2010; Obata et al., 2010; Round and 
Mazmanian, 2010). Several murine models of spontaneous intestinal inflammation, in 
part characterized by overproduction of proinflammatory cytokines in the intestinal 
microenvironment, exhibit amelioration of disease when re-derived in a sterile, germ-free 
environment (Dianda et al., 1997; Schultz et al., 1999; Sellon et al., 1998). Collectively, 
these studies demonstrate a fundamental relationship between commensal bacteria and 
the intestinal immune system. 
However, whether commensal bacteria-derived signals shape the systemic immune 
system, which is not in direct contact with commensal bacteria that reside at barrier 
surfaces of the body, is less well characterized. GF mice have fewer germinal centers 
and plasma cells in the spleen supporting a role for commensal bacteria in immune 
development beyond the GALT (Macpherson and Harris, 2004). It has also been 
reported that the commensal specie Segmented Filamentous Bacteria can impact 
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disease progression in murine models of autoimmune inflammatory disorders such as 
arthritis, multiple sclerosis and diabetes (Ivanov et al., 2009; Kriegel et al., 2011; Lee et 
al., 2011; Wu et al., 2010b), suggesting that commensal bacterial communities can have 
an impact on systemic inflammatory responses. It is unknown, however, whether 
commensal bacteria-derived signals help shape the systemic immune response to a 
pathogen that infect multiple tissues throughout the host. This chapter addresses the 
impact of commensal bacteria-derived signals on the host immune response to a 
systemic pathogen, Lymphocytic Choriomeningitis Virus (LCMV). 
Unlike influenza virus, which was employed in studies described in Chapter 2, LCMV 
is a non-cytolytic virus that can infect multiple organs, such as the spleen, liver, kidney, 
lung as well as the gastrointestinal tract (Buchmeier et al., 1980; Sydora et al., 1996). 
Infection can result in a chronic viremia if not efficiently controlled by the antiviral 
immune response with viral reservoirs persisting at immuno-privileged sites such as the 
CNS and kidney (Ahmed et al., 1987; Ahmed et al., 1984b; Zajac et al., 1998). LCMV 
infection elicits a potent CD8 cytotoxic T lymphocyte (CTL) response that is crucial for 
viral control through the production of proinflammatory cytokines (e.g. TNF-α and IFN-γ) 
and cell-mediated cytotoxicity (Ahmed et al., 1984a; Kaech et al., 2002; Welsh et al., 
1990). Dendritic cells and macrophages of the innate immune system are critically 
important in the priming and expansion of the LCMV-specific CD8 T cell response via 
antigen presentation, co-stimulatory molecule interaction, and production of 
proinflammatory cytokines such as type I IFNs that provide a 3rd signal to initiate T cell 
activation (Belz et al., 2005; Cousens et al., 1999; Montoya et al., 2005; Oehen et al., 
2002; Seiler et al., 1997). In this chapter, we demonstrate that following LCMV infection 
mice depleted of commensal bacteria exhibit a functionally defective LCMV-specific CD8 
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T cell response that correlates with delayed control of viral replication. Compared to 
CNV mice, ABX-treated mice exhibited diminished induction of innate proinflammatory 
cytokines and antiviral defense genes early following infection. Specifically, 
macrophages from ABX-treated mice exhibited an impaired response to type I IFN 
signaling and a diminished activation profile. Thus, commensal bacteria-derived signals 
are critical in the intiation of the early innate immune response to systemic viral infection. 
Lack of sufficient commensal bacteria-derived signaling lead to downstream defects in 
the adaptive immune response and ultimately an inability to control viral infection. 
3.3 Methods 
3.3.1 Mice and viruses 
C57BL/6 mice (4-6 weeks old) were purchased from the National Cancer Institute 
(Frederick, MD). Mice were maintained in specific pathogen–free facilities at the 
University of Pennsylvania. The University of Pennsylvania Institutional Animal Care and 
Use Committee (IACUC) approved all protocols, and all experiments were performed 
according to the guidelines of the University of Pennsylvania IACUC. Mice were 
inoculated intravenously (i.v.) with LCMV T1b (4x106 PFU). LCMV viral titers were 
determined by plaque assay on Vero cell monolayers (Ahmed et al., 1984b). 
3.3.2 Oral antibiotic treatment 
Mice were provided autoclaved drinking water supplemented with ampicillin (0.5 mg/mL, 
Sigma), gentamicin (0.5 mg/mL, Gemini Bio-Products), metronidazole (0.5 mg/mL 
Sigma), neomycin (0.5 mg/mL, Med-Pharmex), vancomycin (0.25 mg/mL, Novaplus), 
and sucralose (4mg/mL, Splenda, McNeil Nutritionals, LLC). Splenda was added to 
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make the antibiotic cocktail more palatable. Antibiotic treatment was started 2-4 weeks 
prior to infection and continued for the duration of the experiment. 
3.3.3 Isolation of cells and flow cytometric staining 
Lymphocytes were isolated from the spleen or lymph node by mechanical disruption 
through 70µm cell strainers followed by red blood cell (RBC) lysis. Peripheral blood 
mononuclear cells (PBMCs) were isolated using a Histopaque gradient (Sigma). 
Peritoneal exudates cells (PECs) were obtained by injecting and recovering PBS from 
the peritoneal cavity. Single cell suspensions were surface stained in FACS Buffer (PBS, 
2% BSA, 0.2mg Sodium Azide, 2mM EDTA) using standard flow cytometric staining 
protocols with fluorescently conjugated antibodies specific to CD3ε, CD4, CD8α, CD11c, 
CD19, CD25, CD43, CD45, CD69, CD160, F4/80, Ly6c, MHC-I (H-2Kb), MHC-II (I-A/I-E) 
(eBioscience), CD5, CD44, CD80, CD86, Ly6g (clone 1A8), ICOS, LAG-3, PD-1 (clone 
RMP1-30) (Biolegend), CD40 (BD Biosciences), CXCR3 (R&D Systems), 2B4 (BD 
Pharmingen), CD11b, and granzyme B (Invitrogen). Major histocompatibility complex 
(MHC) class I peptide tetramers were made and used to identify virus-specific CD8 T 
cells (Altman et al., 1996). For intracellular cytokine analysis, 106 splenocytes were 
cultured in a 96-well plate in complete media with viral peptides (0.2 µg/ml) and brefeldin 
A (Golgiplug, eBioscience) for 5 hrs at 37°C. After staining for surface antigens as 
described above, cells were stained for intracellular cytokines using the 
Cytofix/Cytoperm kit (BD Pharmingen) and fluorescently conjugated antibodies specific 
for IL-2 (eBioscience), IFN-γ (BD Pharmingen), TNF-α (Biolegend), MIP-1α (R&D 
Systems). The CD107a assay was performed as previously described (Blackburn et al., 
2009). Cell viability was assessed with Live/Dead AQUA stain (Invitrogen). Samples 
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were collected by using a LSR II flow cytometer (Becton Dickinson). All flow cytometry 
data was analyzed by FlowJo v 8.8 (Treestar). Pie charts were created using the Pestle 
and SPICE programs (Mario Roederer; Vaccine Research Center, NIAID, NIH). 
3.3.4 Virus-specific antibody and cytokine ELISA 
LCMV-specific IgM and IgG serum antibody concentrations were determined by ELISA 
as previously described (Ahmed et al., 1984b; Mozdzanowska et al., 2000). In brief, 
LCMV was adsorbed to plates and bound antibody was detected using anti-IgM or -IgG 
conjugated to alkaline phosphatase (Sigma) and developed with p-nitrophenol 
phosphate (Sigma). Optical densities (OD405-750) were measured using an ELISA reader 
and concentrations calculated using SoftMax Pro software (Molecular Devices). Serum 
samples were analyzed for cytokines and chemokines by luminex multiplex bead array 
(Millipore). Tissue from the spleen was mechanically homogenized in DMEM, 
centrifuged, and the resultant supernatant was measured  for cytokine secretion by 
ELISA (eBioscience). IFN-β protein levels in the serum or spleen homogenates were 
measured by ELISA (PBL Interferonsource). 
3.3.5 RNA isolation, cDNA preparation, and RT-PCR 
RNA was isolated from cells using an RNeasy mini-kit (Qiagen) and from spleen tissue 
using mechanical homogenization and TRIzol isolation (Invitrogen) according to the 
manufacturer’s instructions. cDNA was generated using SuperScript reverse 
transcriptase (Invitrogen). RT-PCR was performed on cDNA using SYBR green 
chemistry (Applied Biosystems) and commercially available primer sets (Qiagen). 
Reactions were run on an RT-PCR system (ABI7500; Applied Biosystems). Genes of 
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interest were normalized to hypoxanthine guanine phosphoribosyl transferase (Hprt) and 
displayed as fold difference relative to uninfected CNV control mice. 
3.3.6 In vivo Phosflow STAT1 staining following LCMV infection 
LCMV-infected CNV or ABX-treated mice were sacrificed at 6 or 12 hrs post-infection. 
Cells were immediately fixed to preserve phosphorylation status as described in (Krutzik 
et al J.I. 2005). Briefly, cells were directly resuspended in DMEM w/ 1.6% PFA. 
Following a 10 minute incubation at room temperature, cells were centrifuged and 
resuspended in 90% methanol for 30 minutes at 4 oC then washed 3x with FACS buffer 
followed by staining with surface markers and pSTAT1 with PE-conjugated anti-STAT1 
(pY701) antibody (BD biosciences).  
3.3.7 Statistical analysis 
Results represent means ± SEM. Statistical significance was determined by the 
unpaired, two tailed, Student’s t-test for individual timepoints, two-way ANOVA test for 
timecourse experiments, logrank test for survival curve, or two-part t-test for comparison 
of groups that contained samples that were below the limit of assay detection. Statistical 
analyses were performed using Prism GraphPad software v4.0. (*p < 0.05; **p < 0.01; 
***p < 0.001). 
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3.4 Results  
3.4.1 Diminished adaptive immune response and delayed clearance of LCMV 
following ABX-mediated depletion of commensal bacteria  
Signals from commensal bacteria regulate immune cell homeostasis and susceptibility to 
multiple infectious and inflammatory diseases in the gastrointestinal tract (Garrett et al., 
2010b; Honda and Littman, 2012; Round and Mazmanian, 2009). However, it is not clear 
whether commensal bacteria-derived signals regulate immunity to pathogens that infect 
sites distal to the gastrointestinal tract.  To address this question, naïve C57BL/6 mice 
were orally administrated broad-spectrum antibiotics for two weeks and subsequently 
infected with 2x106 PFU LCMV T1b, a strain of virus that results in viremia for 1-2 weeks 
and requires a robust innate and adaptive immune response for viral clearance 
(Blackburn et al., 2009; King et al., 1990). Consistent with our earlier studies, exposure 
to antibiotics resulted in loss of culturable bacteria from enteric contents, a reduction in 
total bacterial 16S rDNA in the intestine and a dramatic reorganization of the commensal 
community structure (Figure 18A) (Hill et al., 2010). CNV mice and ABX-treated mice 
were longitudinally bled following LCMV infection to assess viral clearance and induction 
of virus-specific cellular and humoral adaptive immune cell response. CNV mice 
exhibited maximal viremia at day 7 (d7) post-infection and successfully controlled 
viremia by d23 (Figure 18B). Control of infection was associated with the population 
expansion of LCMV-specific H-2Db gp33+ and H2-Db gp276+ tetramer+ (H-2Db/GP33+ 
and H-2Db/GP276+) CD8 T cells (Figure 18C,D), the two dominant CD8 T cell epitopes, 
as well as the presence of LCMV-specific IgG in the serum (Figure 18E).  In contrast, 
ABX-treated mice exhibited a significant delay in clearance of LCMV (Figure 18B) that 
was associated with a delayed expansion of LCMV-specific CD8 T cell response and 
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reduced IgG antibody titers in the serum (Figure 18C-E). Thus, longitudinal bleeds to 
monitor a systemic viral infection in mice depleted of commensal microbial communities 
revealed a significant defect in the ability to control viremia and mount an adaptive 
immune response to LCMV infection in ABX-treated mice. 
CNV or ABX-treated mice were sacrificed one month following LCMV infection and 
virus-specific immune responses and persisting viral reservoirs in peripheral tissues 
were analyzed. At d31 post-infection, ABX-treated mice exhibited increased viral titers in 
the kidneys (Figure 19A) that correlated with fewer total numbers of LCMV-specific 
tetramer+ (H-2Db/GP33+, H-2Db/GP276+ and H-2Db/NP396+) CD8 T cells in the spleen 
(Figure 19C-D). Elevated viral titers and decreased numbers of LCMV-specific CD8 T 
cells in ABX-treated mice indicate a significant impaired ability to control systemic viral 
infection in ABX-treated mice.  
3.4.2 ABX-treated mice exhibit a functionally impaired LCMV-specific CD8 T cell 
response 
Persisting viral reservoirs and fewer virus-specific CD8 T cells has been closely linked to 
functionally impaired CD8 T cell responses (Fuller et al., 2004; Wherry et al., 2005; 
Zajac et al., 1998), which can be characterized by a hierarchical increase in expression 
of multiple inhibitory receptors and decreased expression of effector molecules, 
attributes considered to be hallmarks of CD8 T cell exhaustion (Blackburn et al., 2009; 
Wherry et al., 2003). Therefore, LCMV-specific CD8 T cells isolated from the spleen of 
CNV or ABX-treated mice were assessed for expression of inhibitory receptors and 
effector molecules to measure CD8 T cell function. At d31 post-infection, LCMV-specific 
H2-Db/GP33 tetramer+ CD8 T cells isolated from ABX-treated mice expressed increased 
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levels of multiple inhibitory receptors PD-1, 2B4, CD160 and LAG-3 compared to H2-
Db/GP33 tetramer+ CD8 T cells from CNV mice (Figure 20A,B).  
Following ex vivo stimulation with viral peptides, cytotoxic CD8 T cells (Figure 21A,B 
from CNV mice readily produced effector cytokines such as IFN-γ and TNF-α, critical 
effector molecules with potent antiviral properties (Leist et al., 1989; Ramshaw et al., 
1997). In contrast, GP33 responsive CD8 T cells from ABX-treated mice were less 
efficient producers of multiple effector molecules (IFN-γ, TNF-α, IL-2, MIP-1α, CD107a) 
(Figure 21A,B). To evaluate whether the impaired DbGP33 tetramer+ CD8 T cell 
response in ABX-treated mice is indicative of the global LCMV-specific CD8 T cell 
response, splenocytes were stimulated with a pool of 20 LCMV-specific peptides (Kotturi 
et al., 2007). Following stimulation with pooled LCMV-specific peptide, fewer IFN-
γ+/TNF-α+ dual producing CD8 T cells were observed in ABX-treated mice compared to 
CNV mice (Figure 21C,D) confirming that the functionally impaired response to the 
GP33-41 epitope was representative of the total LCMV-specific CD8 T cell response in 
ABX-treated mice. Together, these data are consistent with more severe T cell 
exhaustion in the ABX-treated group, a characteristic sign of impaired immunity to LCMV 
infection (Wherry, 2011; Yi et al., 2010).  
In addition, while there was no significant difference in the total number of LCMV-
specific I-Ab/GP61 tetramer+ CD4 T cells in the spleen at d31 post-infection (Figure 
22A), a significant increase in PD-1 expression on GP61 tetramer+ CD4 T cells was 
observed in the spleen ABX-treated mice compared to CNV mice (Figure 22B), 
indicating impairment in the quality of the virus-specific CD4 T cell response. Stimulation 
of splenocytes with GP61 peptide revealed that fewer GP61 tetramer+ CD4 T cells 
isolated from ABX-treated mice produced cytokines (IFN-γ and IL-2) compared to CD4 T 
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cells from CNV mice (Figure 22C). Combined, these data indicate that deliberate 
manipulation of commensal bacteria-derived signals results in defective virus-specific 
adaptive CD4 and CD8 T cell responses and impaired control of viral replication 
following systemic infection. 
3.4.3 Impaired innate immune response to LCMV infection in ABX-treated mice 
Studies discussed in Chapter 2 demonstrated that depletion of commensal bacteria 
resulted in reduced adaptive immune responses and impaired viral clearance that 
correlated with diminished induction of innate proinflammatory cytokines and antiviral 
defense genes early following infection. To determine whether a diminished innate 
antiviral response was a generalized phenomenon in ABX-treated mice, expression of 
macrophage-associated antiviral response genes and production of proinflammatory 
cytokines were examined during LCMV infection. As early as 12 hours post-LCMV 
infection significantly reduced expression of mRNA encoding Ifnb, Irf7, Mx1, Oas1a and 
Stat1 in the spleen (Figure 23A) and decreased IFN-β in the serum (Figure 23B) was 
observed in ABX-treated mice compared to CNV mice. Furthermore, reduced levels of 
proinflammatory cytokines were detected in the spleen homogenates of ABX-treated 
mice following LCMV infection (Figure 23C), indicating a diminished innate antiviral 
responses following systemic viral infection. In addition, expression of costimulatory 
molecules on macrophages and dendritic cells from CNV or ABX-treated mice was 
assessed as a measure of innate immune activation following infection. Macrophages 
isolated from ABX-treated LCMV-infected mice exhibited reduced expression of MHC-I 
and CD86 (Figure 23D) and DCs expressed reduced MHC-II and CD86 at d1 post-
infection (Figure 23E). Collectively, these findings indicate that ABX-mediated alterations 
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in commensal bacteria result in selective dysregulation of innate immune responses 
following systemic viral infection. 
3.4.4 Impaired in vivo antiviral macrophage response following LCMV in ABX-
treated mice 
Induction of type I IFNs in response to viral infection is a critical step in initiating early 
innate antiviral defense mechanisms (Hwang et al., 1995; Muller et al., 1994). IFN 
signaling leads to transcription of antiviral defense genes, the recruitment and activation 
of innate immune cells, and aid in the induction of T cell expansion and differentiation 
(Ramshaw et al., 1997; Sen, 2001). Diminished activation of innate immune cells and 
induction of proinflammatory cytokines in ABX-treated mice early following LCMV 
infection suggests defects in the IFN response. STAT1 is a transcription factor 
downstream of the IFN receptor signaling pathway (Li et al., 1997). Following IFN 
stimulation, STAT1 is phosphorylated, translocates into the nucleus, and initiates 
transcription of multiple antiviral defense genes including a positive feedback loop of 
more type I IFN production (Schindler et al., 1992; Shuai et al., 1992). Therefore, STAT1 
phosphorylation can be used as a bio-marker for IFN signaling. To determine whether 
defects in macrophage interferon signaling exist in vivo following viral infection, CNV or 
ABX-treated mice were infected with LCMV and the STAT1 phosphorylation status of 
innate immune cells in the spleen and peritoneal cavity was assessed by fixing cells 
directly ex vivo. This procedure preserves the phosphorylation status of the STAT 
protein in the cell as it existed in vivo (Krutzik et al., 2005). As early as 6 hr post-
infection, macrophages isolated from the spleen of ABX-treated mice displayed reduced 
pSTAT1 compared to splenic macrophages in CNV mice (Figure 24A,B). By 12hr post-
infection, peritoneal macrophages from ABX-treated mice had yet to display a significant 
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phosphorylation of STAT1 while pSTAT1 induction was detectable in peritoneal 
macrophages from CNV mice (Figure 24C,D). These results indicate that antiviral 
responses in macrophages from ABX-treated mice following LCMV infection are 
impaired in vivo. These data, in combination with the data presented in Chapter 2 
identifying diminished expression of antiviral defense genes in alveolar macrophages 
isolated from ABX-treated mice following influenza virus infection (Figure 16), suggest a 
global defect in macrophage antiviral response in hosts lacking exposure to commensal 
bacteria-derived signals. 
3.5 Discussion 
Commensal bacterial communities can modulate immune cell homeostasis and disease 
by providing either immunoregulatory or proinflammatory signals (Round and 
Mazmanian, 2009). For example, the microbial product polysaccharide A, isolated from 
Bacteroides fragilis, can reduce the severity of intestinal inflammation in two murine 
models of IBD (Mazmanian et al., 2008). In addition, Segmented Filamentous Bacteria, 
an enteric commensal bacteria induces a CD4+ TH17 cell population in the small 
intestine leading to increased susceptibility to autoimmune arthritis and experimental 
autoimmune encephalomyelitis (Lee et al., 2011; Wu et al., 2010b), demonstrating that 
intestinal bacteria can shape the inflammatory response at sites outside of the local 
gastrointestinal environment. These studies provoke the hypothesis that commensal 
bacteria-derived signals might influence the systemic immune response to infection. 
The results presented in this chapter demonstrate a role for commensal bacterial 
communities in influencing the immune response to a systemic viral infection. Antibiotic-
mediated disruption of commensal bacterial communities compromised innate and 
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adaptive antiviral immunity following LCMV infection. Severe defects in the adaptive 
immune response to LCMV as well as poor control of viral replication pointed toward 
early defects in the initiation of antiviral responses.  Indeed, significant differences in the 
macrophages between CNV and ABX-treated mice were apparent as early as 6 hours 
following infection. For rapidly replicating viruses, such a delay in initiating antiviral 
pathways and activating downstream events, such as humoral and cell-mediated 
adaptive immune responses, can lead to failure to control infection, as well as more 
dramatic consequences such as host mortality, as was observed with influenza virus in 
Chapter 2. Together, these data suggest a model in which signals from commensal 
bacteria are priming the innate immune system to ensure a rapid and robust immune 
response upon encounter with viral pathogens. The impact of commensal bacteria-
derived signals on shaping innate immune cells prior to infection will be addressed in 
Chapter 4.  
This chapter established that commensal bacteria influence activation of IFN signaling, 
a ubiquitous innate antiviral response pathway. Induction of a type I IFN response is 
fundamental and critical for defense against the majority of viruses and is a hard-wired 
response usually induced within minutes to hours of viral infection (Ramshaw et al., 
1997; Sen, 2001). Macrophages isolated from ABX-treated mice, however, displayed 
defects in phosphorylation of STAT1, an immediate downstream molecule of type I IFN/ 
IFN receptor interactions, early following viral infection compared to macrophages from 
CNV mice. This reduction in STAT1 phosphorylation was associated with a significant 
decrease in proinflammatory cytokine production and reduced induction of antiviral 
defense genes.  
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It was notable that macrophages isolated from ABX-treated mice that had not been 
infected with LCMV also displayed less detectable in vivo STAT1 phosphorylation 
compared to macrophages from naïve CNV counterparts (Figure 23). This trend was 
consistent over several experiments, however did not reach statistical significance. 
Potentially, commensal bacteria-derived signals may induce tonic, low-level STAT1 
activation at steady-state impacting basal transcription of antiviral defense genes prior to 
infection. This possibility will be further explored in Chapter 4. Notwithstanding this, the 
mechanisms through which commensal bacteria-derived signals stimulate immune cells 
in the periphery are poorly understood. One possibility is that lymphoid tissue-resident 
immune cells are directly exposed to commensal bacteria or their products. Small 
numbers of live commensal bacteria can be found in the Peyer’s patches and 
mesenteric lymph nodes of mice at steady-state, and there is some evidence that 
absorbed commensal products circulate throughout the host (Clarke et al., 2010; 
Macpherson and Uhr, 2004; Obata et al., 2010). Thus, direct interaction between 
peripheral immune cells and microbial products is plausible; however, the mechanism of 
microbial translocation from sites of bacterial colonization remains poorly defined. 
Another possibility is that commensal bacteria act indirectly on peripheral immune cells 
via responses evoked from epithelial or other mucosal-associated cells. Commensal-
driven secretion of epithelial-derived cytokines can regulate intestinal immune cell 
homeostasis (Bouskra et al., 2008; He et al., 2007; Rimoldi et al., 2005b; Zaph et al., 
2007), raising the possibility that epithelial cells exposed to commensal bacteria in the 
steady-state could secrete immunomodulatory factors into the circulation that influence 
other hematopoietic cells. Defining the potential pathways involved in microbial sensing 
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by the peripheral immune system will be crucial to understanding how microbial 
crosstalk influences immune cell homeostasis and host protective immunity.  
In summary, these studies have uncovered a previously unrecognized role for 
commensal bacteria-derived signals in influencing the immune response to a systemic 
virus.  In addition, these studies provide novel insights into how distinct microbial 
sensing and response pathways are integrated and provide evidence for critical cross-
regulation of antiviral immunity by bacterial communities. These findings could lead to 
new opportunities to improve antiviral immunity and to understand the role of commensal 
bacteria in influencing patients’ predisposition to distinct immunologic and pathologic 
outcomes from viral infections. 
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Figure 18. (A) Total bacterial 16S rDNA in stool samples from naïve CNV or ABX‐treated mice 
following  two weeks of antibiotic  treatment.  (B‐E) CNV or ABX‐treated C57BL/6 mice were 
infected  i.v.  with  2x106  PFU  of  LCMV  T1b.  (B)  Viral  titer  in  the  serum  following  infection 
(L.o.D., limit of detection). LCMV‐specific (C) DbGP33 and (D) DbGP276 tetramer+ CD8 T cells 
per  106  peripheral  blood mononuclear  cells  (PBMCs)  at  d7,  14,  and  23  post‐infection.  (E) 
Serial dilution of LCMV‐specific  IgG antibody titers  in serum of CNV or ABX‐treated mice at 
d23  post‐infection.  Naïve  serum  from  CNV mice  used  for  baseline.  Data  representative  of 
three independent experiments with n=5 mice per group. Data shown are the mean ± SEM. 
Serum  viral  titer  statistics  determined  by  two‐part  t‐test  for  each  timepoint.  *p<0.05, 
**p<0.01. 
 
 
Figure 18. Systemic LCMV T1b infection results in delayed viral clearance and 
reduced expansion of the LCMV-specific CD8 T cell response in ABX-treated 
mice. 
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Figure  19.  (A)  Viral  load  in  the  kidney  of  CNV  or  ABX‐treated  mice  at  d31  post‐LCMV 
infection. (B) Total number of DbGP33, DbGP276, and DbNP396 tetramer+ CD8 T cells in the 
spleen. Data representative of two‐three independent experiments with n=5 mice per group. 
Data shown are the mean ± SEM. *p<0.05, **p<0.01, ***p<0.001. 
 
 
 
Figure 19. ABX-treated mice exhibit persisting viral reservoirs and fewer LCMV-
specific CD8 T cells at D31 post-infection.   
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Figure  20.  (A)  Expression  of  inhibitory  receptors  PD‐1,  2B4,  CD160,  LAG‐3  on  DbGP33 
tetramer+ CD8 T cells  isolated  from the spleen of CNV (black  line) or ABX‐treated  (red  line) 
mice at d31 post‐LCMV infection. Shaded histograms represent CD44lo CD8 T cells. Numbers 
in  italics  represent mean  fluorescence  intensity  (MFI).  (B)  Proportion of DbGP33  tetramer+ 
CD8  T  cells  expressing  multiple  inhibitory  receptors.  Data  representative  of  two‐three 
independent  experiments  with  n=5  mice  per  group.  Data  shown  are  the  mean.  *p<0.05, 
**p<0.01. 
 
 
 
Figure 20. Increased expression of inhibitory receptors on LCMV-specific CD8 T 
cells in ABX-treated mice. 
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Figure  21.  Splenocytes  from  d31  LCMV‐infected  mice  were  incubated  with  GP33  peptide 
(A,B)  or  a  pool  of  20  LCMV‐specific  peptides  (C,D)  (Kotturi  et  al.,  2007)    for  5  hrs  in  the 
presence of BFA and assessed  for production of  effector molecules  (IFN‐γ,  TNF‐α, MIP‐1α, 
CD107a,  IL‐2).  (A)  Frequency  of  IFN‐γ/TNF‐α  dual  producing  CD8  T  cells  in  the  spleen 
following GP33 peptide  stimulation.  (B)  Proportion of GP33 peptide  responsive CD8 T  cells 
producing multiple effector molecules.  (C)  Frequency and  (D)  total number of  IFN‐γ/TNF‐α 
dual producing CD8 T cells  in  the spleen  following stimulation with pooled LCMV peptides. 
FACS  plots  gated  on  live,  CD8α+  cells.  Data  representative  of  two‐three  independent 
experiments with n=5 mice per group. Data shown are the mean ± SEM. *p<0.05, **p<0.01. 
 
 
 
Figure 21. LCMV-specific CD8 T cells isolated from ABX-treated mice produce 
less effector cytokines. 
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Figure 22. (A) Total number of I‐AbGP61 tetramer+ CD4 T cells in the spleen of CNV or ABX‐
treated mice at d31 post‐LCMV infection. (B) Expression of PD‐1 on I‐AbGP61 tetramer+ CD4 
T  cells  from  the  spleen  of  CNV  (black  line)  or  ABX‐treated  (red  line)  mice  at  d31  post‐
infection. Shaded histogram represents CD44lo CD62Lhi naïve CD4 T cells. Numbers  in  italics 
represent MFI.  (C) Splenocytes  from d31  infected mice were  either  stained with  I‐AbGP61 
tetramer or  incubated with  LCMV peptide  (GP61‐80)  for  5 hrs  in  the presence of BFA and 
assessed for production of IFN‐γ and IL‐2. Data shown are the mean ± SEM. *p<0.05. 
 
 
Figure 22. ABX-treated mice exhibited a functionally impaired CD4 T cell response 
following LCMV infection. 
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Figure 23. Innate antiviral immune response is diminished in ABX-treated mice 
following LCMV infection. 
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Figure 23. (A) Fold induction of antiviral defense genes in the spleen 12 hrs following LCMV  
infection  compared  to  expression  in  the  spleen  of  naïve  CNV mice.  (B)  IFN‐β  levels  in  the 
serum  at  12  hrs  post‐LCMV  infection  as  detected  by  ELISA.  (C)  Proinflammatory  cytokine 
levels  in  spleen  homogenates  at  6‐24hr  post  LCMV  infection  (n.d.,  not  detectable).   (D) 
Expression  of  MHC‐I  and  CD86  on  peritoneal  macrophages  and  (E)  MHC‐II  and  CD86  on 
peritoneal  dendritic  cells  from CNV or ABX‐treated mice  24  hrs  post  LCMV  infection. Data 
representative of  two or more  independent  experiments with n=3‐5 mice per  group. Data 
shown are the mean ± SEM. *p<0.05, **p<0.01. 
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Figure  24.  CNV  or  ABX‐treated  mice  were  inoculated  with  LCMV  or  PBS  i.v.  and  (A,B) 
splenocytes at 6 hrs post‐infection or (C,D) peritoneal exudate cells at 12 hrs post‐infection 
were isolated and immediately fixed to preserve the in vivo STAT1 phosphorylation status of 
macrophages. (A,B) Frequency of pSTAT1+ splenic macrophages. Splenic macrophages gated 
on  Non  T,  Non‐B,  Non  NK  cells  (NTNBNNK),  CD11c‐,  Ly6g‐,  Ly6c‐,  F4/80+,  CD11blo.  (C,D) 
Frequency of pSTAT1+ peritoneal macrophages. Peritoneal macrophages gated on NTNBNNK, 
F4/80+, CD11b+.   Data representative of two independent experiments with n=3‐5 mice per 
group. Data shown are the mean ± SEM. *p<0.05, **p<0.01. 
Figure 24 Antiviral macrophage response is impaired in ABX-treated mice 
following LCMV infection. 
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Chapter 4 
Commensal bacteria-derived signals calibrate the activation 
threshold of the innate immune system 
4.1 Abstract 
Commensal bacterial communities shape intestinal immune cell homeostasis and can 
influence the predisposition to intestinal and systemic inflammatory and autoimmune 
diseases. Further, commensal bacteria can act as an adjuvant and boost the immune 
response to an ongoing infection. However, it is unclear whether commensal bacteria-
derived signals can shape immune cell activation prior to infection rendering the immune 
system more or less susceptible to a potential pathogenic challenge. Defective 
macrophage responses to viral infection in mice depleted of commensal bacterial 
communities, as reported in Chapters 2 and 3, suggested an inherent impairment in the 
ability of macrophages from ABX-treated mice to respond to viruses. Genome-wide 
transcriptional profiling of macrophages isolated from naïve ABX-treated mice revealed 
decreased expression of genes associated with antiviral immunity. Moreover, 
macrophages isolated from ABX-treated mice exhibited defective responses to type I/II 
IFNs and impaired capacity to limit viral replication. Transfer of macrophages from CNV 
mice into ABX-treated mice immediately prior to LCMV infection improved the virus-
specific adaptive immune response and restored the ability to control viremia. 
Collectively, these data indicate that commensal bacteria-derived signals provide tonic 
immune stimulation that calibrates the activation threshold of the innate immune system 
required for optimal antiviral immunity. 
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4.2 Introduction 
Host defense against invasive pathogens requires a coordinated response by the innate 
and adaptive immune system. The role of the innate immune system is detection of 
pathogens and initiation of the proper immune response needed to eliminate infection. In 
the absence of antigen-specificity, which evolved with the adaptive immune system to 
enable a targeted immune response against a specific pathogen, the innate immune 
system relies on germ-line encoded PRRs that recognize distinct PAMPs to distinguish 
between types of pathogens. PAMP recognition by PRRs expressed by innate immune 
cells activates defense pathways that initiate immune responses tailored to effectively 
combat the particular class of pathogen from which the PAMP originates (Medzhitov, 
2007). For example, the innate immune response to parasitic infection leads to activation 
of genes programmed to prevent colonization and expel the parasite (Reese et al., 2007; 
Stetson et al., 2004) while viral infection activates genes that limit cytosolic RNA 
synthesis and thus viral replication (Seth et al., 2006). These innate defense 
mechanisms can be constitutively expressed, thereby limiting the ability of pathogens to 
establish a productive infection, but must also be carefully balanced, as overexpression 
of host defense genes can be detrimental to the host. For example, constitutive 
expression of type I IFN, a potent antiviral cytokine, can lead to autoimmune diseases 
when unchecked by negative regulators (Arakura et al., 2007; Hida et al., 2000). In 
addition, overexpression of proinflammatory cytokines in the intestine, which have 
important roles in maintaining the intestinal barrier, are associated with an increased 
incidence of IBD and colonic cancer (Karin et al., 2006; Papadakis and Targan, 2000). 
Thus, the innate immune system must be dynamically calibrated to enable rapid 
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response upon encounter with pathogens while limiting detrimental side effects to the 
host. 
The mammalian innate immune system has evolved diverse strategies to detect and 
respond to a vast array of microbial signals, allowing induction of distinct defense 
mechanisms tailored to different types of pathogens (anti-bacterial vs. antiviral vs. anti-
protozoan response) (Medzhitov, 2007). Despite this apparent specialization in pattern 
recognition and induction of innate immune responses, crosstalk between pathways has 
been reported where stimulation from one class of pathogens influences the immune 
response against another class (Actor et al., 1993; Barton et al., 2007; Spencer et al., 
1977). However, it is unclear if commensal bacteria influence innate immune pathways 
in the steady-state and, if so, whether these interactions modulate the systemic immune 
response to viral pathogens. Iwasaki and colleagues reported impaired antiviral 
immunity in the lung following deliberate manipulation of commensal bacteria (Ichinohe 
et al., 2011).  This effect was associated with defective activation of the inflammasome, 
a pathway activated by bacterial products that is also important in conferring protective 
immunity against a subset of viruses, including influenza virus and poxviruses (Lamkanfi 
and Dixit, 2011). Whether depletion of commensal bacteria selectively regulates 
inflammasome-dependent pathways or represents broader immunological crosstalk 
between commensal bacteria and other antiviral pathways remains to be determined. 
In this chapter, I examine this fundamental question and demonstrate a critical role for 
commensal bacteria in setting the immune activation threshold of macrophages required 
for antiviral immunity. Manipulating commensal bacterial communities dramatically 
impaired host protective immunity following either mucosal (influenza virus, Chapter 2) 
or systemic (LCMV, Chapter 3) viral infection, leading to dysregulated adaptive immune 
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responses and underlying defects in innate antiviral defense pathways. Genome-wide 
transcriptional profiling of macrophages isolated from naive ABX-treated mice revealed 
reduced expression of genes associated with IFN activation and antiviral immunity 
indicating an inherent impairment in responsivness to viruses in ABX-treated mice prior 
to infection. Moreover, transfer of macrophages isolated from CNV mice into ABX-
treated mice re-established antiviral immunity to LCMV infection in ABX-treated mice. 
Taken together, these data indicate that commensal bacteria provide tonic signals that 
calibrate the activation threshold and sensitivity of the innate antiviral immune system. 
4.3 Methods 
4.3.1 Mice  
C57BL/6 mice (4-6 weeks old) were purchased from the National Cancer Institute 
(Frederick, MD). Mice were maintained in specific pathogen–free facilities at the 
University of Pennsylvania. GF Swiss/Webster mice were maintained in plastic isolator 
units and fed autoclaved chow and water. The University of Pennsylvania Institutional 
Animal Care and Use Committee (IACUC) approved all protocols, and all experiments 
were performed according to the guidelines of the University of Pennsylvania IACUC. 
4.3.2 Oral antibiotic treatment 
Mice were provided autoclaved drinking water supplemented with ampicillin (0.5 mg/mL, 
Sigma), gentamicin (0.5 mg/mL, Gemini Bio-Products), metronidazole (0.5 mg/mL 
Sigma), neomycin (0.5 mg/mL, Med-Pharmex), vancomycin (0.25 mg/mL, Novaplus), 
and sucralose (4mg/mL, Splenda, McNeil Nutritionals, LLC). Splenda was added to 
make the antibiotic cocktail more palatable. Antibiotic treatment was started 2-4 weeks 
prior to infection and continued for the duration of the experiment. 
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4.3.3 Isolation of cells and flow cytometric staining 
Single cell suspensions were isolated from the spleen by mechanical disruption through 
70µm cell strainers followed by red blood cell (RBC) lysis. Peritoneal exudates cells 
(PECs) were obtained by injecting and recovering PBS from the peritoneal cavity. Cells 
were surface stained in FACS Buffer (PBS, 2% BSA, 0.2mg Sodium Azide, 2mM EDTA) 
using standard flow cytometric staining protocol with fluorescently conjugated antibodies 
specific to CD3ε, CD4, CD8α, CD11c, CD19, CD25, CD43, CD45, CD69, CD119, 
CD160, F4/80, Ly6c, MHC-I (H-2Kb), MHC-II (I-A/I-E) (eBioscience), CD5, CD44, CD80, 
CD86, Ly6g (clone 1A8), ICOS, LAG-3, PD-1 (clone RMP1-30) (Biolegend), CD40, 
IFNαRI (BD Biosciences), CD11b (Invitrogen). 
4.3.4 Cell sorting and microarray-data analysis 
Peritoneal macrophages (CD3ε-, CD19-, CD11b+, F4/80+) from naïve CNV or ABX-
treated mice were sorted directly into TRIzol LS (Invitrogen) on a BD Aria (Beckson 
Dickson). Additional macrophages from the sample were separately sorted to ensure 
sort purity (≥95%). For microarray analysis, RNA was extracted from sorted peritoneal 
macrophages from three biological replicates of naïve CNV or ABX-treated mice. cDNA 
was amplified using NuGen WT Ovation Pico kit and hybridized to Affymetrix GeneChip 
Mouse Gene 1.0 ST microarray at the University of Pennsylvania's Microarray facility. 
Expression levels were summarized using the Robust Multichip Averaging (RMA) 
algorithm (Irizarry et al., 2003), as implemented by the Affymetrix Power Tool (apt-
probeset-summarize). The ClassNeighbors module of GenePattern (Broad Institute, 
Cambridge MA) was used to identify differentially expressed genes. Gene transcripts 
with greater than 1.6-fold difference in expression were analyzed using Ingenuity 
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pathway analysis software (Ingenuity® Systems, www.ingenuity.com). A right-tailed 
Fisher’s exact test was used to calculate a p-value determining the probability that the 
association between the genes in the dataset and the pathway or biological function 
could be explained by chance. GSEA was performed as described (Subramanian et al., 
2005). 
4.3.5 IFN stimulation and Phosflow STAT1 staining of macrophages 
PECs from naïve CNV or ABX-treated mice were plated on a 6 well plate for 3 hrs to 
allow macrophage adherence. Non-adherent cells were washed away with PBS and 
remaining cells were counted and seeded at 1x105 cells per well in complete media in a 
96 well plate and incubated at 37oC for 3 hrs to allow cell adherence. Media was then 
removed and cells washed 2x with PBS. Macrophages were stimulated with recombinant 
IFN-γ (R&D Systems) or IFN-β (PBL Interferonsource) in complete media. Following 
stimulation, media was removed and replaced with 0.05% trypsin and incubated at 37oC 
for 2 minutes. Cells were then fixed with 1.6% PFA in complete media for ten minutes at 
room temperature, transferred to a 96-well round bottom plate, centrifuged, and 
permeabilized with ice cold 90% methanol for 10 minutes. Cells were washed 3x with 
FACS buffer and stained for surface markers and with PE-conjugated anti-STAT1 
(pY701) antibody (BD biosciences) as described in (Krutzik and Nolan, 2003). 
4.3.6 In vitro viral infection of peritoneal macrophages 
Sort-purified macrophages isolated from naïve CNV or ABX-treated mice were seeded 
at 1x105  cells per well in a 96-well plate and incubated at 37oC for 3 hrs to allow cell 
adherence. Macrophages were then infected with either LCMV clone 13 strain (MOI of 
0.2) or influenza virus X31-GP33 strain (MOI of 5) for 1 hr then washed 2x to remove 
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virus. At indicated timepoints, supernatants were collected to assess viral titers by 
plaque assay or macrophages were directly lysed using RLT lysis buffer (Qiagen) and 
RNA was isolated using an RNeasy mini-kit (Qiagen). cDNA was generated using 
SuperScript reverse transcriptase (Invitrogen). RT-PCR was performed on cDNA using 
SYBR green chemistry (Applied Biosystems) and commercially available primer sets 
(Qiagen). 
4.3.7 Macrophage purification and transfer 
PECs from CNV or ABX-treated mice were isolated on day -1, 0, 1 of LCMV (T1b strain) 
infection. PECs were incubated with biotin CD3ε, CD5, CD11c, CD19, B220, and Ter-
119 for 15 min at 4 °C followed by incubation with strepavidin conjugated magnetic 
beads (Dynabeads) for 20 min at 4 °C. Samples were separated by magnet and the 
negatively selected cells were collected. An aliquot was set aside to determine 
macrophage (CD11b+, F4/80+) purity (~60-80%). 3x105 macrophages were transferred 
retro-orbitally into day of infection matched ABX-treated recipient mice.  
4.3.8 Statistical analysis 
Results represent means ± SEM. Statistical significance was determined by the 
unpaired, two tailed, Student’s t-test for individual timepoints, two-way ANOVA test for 
timecourse experiments, logrank test for survival curve, or two-part t-test for comparison 
of groups that contained samples that were below the limit of assay detection. Statistical 
analyses were performed using Prism GraphPad software v4.0. (*p < 0.05; **p < 0.01; 
***p < 0.001). 
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4.4 Results 
4.4.1 Macrophages, but not dendritic cells, exhibit an altered activation profile 
prior to viral infection in ABX-treated mice 
Chapters 2 and 3 demonstrated an integral role for commensal bacterial communities in 
shaping the innate and adaptive immune response to mucosal or systemic viral infection. 
This chapter will investigate the mechanisms through which commensal bacteria-derived 
signals modulate antiviral immunity. Early defects in the innate antiviral immune 
response following influenza virus or LCMV infection in ABX-treated mice provoke the 
hypothesis that commensal bacteria-derived signals regulate the basal activation status 
of innate immune cells prior to viral infection. Therefore, to interrogate the potential 
mechanisms through which signals derived from commensal bacteria regulate innate 
immune responses and antiviral immunity, a phenotypic characterization of 
macrophages and dendritic cells isolated from the peritoneal cavity of naïve CNV or 
ABX-treated mice was performed. Macrophages (Figure 25A), but not dendritic cells 
(Figure 25B), isolated from ABX-treated mice selectively displayed decreased 
expression of a class of molecules (MHC-I, IFNγRI, CD40 and CD86) that are critical for 
the early propagation of the immune response to viral infection. These observations 
provide evidence that in the steady-state commensal bacteria-derived signals can shape 
immune cell activation status outside of the intestinal tract and contribute to maintaining 
macrophages in a poised state capable of rapidly respond to an invading pathogen.  
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4.4.2 Defective expression of antiviral defense genes in macrophages isolated 
from ABX-treated mice prior to viral infection 
Differential expression of activation molecules on macrophages isolated from naive 
ABX-treated mice suggested an inherent impairment in the ability of macrophages to 
respond to infection. To interrogate the potential mechanisms through which signals 
derived from commensal bacteria regulate macrophage responses and innate antiviral 
immunity, we employed genome-wide transcriptional profiling of macrophages isolated 
from ABX-treated or CNV mice prior to viral infection. Fundamental differences in 
transcriptional profiles were readily apparent between macrophages isolated from CNV 
versus ABX-treated mice (Figure 26A). To further define these transcriptional 
differences, two separate analyses were conducted. First, Ingenuity Pathways Analysis 
(IPA) was used to identify enriched biological processes and networks. In total, there 
were 367 gene transcripts upregulated by at least 1.6 fold in macrophages isolated from 
CNV mice relative to macrophages isolated from ABX-treated mice (Figure 26B). 
Analysis of the 367 gene transcripts using IPA identified the IFN signaling pathway as 
the most significantly enriched pathway in macrophages isolated from CNV mice versus 
ABX-treated mice (Figure 26C). IPA can also identify complex biological networks by 
cross-referencing gene lists with a database consisting of empirically defined biological 
interactions between different genes. This analysis enables visualization of how different 
molecules interact to form complex biological networks. IPA identified the STAT1/STAT2 
transcription factor complex as one of the central molecules in the network of 
inflammatory immune response genes elevated in macrophages isolated from CNV mice 
compare to ABX-treated mice (Figure 27A) Further analysis of this complex immune 
network revealed that macrophages isolated from ABX-treated mice had defects in 
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immune response genes critical in detecting viral infection and limiting viral replication 
(Figure 27B). Thus IPA suggested an inherent defect in the antiviral immune response 
following antibiotic-mediated disruption of commensal bacterial communities. 
In addition to IPA, a second approach using gene set enrichment analysis (GSEA) was 
undertaken to compare the gene transcription profile of macrophages isolated from CNV 
mice to macrophages isolated from ABX-treated mice. GSEA enables an unbiased 
analysis of the whole genome microarray data to identify coordinated patterns of gene 
expression based on empirically defined gene sets (Haining and Wherry, 2010; 
Subramanian et al., 2005). GSEA revealed that six of the top eight most enriched gene 
sets in macrophages from CNV mice were related to IFN responses (Figure 28A,B). In 
addition, macrophages isolated from CNV mice were relatively enriched in a set of 
genes, independently reported by Agarwal et al. (Agarwal et al., 2009), responsive to 
IFN-α stimulation (Figure 28C). Specific gene expression analysis of macrophages 
isolated from ABX-treated mice revealed a relative downregulation of several genes that 
regulate detection of virus (Ifih1 (MDA5), Ddx58 (RIG-I)), the response to interferon 
signaling (Irf7, Ifngr1, Stat1, Stat2) or inhibition of viral replication (Mx1, Oas1a) (Figure 
29A), but not genes associated with the inflammasome (Figure 29B) or TLR signaling 
pathways (Figure 29C), two alternative innate pathogen recognition mechanisms. 
Differential expression of IFN-pathway related antiviral defense genes was 
independently confirmed by qRT-PCR analysis on sorted macrophages from naïve CNV 
or ABX-treated mice (Figure 29D). Taken together, genome-wide transcriptional profiling 
and computational analyses suggest that signals derived from commensal bacteria 
calibrate the activation threshold of antiviral immune response pathways in 
macrophages.  
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4.4.3 Alteration or absence of commensal bacteria renders macrophages less 
responsive to IFN stimulation or viral infection 
Genome-wide transcriptional profiling suggested that commensal bacteria-derived 
signals modulate the responsiveness of macrophages to viral infection or IFN 
stimulation. To functionally test this hypothesis, the response of macrophages isolated 
from naive CNV or ABX-treated mice to IFN stimulation or viral infection was assessed 
ex vivo. IFN receptor signaling by type I or II IFNs results in phosphorylation of STAT1 
followed by translocation into the nucleus, where pSTAT1 initiates transcription of an 
array of IRGs crucial to the early antiviral response (Schindler et al., 1992; Shuai et al., 
1992). To test IFN responsiveness, macrophages isolated from naïve, CNV or ABX-
treated mice were stimulated with IFN-γ (0.4-200ng/mL) or IFN-β (1x103U/mL) for 5-15 
minutes in vitro, and phosphorylation of STAT1 was measured by flow cytometry. 
Stimulated macrophages isolated from ABX-treated mice exhibited significantly reduced 
pSTAT1 levels compared to CNV macrophages following IFN-γ (Figure 30A,B) or IFN-β 
(Figure 30C,D) stimulation. Similar deficiencies in STAT1 phosphorylation were 
observed following IFN-γ (Figure 31A,B) or IFN-β (Figure 31C,D) stimulation of 
macrophages isolated from GF mice. These biological observations are consistent with 
diminished expression of antiviral defense genes identified by transcriptional profiling 
(Figure 26-29), and, together, suggest that signals from commensal bacteria are crucial 
to maintain optimal responsiveness to IFN stimulation in macrophages. 
To examine whether these deficiencies impaired macrophage responsiveness to viral 
infection, macrophages isolated from CNV or ABX-treated mice were infected ex vivo 
with influenza virus (X31-gp33) and induction of antiviral defense genes was examined. 
This method of direct ex vivo viral infection of isolated macrophages assesses whether 
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macrophages are intrinsically impaired in responding to viruses. Expression of multiple 
antiviral defense genes (Mx1, Oas1a, Ifnb, Stat2), identified from our microarray analysis 
(Figure 29A,D), was reduced in macrophages from ABX-treated mice compared to CNV 
mice at 6-24 hrs after infection, indicating an impaired ability to respond to viral infection 
(Figure 32). Further, macrophages isolated from ABX-treated (Figure 33A) or GF (Figure 
33B) mice supported significantly more viral replication upon ex vivo infection with LCMV 
demonstrated by higher titers of virus present in the supernatant at 48-72 hrs post-
infection compared to CNV macrophages. Combined, these data demonstrate that 
manipulation of commensal bacterial communities by ABX treatment fundamentally 
alters expression of antiviral defense genes, rendering cells of the innate immune 
system less able to respond to viral infection. 
4.4.4 Adoptive transfer of macrophages isolated from CNV mice improves control 
of viral replication and quality of antiviral immune response in ABX-treated mice 
Tonic signaling from commensal bacteria primes macrophages to rapidly respond to 
virus and virus-induced interferon stimulation (Figure 29-32). Further, in Chapter 2 and 3 
we reported that ABX-mediated disruption of commensal bacterial communities renders 
mice susceptible to viral infection. To assess if commensal bacteria-derived tonic 
signaling on macrophages is sufficient restore antiviral immune responses and control 
viral replication in ABX-treated mice, macrophages from CNV mice were adoptively 
transferred into ABX-treated mice at d -1,0, and 1 following LCMV infection (Figure 34A). 
As an additional control, macrophages from ABX-treated mice were adoptively 
transferred to another group of ABX-treated mice. Thus, upon LCMV infection ABX-
treated recipient mice received either commensal bacteria “exposed” or “unexposed” 
donor macrophages. Following LCMV infection, the immune response and control of 
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viral replication in macrophage recipient ABX-treated mice was compared to CNV mice 
and ABX-treated mice that did not receive macrophage transfers.  
Following macrophage transfer and LCMV infection, the four groups (CNV, ABX, ABX 
+ CNV Macs, ABX + ABX Macs) were longitudinally assessed for serum viral titers and 
LCMV-specific CD8 T cell responses. Consistent with experiments reported in Chapter 
3 (Figure 18), CNV mice cleared virus from the serum within 2 weeks following infection 
while ABX-treated mice exhibited persisting viremia for a month (Figure 34B). In 
contrast, ABX-treated mice receiving “commensal exposed” macrophages exhibited 
significantly improved control of virus in the serum compared to ABX-treated mice 
(Figure 34B). ABX-treated mice, receiving “commensal unexposed” macrophages, 
however, exhibited persisting viremia for a month following infection (Figure 34B). Thus, 
only donor macrophages harvested from an environment where commensal bacteria-
derived signals were present were able to improve viral control in ABX-treated mice. 
 Fewer LCMV-specific H-2Db gp33 (Figure 34C) and H2-Db gp276 CD8 tetramer+ 
(Figure 34D) T cells were detected within the peripheral mononuclear cells (PBMC) 
isolated from the blood of ABX-treated mice at d23 post-infection. Phenotypic 
characterization of LCMV-specific CD8 T cells isolated from ABX-treated mice revealed 
increased expression of the inhibitory receptor PD-1 (Figure 34E,F), which has been 
shown to be associated with the quality of the antiviral immune response (Barber et al., 
2006; Blackburn et al., 2009), indicating ABX-treated mice had an impaired antiviral 
immune response that correlated with delayed viral clearance, consistent with the results 
reported in Chapter 3. However, ABX-treated mice receiving “commensal exposed” 
macrophages, but not ABX-treated mice receiving “commensal unexposed” 
macrophages, exhibited significantly increased populations of LCMV-specific CD8 T 
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cells in the blood at d23 post-infection (Figure 34C,D) compared to ABX-treated mice not 
receiving a macrophage transfer. The LCMV-specific CD8 T cells from ABX + CNV Macs 
mice also expressed less PD-1 (Figure 34E,F) suggesting the macrophage transfer also 
improved the quality of the antiviral immune response. 
At d31 post-infection the four groups of mice were sacrificed and splenocytes were 
stimulated with a pool of 20 LCMV-specific peptides (Kotturi et al., 2007) and assessed 
for effector cytokine production to interrogate the functional quality of the LCMV-specific 
CD8 T cell response. Consistent with previous observations (Chapter 3, Figure 21), 
ABX-treated mice exhibited significantly decreased frequency (Figure 35A) and total 
numbers (Figures 35B) of IFN-γ+/TNF-α+ dual producing splenic CD8 T cells compared 
to CNV mice. In contrast, ABX-treated mice receiving “commensal exposed” 
macrophages, but not ABX-treated mice receiving “commensal unexposed” 
macrophages, exhibited a significant increase in the frequency and total number of IFN-
γ+/TNF-α+ dual producing CD8 T cells compared to ABX-treated mice (Figure 35A,B), 
indicating a significant improvement in the quality of the adaptive antiviral immune 
response. Thus, macrophages previously exposed to commensal bacteria-derived 
signals were sufficient to partially restore control of viral replication and improve the 
antiviral immune response in an environment devoid of commensal bacteria-derived 
signals. Collectively, these data demonstrate the in vivo relevance of tonic signaling by 
commensal bacteria in setting the immune activation threshold of macrophages required 
for antiviral immunity.  
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4.5 Discussion 
The results described in this chapter reveal a novel interplay between commensal 
bacteria and antiviral IFN signaling pathways that is critical in response to viral infection. 
Genome-wide transcriptional profiling uncovered a global defect in expression of antiviral 
defense genes in macrophages isolated from ABX-treated mice compared to 
macrophages from CNV mice prior to viral infection. This reduction in steady-state 
transcription of antiviral defense genes was associated with a significant deficiency in 
responsiveness to virus or the virus-induced type I/II IFNs. Furthermore, adoptive 
transfer of macrophages isolated from CNV mice, but not ABX-treated mice, was 
sufficient to restore antiviral immunity in ABX-treated mice.  Collectively, these data 
indicate a previously unrecognized aspect of innate immune cross-talk where low-level 
tonic signaling by commensal bacteria calibrate the activation threshold of innate 
antiviral immune responses.  
Tonic signaling has been proposed to be a mechanism to maintain optimal 
responsiveness of signaling pathways in other settings (Macia et al., 2009). For 
example, naïve T cells use low affinity interactions with self MHC to generate tonic 
signals thought to be important for naïve T cell homeostasis and for optimal dynamic 
responsiveness upon engagement of cognate antigen (Takeda et al., 1996; Tanchot et 
al., 1997). Similarly, pre-TCR and pre-BCR are used during lymphocyte development to 
generate low-level signals that help guide these cells to maturity (Rajewsky, 1996; Scott 
et al., 1989). The tonic signaling involved in maintaining responsiveness of antiviral 
pathways described in this chapter was not dependent on signals that normally evoke 
antiviral IFN responses but rather on commensal bacteria-derived signals. Such 
crosstalk between anti-bacterial and antiviral immunity can occur in other settings.  For 
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example, latent viral infections can render mice less susceptible to bacterial challenge, 
an effect attributed to basal macrophage activation driven by antiviral IFN-g production 
(Barton et al., 2007). Conversely, the symbiotic bacteria, Wolbachia, confers protection 
against viral infections in Drosphilia (Teixeira et al., 2008). Anti-bacterial responses 
driven by LPS triggered TLR4 signaling can also upregulate transcription of antiviral 
genes (Amit et al., 2009; Doyle et al., 2002). In the case of LPS/TLR4 signaling, antiviral 
gene expression is initially induced, but rapidly limited by the polycomb repressor Cbx4 
(Amit et al., 2009).  
This latter observation suggests a potential explanation for the commensal-antiviral 
immune fitness axis at the transcriptional level.  Induction of transcription followed by 
repression might maintain key antiviral genes in a state of poised transcriptional 
regulation, rather than a repressed or inactive state.  Transcriptional poising, or the 
presence of both activating and repressive chromatin, can allow for faster or more 
efficient transcriptional induction upon exposure to a true inducer of the gene of interest 
(Cuddapah et al., 2010; Zediak et al., 2011). This state of dynamic transcriptional 
regulation provided by tonic commensal bacteria stimulation may enable rapid induction 
of antiviral defense genes upon infection. Examples of this type of regulation exist in 
other settings. In yeast, the Hog1/MAPK pathway uses basal signaling and a negative 
feedback loop to maintain rapid and sensitive responses to environmental stimuli, 
suggesting that a pathway with active low-grade signaling might be biologically more 
responsive than one that lies dormant until a de novo signal is received (Macia et al., 
2009). Our results suggest commensal bacteria provide such a signal that maintains 
antiviral innate immune pathways in a state of optimal readiness allowing dynamic and 
robust responses upon challenge by systemic or mucosal viral infections.  
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Figure 25. Macrophages isolated from ABX-treated mice exhibit reduced 
expression of activation molecules in the steady-state. 
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Figure 25. Phenotypic characterization of (A) macrophages or (B) dendritic cells isolated from 
the  peritoneal  cavity  of  naïve  CNV  (black  line)  or  ABX‐treated  (red  line)  mice.  Shaded 
histogram represents isotype control (or FMO for MHC‐I and TLR‐9). FACS plots gated on live, 
CD45+, non‐T, non‐ B, non‐NK cells. Data representative of three independent experiments. 
n=4‐5 mice per group. Data shown are the mean ± SEM.  *p<0.05, **p<0.01, ***p<0.001. 
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Figure 26. Macrophages isolated from ABX-treated mice have an altered gene 
expression profile. 
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Figure 26. RNA was extracted  from sort‐purified peritoneal macrophages  (sorted on CD3ε‐, 
CD19‐,  F4/80+,  CD11b+)  isolated  from  naïve  CNV  or  ABX‐treated mice.  Extracted  RNA  was 
hybridized to an Affymetrix GeneChip microarray to assess gene expression. (A) Heat map of 
differentially expressed genes in macrophages isolated from CNV or ABX‐treated mice. Red = 
high  expression,  blue  =  low  expression.  (B)  Frequency  and  total  number  of  elevated  gene 
transcripts in CNV macrophages compared to macrophages isolated from ABX‐treated mice. 
(C) Highly  enriched biological  pathways  and  functions  found within  the  subset  of  elevated 
gene  transcripts  from CNV macrophages as assessed by  Ingenunity Pathways Analysis. Red 
bars  indicate the percent of genes  in a pathway upregulated  in macrophages  isolated from 
CNV mice. Yellow line indicates p‐value calculated by Fisher’s Exact test. 
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Figure 27. Key molecules in the inflammatory immune response network are 
relatively elevated in macrophages isolated from CNV mice.  
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Figure 27. (A) Ingenuity Pathway analysis identified direct and indirect biological interactions 
amongst  the  subset  of  367  genes  relatively  elevated  in  CNV  macrophages  creating  an 
inflammatory  immune  response  network.    Connection  lines  in  yellow  highlight  the 
interrelationship  of  STAT1  with  other  genes  in  the  network.  Molecules  shaded  in  red 
represent  gene  expressed  at  relatively  higher  levels  in  CNV  macrophages  compared  to 
macrophages  isolated  from ABX‐treated mice.  (B)  Simplified network  identifying molecules 
relatively  elevated  in  CNV macrophages  that  are  crucial  in  the  detection  and  inhibition  of 
viral  replication.  Network  maps  were  created  using  Ingenuity  pathway  analysis  software 
(Ingenuity® Systems, www.ingenuity.com) 
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Figure  28.  (A)  Gene  set  enrichment  analysis  (GSEA)  of  CNV  macrophages  compared  to 
macrophages  isolated  from  ABX‐treated  mice.  The  most  highly  enriched  gene  sets 
determined  by  the  normalized  enrichment  score  (NES).  (B)  Enrichment  curve  of  the  top 
ranked  gene  set  as  defined  by  GSEA.  (C)  GSEA  enrichment  curve  of  genes  upregulated 
following IFN‐α stimulation, empirically defined from (Agarwal et al., 2009).  
 
 
 
 
Figure 28. Macrophages isolated from CNV mice exhibit a relative enrichment in 
IFN responsive genes.  
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Figure  29.  (A‐C)  Heat  map  of  genes  encoding  (A)  antiviral  defense  mechanisms,  (B) 
inflammasome components or  (C) TLR signaling components  in macrophages  isolated  from 
naïve CNV or ABX‐treated mice. (D) Expression of antiviral defense genes by qPCR analysis of 
RNA isolated from sort‐purified macrophages from two independent experiments with n=3‐5 
mice per group. *p<0.05, **p<0.01. 
 
 
 
 
 
Figure 29. Decreased expression of antiviral defense genes but not 
inflammasome or TLR signaling components in macrophages isolated from ABX-
treated mice. 
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Figure  30.  (A‐D)  Peritoneal  macrophages  isolated  from  CNV  or  ABX‐treated  mice  were 
stimulated with IFN‐γ or IFN‐β in vitro. Histograms of STAT1 phosphorylation in macrophages 
following (A) IFN‐γ stimulation (0.4, 4, 20, 200ng/mL) or (C) IFN‐β stimulation (103 Units/mL 
for  5,  10,  and  15 minutes). Mean  fluorescence  intensity  (MFI)  of  pSTAT1  in macrophages 
following (B) IFN‐γ or (D) IFN‐β stimulation. Data representative of two or more independent 
experiments with n=3‐5 mice per group. Data shown are the mean ± SEM.   *p <0.05, ***p 
<0.001. 
 
 
 
 
 
Figure 30. Macrophages isolated from ABX-treated mice have an impaired 
response to type I/II IFN stimulation. 
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Figure 31. (A‐D) Peritoneal macrophages isolated from naïve CNV or GF Swiss/Webster mice 
were  stimulated  with  IFN‐γ  or  IFN‐β  in  vitro.  Histograms  of  STAT1  phosphorylation  in 
macrophages  following  (A)  IFN‐γ  (0.2,  2,  20,  200ng/mL)  or  (C)  IFN‐β  (101,  102,  103,  104 
Units/mL)  stimulation  for  15  minutes.  Mean  florescence  intensity  (MFI)  of  pSTAT1  in 
macrophages  following  (B)  IFN‐γ  or  (D)  IFN‐β  stimulation.  Data  representative  of  two 
independent experiments with n=3‐5 mice per group. Data shown are the mean ± SEM. ***p 
<0.001. 
 
 
 
 
 
 
 
Figure 31. Macrophages isolated from GF mice also display an impaired response 
to type I/II IFN stimulation.  
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Figure 32. Peritoneal macrophages sorted from naive CNV or ABX‐treated mice were infected 
with  influenza  virus  in  vitro  (X31‐GP33, MOI of  5).  RNA was purified  at  6  and 24 hrs post‐
infection  and  analyzed by  qPCR  for  upregulation of  antiviral  genes. Data  representative  of 
three independent experiments with n=3‐5 mice per group. Data shown are the mean ± SEM.   
**p<0.01. 
 
 
 
 
 
Figure 32. Macrophages isolated from ABX-treated mice exhibit delayed induction 
of antiviral defense genes.  
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Figure 33. Peritoneal macrophages isolated from (A) naïve C57BL/6 CNV or ABX‐treated mice 
or (B) naïve CNV or GF Swiss/Webster mice were infected with LCMV cl‐13 strain (MOI of 0.2) 
in vitro. LCMV viral titers in supernatant of in vitro infected macrophages at 24‐96 hrs post‐
infection  were  assessed  by  viral  plaque  assays.  Data  representative  of  three  independent 
experiments; n=3‐5 mice per group. Data shown are the mean ± SEM.  *p<0.05, **p<0.01. 
 
 
 
 
 
 
Figure 33. Macrophages isolated from naive ABX-treated or GF mice have a 
diminished ability to respond to viral infection in vitro. 
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Figure 34. Macrophages transferred from CNV mice into ABX-treated mice 
improve viral control following LCMV infection. 
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Figure 34.    (A) Diagram schematic of macrophage transfer  from CNV or ABX‐treated donor 
mice into ABX‐treated recipients. CNV, ABX‐treated, ABX‐treated + CNV Macs, ABX‐treated + 
ABX Macs mice were  infected  i.v. with 2x106 PFU of LCMV T1b.  (B) Viral  titer  in  the serum 
following  infection  (L.o.D.,  limit  of  detection).  LCMV‐specific  (C)  DbGP33 and  (D)  DbGP276 
tetramer+  CD8  T  cells  per  106  peripheral  blood  mononuclear  cells  (PBMCs)  at  d23  post‐
infection.  (E‐F)  Expression  of  inhibitory  receptor  PD‐1  on  (E)  DbGP33  or  (F)  DbGP276 
tetramer+  CD8  T  cells  isolated  from  the  blood  at  d23  post‐infection.  Viral  titer  statistics 
determined by  two‐way ANOVA comparing CNV  to ABX  (p<0.01), ABX + CNV Macs  to ABX 
(p<0.01), or ABX + ABX Macs (n.s.). Data shown are the mean ± SEM. *p<0.05, **p<0.01. 
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Figure 35.  (A) Splenocytes from d31 infected mice were incubated with a pool of 20 LCMV‐
specific peptides (Kotturi et al., 2007) for 5 hrs in the presence of BFA and CD8 T cells were 
assessed for production of  IFN‐γ and TNF‐α. FACS plots gated on live, CD8α+ cells. (B) Total 
number of IFN‐γ/TNF‐α dual producing CD8 T cells in the spleen at d31 post‐infection. Data 
shown are the mean ± SEM. *p<0.05, **p<0.01. 
 
Figure 35. Adoptive transfer of CNV macrophages improves quality of LCMV-
specific CD8 response in ABX-treated mice.  
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Chapter 5 
Summary, Discussion and Future Directions 
5.1 Commensal bacterial communities modulate immune responses to 
infection 
The innate immune system has evolved to detect distinct molecular patterns conserved 
within specific groups of pathogens. This enables the innate immune system to be able 
to respond to a multitude of pathogens with a relatively limited number of pathogen 
recognition mechanisms. For example, TLR4 detects lipopolysaccarides (LPS) that are 
prominently displayed on the outer membrane of all gram-negative bacteria (Miller et al., 
2005), while cytosolic proteins such as RIG-I and MDA5 can detect cytoplasmic dsRNA, 
a common intermediate in the replication cycle of viruses (Medzhitov, 2007). Detection 
of PAMPs initiates a cascade of signaling pathways that results in induction of innate 
immune response genes and activation of the adaptive immune system.  
Intestinal commensal bacteria express the same molecular motifs as pathogenic 
bacteria, yet the immune system has evolved to interact with commensal bacterial 
communities without causing overt, persistent inflammation. This is accomplished, in 
part, by physical separation of intestinal commensal bacteria from the intestinal epithelial 
lining. Specialized IECs, called goblet cells, secrete mucin glycoproteins into the 
intestinal lumen creating a mucus layer coating the intestinal epithelia and limiting 
bacterial attachment to epithelial cells (Deplancke and Gaskins, 2001). Antimicrobial 
peptides and commensal bacteria-specific IgA are secreted into the mucus layer further 
preventing bacterial penetrance. (Macpherson et al., 2001; Vaishnava et al., 2011). 
Physical separation of commensal bacteria from host cells is not absolute, however, and 
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intestinal immune cells regularly come in direct contact with live commensal bacteria 
(Ivanov et al., 2009; Macpherson and Uhr, 2004; Obata et al., 2010). These interactions 
occur continuously throughout the life of the host and result in a dynamic relationship 
between commensal bacteria and the host immune system. Intestinal immune cell 
populations shaped by these interactions, can be driven to a proinflammatory or 
immunoregulatory differentiated state. This homeostatic regulation of the immune 
system by commensal bacterial communities can shape host fitness rendering the host 
more or less susceptible to inflammation, infection, allergy, or autoimmunity (Honda and 
Littman, 2012).  
The data presented in this thesis describe a fundamental role for commensal bacterial 
communities in setting the activation threshold the innate immune system requires to 
respond to mucosal-associated or systemic viral infections. ABX-mediated disruption of 
commensal bacterial communities resulted in diminished expression of antiviral defense 
genes in macrophages isolated from ABX-treated mice compared to macrophages 
isolated from CNV mice prior to viral infection. This observation suggests that tonic 
stimulation by commensal bacteria-derived signals induces basal transcription of 
antiviral defense genes in innate immune cells in the steady-state that enables rapid 
immune responses upon exposure to viruses. Induction of innate immune response 
genes trigger robust expansion of adaptive immune responses, and, ultimately, 
successful control of infection. Even a slight delay in innate immune activation can swing 
the host versus virus equilibrium in favor of the pathogen and can have severe 
physiological consequences for the host. This was demonstrated in Chapter 2, in which 
influenza virus infection of ABX-treated mice resulted in impaired induction of innate 
proinflammatory cytokines and chemokines leading to diminished induction of adaptive 
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immune responses. Impaired immune responses to influenza virus in ABX-treated mice 
compared to CNV mice resulted in ineffective viral clearance, severe damage to the 
bronchiole epithelium, defective gas exchange, and ultimately host mortality.  
The results presented in Chapter 3 demonstrate defective antiviral innate and 
adaptive immune responses to a systemic viral infection (LCMV) following ABX-
mediated disruption of commensal bacterial communities. Antiviral immunity could be 
rescued in mice depleted of commensal bacteria by either restoring IFN responsiveness 
as described in Chapter 2 or supplementing ABX-treated mice with macrophages 
harvested from CNV mice and therefore exposed to commensal bacteria-derived 
signals, as reported in Chapter 4. Collectively, these data indicate that in the steady-
state, commensal bacteria provide tonic signals that regulate the activation threshold of 
the innate immune system required for optimal antiviral immune responses (Figure 36).  
5.2 Dynamic interrelationship between the immune system, commensal 
bacteria and viruses 
The immune system has evolved distinct anti-bacterial or antiviral immune mechanisms 
that enable efficient and targeted responses tailored to each particular class of pathogen 
(Cousens et al., 1999; Curtis and Way, 2009; Kumar et al., 2009). Therefore, it was 
surprising that ABX-mediated disruption of commensal bacterial communities resulted in 
an impaired antiviral immune response. The results presented in this thesis suggest a 
conserved element of the innate immune system that utilizes tonic signaling from 
commensal bacteria to calibrate the activation threshold required to respond to viral 
infections. It has been previously demonstrated that components classically considered 
part of the anti-bacterial response, such as the LPS/TLR4 signaling axis, can also trigger 
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transcription of an antiviral gene program (Amit et al., 2009; Doyle et al., 2002). Further, 
the bacterial colonization with Wolbachia in Drosphilia flies confers protection against 
viral infections (Teixeira et al., 2008). Conversely, latent viral infections can basally 
activate innate immunity rendering latently-infected hosts less susceptible to bacterial 
challenge (Barton et al., 2007). These studies provide novel insights into how distinct 
microbial sensing and response pathways are interwoven and provide evidence for 
critical cross-regulation of antiviral immunity by bacterial communities. 
Commensal bacteria-driven gene transcription of immune response genes in the 
steady-state may be a universal mechanism to modulate the pathogen response profile 
of immune and non-immune cell types. Hooper and colleagues first reported marked 
differences in immune response gene expression in cells derived from the intestinal 
epithelium (Hooper et al., 2001). The findings reported in Chapter 4 of thesis 
demonstrate a role for commensal bacteria-driven gene transcription in cells outside the 
gastrointestinal tract. Disruption of microbial signaling by commensal bacteria reduced 
expression of antiviral defense genes in macrophages (Chapter 4; Figure 28). Further, 
while analysis of macrophages in this thesis did not reveal changes in expression of 
inflammasome related genes, Ichinohe and colleagues reported decreased expression 
of inflammasome components in the lung of ABX-treated mice both in the steady-state 
and following influenza virus infection (Ichinohe et al., 2011). These data suggest that 
gene expression of the inflammasome in a non-macrophage resident lung cell 
population may be mediated by commensal bacteria-derived signals. Collectively, these 
studies support a model where commensal bacteria-derived signals can coordinately 
influence the gene expression profile of multiple cell types thereby modulating the 
immune system at homeostasis and in an infection setting. 
  134 
5.3 Mediators of constitutive type I IFN expression 
Genome-wide transcriptional profiling of macrophages isolated from naïve CNV or ABX-
treated mice revealed an altered gene expression profile following disruption of 
commensal bacterial communities by ABX treatment. Examination of the top 50 
relatively upregulated genes in macrophages isolated from CNV mice compared to ABX-
treated mice revealed increased basal expression of several interferon response genes 
(IRGs) that regulate or are regulated by the IFN signaling pathway (Table 2). Analysis of 
the gene expression microarray data with Ingenuity Pathways software and GSEA 
independently identified the interferon response as one of the main pathways disrupted 
in macrophages isolated from ABX-treated mice. Functional assays confirmed 
macrophages isolated from ABX-treated exhibited a defect in responding to IFN 
stimulation and, in turn, an impaired ability to control viral replication. Basal transcription 
of IRGs is thought to be maintained by constitutive type I IFN expression (Gough et al., 
2012). It has long been appreciated that even in the absence of viral infection, low-level 
expression of type I IFNs can be detected in multiple tissues of mice and humans (Bocci, 
1980; Tovey et al., 1987; Yaar et al., 1986). Constitutive IFN expression is important in 
maintaining a state of antiviral readiness as ablation of constitutive IFN signaling by 
using anti-interferon-α/β neutralizing antibodies or genetic deletion of the IFN-α/β 
receptor results in decreased expression of IRGs such as STAT1, STAT2 and IRF7 
(Gough et al., 2010; Hata et al., 2001). Further, macrophages isolated from mice treated 
with anti-IFN neutralizing antibodies exhibited delayed induction of antiviral defense 
mechanisms and impaired control of viral replication, demonstrating the physiological 
relevance of constitutive IFN in priming immune cells to be ready to respond to viruses 
(Belardelli et al., 1984). Currently, the origins of the stimuli for constitutive IFN 
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expression are not known, although the observation that macrophages isolated from 
C3H/HeJ mice, which have defective TLR4 signaling, do not express constitutive IFN 
and have impaired phagocytic and antiviral function has lead to speculation that 
commensal bacteria-derived signals may be important regulators of constitutive IFN 
expression (Gough et al., 2012; Musso et al., 2011; Vogel and Fertsch, 1984). 
While type I IFN production following viral infection is critically dependent on 
IRF3/IRF7, these two transcription factors do not have a role in mediating constitutive 
IFN expression (Hata et al., 2001; Sato et al., 2000). Rather, relA and c-Jun, subunits of 
the NFκB and AP-1 transcription factor complex respectively, bind to distinct positive 
regulatory domains of the Ifnb promoter and are essential for constitutive IFN expression 
(Balachandran and Beg, 2011; Gough et al., 2012; Maniatis et al., 1998). Loss of 
constitutive IFN expression in c-Jun-deficient fibroblasts result in decreased STAT1 
protein levels and impaired responsiveness to IFN-γ stimulation (Gough et al., 2012). 
Meanwhile, reduced expression of Ifnb mRNA in rela-/- MEFs correlated with decreased 
expression of genes involved in viral detection (MDA5 and RIG-I) and propagation of the 
IFN signaling pathway (STAT1, STAT2 and IRF7) (Basagoudanavar et al., 2011). 
Notably, these same genes were also decreased in macrophages isolated from ABX-
treated mice (Chapter 4, Figure 28). Further, similar to macrophages isolated from ABX-
treated mice, following viral infection rela-/- cells exhibited a delayed induction of antiviral 
defense genes and impaired control of viral replication (Chapter 4, Figures 31-32) 
(Basagoudanavar et al., 2011). In a study by Basagoudanavar et al., constitutive IFN 
expression was induced by continuous degradation of NFκB by IKK-β, releasing relA to 
translocate to the nucleus and bind to the Ifnb promoter region (Basagoudanavar et al., 
2011). At present, the source of IKK-β activation leading to NFκB degradation is unclear; 
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however, it has been reported that commensal bacteria-mediated activation of NFκB in 
intestinal epithelial cells is important in maintaining intestinal homeostasis and initiating a 
protective immune response following intestinal parasitic infection (Nenci et al., 2007; 
Zaph et al., 2007). Thus, it is tempting to speculate that commensal bacteria, perhaps 
through the LPS/TLR4 signaling axis, regulate constitutive IFN expression via NFκB 
degradation and relA-induced transcription. Consistent with this, LPS signaling can lead 
induction to of Ifnb as well as transcription of IRGs, such as Mx1, Irf7, and Ifi1 in a NFκB 
dependent manner (Doyle et al., 2002). In this scenario, two potential models arise: i.) 
commensal bacteria-derived signals circulate through the host and directly induce 
constitutive IFN expression in innate immune cells or ii.) commensal bacteria-derived 
signaling is localized to the intestinal environment and stimulates constitutive IFN 
production by intestinal epithelial and/or intestinal immune cells. Constitutive IFN is then 
released into the circulation and can stimulate basal transcription of IFN response genes 
in peripheral immune and non-immune cells. Cell lineage-specific deletion of type I IFNs 
or the molecular machinery leading to constitutive IFN expression in mice will give 
valuable insight how commensal bacterial communities regulate IFN responses (Figure 
37). 
5.4 Regulation of constitutive type I IFN expression      
Type I IFN expression can initiate a potent antiviral immune response. However, 
uncontrolled expression of IFNs can also be detrimental to the host and has been linked 
to autoimmune diseases such as systemic lupus erythematosus, rheumatoid arthritis, 
and scleroderma (Banchereau and Pascual, 2006; Hooks et al., 1979). Therefore, the 
host must tightly regulate constitutive IFN expression to promote rapid responses to viral 
  137 
pathogens while limiting destructive host tissue damage. Constitutive IFN expression is 
regulated in part by the transcription factor IRF2, an IFN-inducible gene that is 
constitutively expressed in multiple tissues (Senger et al., 2000; Taniguchi et al., 2001). 
IRF2 is believed to repress Ifnb transcription by competitively binding to the positive 
regulatory domain of the Ifnb promoter and via its transcriptional repression domain in 
the carboxyl terminal region (Taniguchi et al., 2001; Yamamoto et al., 1994). Therefore, 
basal IFN production may induce transcription of its own negative regulator, IRF2, 
creating a negative feedback loop to limit constitutive IFN expression. Genetic deletion 
of IRF2 in mice leads to increased baseline expression of IRGs and spontaneous 
induction of a psoriasis-like skin disease (Arakura et al., 2007; Hida et al., 2000) 
indicating unchecked regulation of constitutive IFN expression in these mice. Onset of 
the autoimmune skin disease could be ameliorated by backcrossing the IRF2-/- mice onto 
a IFN signaling deficient background (IFNAR-/- or IRF9-/-) demonstrating that the disease 
pathogenesis was type I IFN-dependent (Hida et al., 2000). Thus transcription of 
constitutive IFN expression is continuously regulated by repressors (IRF2) and activators 
(relA) binding to the promoter region, possibly preventing histone deacetylation of the 
chromatin and maintaining the gene locus in an open formation (Figure 38). Dynamic 
transcriptional regulation, as discussed in Chapter 4, could keep the gene locus in an 
active state that can be quickly accessed upon detection of viral infection by PRRs and 
phosphorylation of IRF3/7, both primary inducers of type I IFN expression. The removal 
of commensal bacteria-derived signals could reduce activator and repressor signals for 
constitutive IFN expression and leave the Ifn gene in a closed dormant state resulting in 
decreased expression of IRGs in cells in the steady-state as observed in Chapter 4 with 
macrophages from ABX-treated mice.  
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In addition to IFN signaling, IRF2 expression can also be modulated by other 
commensal bacteria-derived signals such as LPS (Marson et al., 2004), butyric acid (a 
SCFA produced by degradation of dietary fibers by commensal bacteria) (Joseph et al., 
2004), and oxidized low density lipoprotein (oxLDL) (Marson et al., 2004), which has 
been reported to be elevated in the serum of GF mice (Velagapudi et al., 2010). 
Potential regulation of IRF2 expression by commensal bacteria via IFN-dependent or 
independent mechanisms may result in shaping additional arms of the immune system. 
For example, NK cells, whose cytotoxic activity can be augment by administration of 
probiotics (Matsuzaki and Chin, 2000), exhibit impaired target cell killing following 
stimulation with poly I:C or in a tumor rejection model in IRF2-/- mice (Lohoff et al., 2000). 
Further, Irf2-/- mice exhibit a skewed type-2 inflammatory phenotype with elevated serum 
IgE, increased basophils in the spleen and blood, and an expanded, basophil-dependent 
CD4 TH2 cell population (Hida et al., 2005), attributes which are phenocopied in both 
ABX-treated and GF mice (Hill et al., 2012). Notably, in agreement with these findings, 
genetic polymorphisms in IRF2 and alteration in commensal bacterial communities have 
each been associated with atopic dermatitis, a type 2 cytokine-mediated inflammatory 
disease in human patients (Gao et al., 2011; Penders et al., 2007a). Cell-lineage specific 
deletion of IRF2 and manipulation of commensal bacterial communities in these murine 
models will be needed to better understand the possible connection between 
commensal bacteria, IRF2 expression, and immune cell homeostasis. Combined these 
findings suggest that commensal bacteria-derived signals may differentially modulate 
distinct immune cell populations and highlight the importance of understanding how 
commensal bacteria-derived signals mediate immune regulation and via what cell type 
these signals are eliciting their immunomodulatory effect.  
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5.5 Therapeutic potential of commensal bacterial communities  
Modulating commensal bacterial communities has great therapeutic potential. Clinical 
probiotic treatment can ameliorate intestinal inflammatory diseases (Mimura et al., 2004; 
Sartor, 2004), and success of bacteriotherapy in cases of viral gastroenteritis 
demonstrates the potential use of probiotics as a treatment strategy to combat viral 
infection (Fang et al., 2009; Isolauri et al., 1994; Majamaa et al., 1995; Szajewska and 
Mrukowicz, 2005). Further, prophylactic probiotic administration can limit the duration 
and severity of respiratory viral infections and correlates with increased cell-mediated 
immune responses in human subjects, suggesting that the beneficial effects of probiotics 
on antiviral immunity are not limited to the gastrointestinal tract (de Vrese et al., 2006; 
Pregliasco et al., 2008). Conversely, the data presented in this thesis suggest that 
removing or limiting exposure to commensal bacterial communities, such as in 
populations receiving long-term antibiotic treatment, may increase an individual’s 
predisposition to viral infection. This interpretation should be tempered, however, by 
findings demonstrating how enteric viruses use commensal bacteria to their benefit to 
improve viral infectivity and limit the host’s immune response (Kane et al., 2011; Kuss et 
al., 2011). These two studies highlight the need to further characterize the specific 
bacterial products that can mediate susceptibility to infection. 
Despite many recent advances in defining the diverse microbiome in humans and 
animal models (Peterson et al., 2009), only a few commensal species or microbial 
products that elicit an immunomodulatory effect have been defined (Reading and 
Kasper, 2011). Thus, it is currently unclear which commensal species or specific 
microbial products are associated with the beneficial clinical observations described 
above or the impact on antiviral immunity described in this thesis. The experiments 
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presented in this thesis, as well as numerous other published reports, have used a broad 
spectrum antibiotic cocktail designed to target all classes of bacteria (Gram positive, 
Gram negative; Aerobes, Anaerobes) to address how commensal bacteria modulate the 
immune system. This strategy indiscriminately, albeit successfully, eliminates signals 
derived from multiple commensal bacteria and therefore makes identification of specific 
species or commensal bacteria-derived products that elicit observed immunomodulatory 
effects difficult. It will be important to determine which bacterial products are 
immunomodulatory and to investigate the distinct signaling pathways these products 
stimulate. Such studies should allow for the development of novel strategies to 
therapeutically administer specific commensal bacteria or commensal bacteria-derived 
products and selectively manipulate host immunity. 
5.6 Alternative mechanisms of immune regulation by manipulating 
commensal bacterial communities 
The most direct interpretation of the data presented in this thesis is that in the steady-
state, commensal bacteria provide tonic signals that regulate the activation threshold of 
the innate immune system required for optimal antiviral immune responses. However, 
disruption of commensal bacterial communities may be indirectly impairing antiviral 
immunity via alteration of the host viral microbiome. Disruptions of intestinal commensal 
bacterial communities may also alter the bacteriophage population, endogenous viruses 
residing in intestinal bacteria that substantially contribute to the pool of genes that 
comprise the intestinal metagenome (Letarov and Kulikov, 2009). It is possible that 
depletion of commensal bacteria could be indirectly leading to immune dysregulation via 
loss of a bacterial population that harbors viruses capable of interacting with host 
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immune cells and modulating immune responses. Currently, characterization of the 
human microvirome is still in its infancy and the technologic tools needed to manipulate 
the microvirome to probe the impact of these endogenous viruses on health and disease 
have yet to be developed (Reyes et al., 2010). Thus the role of the intestinal 
microvirome in modulating immune response remains largely unexplored.  
Alternatively, loss of commensal bacteria may influence host immune responses by 
disrupting the breakdown of metabolites that have immunoregulatory properties. 
Intestinal commensal bacteria have a crucial role in the metabolic breakdown of food 
products and loss of commensal bacterial species alters nutrients available to be 
absorbed by the host (Velagapudi et al., 2010). Some food products are already known 
to modulate immune cell homeostasis. For example, vitamin A via its metabolite, retinoic 
acid, can shape immune cell differentiation and mediate tolerance and immunity in the 
gastrointestinal tract (Hall et al., 2011). While vitamin A conversion is not a process 
governed by commensal bacteria, it is possible to envision a scenario where loss of 
commensal bacterial species crucial in the breakdown and release of a metabolite with 
immunomodulatory function would result in shifts in immune homeostasis. Indeed, short 
chain fatty acids (SCFA), metabolic byproducts of fermentation of dietary fibers by 
commensal bacteria, can bind to the G-protein-coupled receptor 43 that is expressed on 
immune cells (Brown et al., 2003; Le Poul et al., 2003) and can limit inflammatory 
responses (Maslowski et al., 2009). GF mice, which cannot produce SCFA due to loss of 
commensal microbes (Hoverstad and Midtvedt, 1986), do not have this 
immunoregulatory mechanism and are more susceptible to chemically-induced intestinal 
inflammation (Maslowski et al., 2009). Further studies are needed to understand how 
disruption commensal bacterial communities are interwoven with changes in metabolism 
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in order to tease apart the precise mechanisms of action used by commensal bacterial 
communities to influence the immune system.  
5.7 Concluding remarks 
This thesis demonstrates the importance of commensal bacteria-derived signals in 
regulating antiviral immunity. In the absence of commensal bacteria-derived signals, the 
immune machinery for antiviral defense, while functionally intact, may lay dormant, 
waiting for activating signals to initiate it into action. This passive state can prove to be 
dangerous to the host if the invading pathogen can establish a replicative advantage 
before the host organism’s immune system is activated to respond. Evolutionarily 
speaking, it would be beneficial for an organism to have its immune system in a state of 
constitutive readiness, producing anti-pathogen factors to prophylactically prevent 
infection and ensure the organism’s fitness for survival and reproduction. Two obstacles 
lie in the way of this strategy. First, continuous expression of immune response genes 
would exact a substantial metabolic burden on the organism and require diversion of a 
large amount of energy resources to sustain. Second, a prolonged fully activated 
immune response could only be tolerated for a certain period of time before eventually 
resulting in pathologic damage to the host’s tissues and organs. The immune system 
may have evolved to simultaneously overcome both of these obstacles by engaging with 
surrounding commensal bacterial communities and utilizing commensal bacteria-derived 
signals as an immuno-rheostat to calibrate itself for efficient and rapid responses to 
potential dangers while limiting energy consumption and exposure to potentially harmful 
immune responses. Using this kind calibration mechanism would give an organism a 
distinct evolutionary survival advantage by establishing basal protection against a threat 
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that has yet to be encountered and thus cannot be predicted, in terms of type, timing and 
location. Therefore, the immune system may have evolved to incorporate signals from 
commensal bacterial communities as part of its repertoire of host defense mechanisms, 
as important to host defense as any other arm of the immune system.  
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Figure  36.  (A)  Commensal  bacteria‐derived  signals  tonically  stimulate  macrophages  and 
initiate basal transcription of  IFN response genes (IRG). (B) Decreased commensal bacteria‐
derived  signaling  results  in  diminished  expression  of  IRGs.  (A,B)  Upon  viral  infection, 
macrophages conditioned by commensal bacteria‐derived signals  induce a rapid and robust 
response, while macrophages that have been deprived of tonic stimulation from commensal 
bacteria exhibit a delayed and impaired antiviral response. 
 
 
 
 
 
Figure 36. Commensal bacteria-derived signals calibrate the activation threshold 
of macrophages required for a rapid and robust antiviral immune response. 
 
  145 
Table 2. Top 50 relatively increased genes in CNV macrophages compared to ABX 
macrophages.  
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Table 2. Top 50 genes that are expressed at relatively elevated levels in macrophages 
isolated from naïve CNV mice compared to macrophages isolated from naïve ABX‐treated 
mice. Bold highlighted genes denote genes that are related to the IFN signaling pathway.  
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Figure 37. (1) Commensal bacteria may signaling via IECs or resident intestinal immune cells 
to  induce  constitutive  type  I  IFN  expression  that  can  be  secreted  into  circulation  and 
stimulate  peripheral  immune  cells.  (2)  Alternatively,  Commensal  bacteria‐derived  products 
could translocate  from the  intestine and directly stimulate  innate  immune cells  to produce 
low  levels  of  constitutive  type  I  IFN  that  induce  basal  transcription  of  IFN  response  genes 
(IRG).  
 
 
 
 
 
 
Figure 37. Potential models for commensal bacteria-driven constitutive type I IFN 
expression. 
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Figure  38.    Expression  of  constitutive  type  I  IFN  is  regulated  by  transcription  factors  relA 
(promoter) and IRF2 (repressor). Constitutive degradation of NFκB releases the relA subunit , 
which  translocates  into  the  nucleus.  relA  binds  to  the  Ifnβ  promoter  region  and  induces 
expression of  type  I  IFN.  Type  I  IFN  signaling  leads  to  the  formation of  the  IFN‐stimulated 
gene  factor  3  transcription  factor  complex  (ISGF3),  which  initiates  transcription  of  IRGs 
including IRF2, a transcriptional repressor of type I IFN. (A) Presence of both promoting and 
repressing  factors  can maintain  genes  in  a  state  of  dynamic  transcriptional  regulation  and 
may allow for faster or more efficient transcriptional induction upon activation by a primary 
inducer  (Viral  PAMPs)  compared  to  a  (B)  dormant  or  inactive  state.  Commensal  bacterial‐
derived  signals  may  influence  constitutive  type  I  IFN  expression  by  regulating  either 
promoter or repressor activation. 
 
 
 
 
        
 
Figure 38. Dynamic versus dormant transcriptional regulation of constitutive type 
I IFN expression. 
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